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ABSTRACT i
STUDIES ON SERUM SOMATOMEDIN ACTIVITY 
AND CARTILAGE RESPONSIVENESS 
IN THE REGULATION OF GROWTH
This thesis describes the results of experimental 
investigation of aspects of the endocrine regulation of growth 
in the rabbit, rat and man. In particular the role of serum 
somatomedin and cartilage responsiveness to somatomedin have been 
examined. Throughout a relationship between the physiological 
control mechanisms, namely the stimulus and the degree of end- 
organ responsiveness, and the velocity of growth has been sought.
A longitudinal growth study of 69 New Zealand White rabbits 
between birth and adulthood provided data on the body weight, body 
length and 16 radiologically determined skeletal dimensions. In 
all respects female rabbits are larger than males from birth, or 
shortly thereafter, and remain so throughout life. A new 
mathematical approach to the analysis of longitudinal growth 
data has been developed and validated.
Serum somatomedin was measured by the porcine cartilage 
bioassay method in a cross-sectional study of rabbits at 
intervals from the intrauterine age of 23 days postcopulation (PC) 
to adulthood. The serum level rises from the youngest age studied 
to a plateau that begins between 100 and 150 days PC. No 
difference between male and females was found.
Cartilage responsiveness was measured in vitro in rabbit
costal cartilage in a cross-sectional fashion at intervals from
the intrauterine age of 15 days PC to adulthood. The uptakes of 
35 3S-sulphate and H-thymidine were used as indices of 
responsiveness of the cartilage. It has been shown that the
Ill
response of the cartilage to serum somatomedin stimulation is 
primarily dependent on the age of the donor animal and not on 
the nature of the somatomedin stimulus. The degree of cartilage 
responsiveness is significantly correlated with velocity of the 
growth in length of the cartilage. Further evidence for an 
"inherent growth capacity" of cartilage was derived from the 
transplantation of rat costal cartilages into recipients of 
varying ages. It has been shown that the in vivo responsiveness 
of the transplanted cartilage is determined by the age of the 
donor animal and not that of the recipient.
Chondrocytes isolated from rabbit costal cartilage also
exhibited age-dependent characteristics in their rate of
3
incorporation of H-thymidine in culture. Experiments comparing 
the effect on thymidine incorporation by isolated chondrocytes 
of native and heated-acidified normal adult human serum suggest 
that such serum may contain somatomedin inhibitors.
Serum somatomedin has been measured in normal children 
under the age of 4 years and falls within the range of normal 
adults. Serum somatomedin is low in children with severe protein- 
energy malnutrition (PEM) and rises, but not always to normal 
levels, with recovery. Intravenous administration of growth 
hormone in children with PEM does not change the somatomedin 
level, neither at the time of admission to hospital, nor after 
recovery.
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CHAPTER 1
SCOPE AND OBJECTIVES OF THE THESIS
"Only begin and then the mind grows heated; 
only begin and the task will be completed."
Goethe
Growth is the hallmark of young animals. The features of 
growth and the factors that regulate it are the subjects of 
study of many disciplines. Ever since Von Bezold combined 
anatomical with chemical techniques in his 1857 publication 
on the composition of the tissues of the infant, the value of 
an interdisciplinary approach to the study of growth has been 
recognized. Yet as Tanner (1962) points out, few authors have 
ventured fully into the use of interdisciplinary methods.
The work of this thesis was planned to combine a 
somatometric, longitudinal growth study with an investigation 
of the role of somatomedin and cartilage responsiveness in the 
regulation of growth rate. This plan evolved when a general 
interest in growth, aroused by a study of Khoi children 
(Beaton 1969), focussed specifically on the endocrine 
regulation of growth. It was recognized that regulating 
factors operate on the velocity of growth, and that growth 
velocity is most effectively determined by longitudinal analysis.
In 1970, indeed as now, the precise nature of the endocrine 
control of growth in mammals was not understood. In particular, 
the role played by growth hormone (GH), although recognized to 
be of central importance, was an enigma. Prior to Salmon and 
Daughaday's discovery of a "sulphation factor" in 1956/7 it was
believed that GH exerted its growth-promoting effects by a direct 
action. Today two factors are known to be of major importance 
in determining GH stimulation of somatic growth; namely GH- 
dependent serum somatomedin (SM) activity and end-organ 
responsiveness. Somatomedin and its end-organs are the subject 
of an ever-increasing research interest. Of some 150 papers 
published in the field since 1957 more than half have appeared 
since 1970. Major reviews have appeared in the past 4 years 
(Daughaday 1971a;Grant 1972; Van den Brande 1973; Hall & Luft 
1974; Van Wyk et al. 1974).
The central question which this work attempts to answer is: 
'What are the relationships in normal, growing mammals between 
the velocity of growth, serum somatomedin activity and end-organ 
responsiveness?'
Chapter 2 discusses the nature of growth, its patterns and 
mechanisms. The important conceptual differences between growth 
and differentiation are described and a definition of growth is 
offered.
Chapter 3 examines the methods of describing and analysing 
growth, differences between cross-sectional and longitudinal 
analysis and the concept of physiological, as opposed to 
chronological, age. Growth characteristics of several species 
of mammals are described briefly.
In Chapter 4 selected aspects of the many factors that 
regulate growth are discussed. The interplay between endogenous 
and environmental factors is stressed. Special emphasis is 
placed on the role of GH in growth regulation, and this leads up 
to the key observation of Salmon and Daughaday on the mechanism 
of GH action on cartilage in vitro.
Chapter 5 reviews the present state of knowledge of SM.
The sulphation factor hypothesis is placed in its historical
3perspective. The bioassay systems currently used are critically 
examined and their respective merits contrasted. The recently 
developed radioreceptor and radioimmunoassays are described and 
compared to the bioassay. Physical properties, site of production 
and biological actions of SM are considered. The role of SM in 
the regulation of normal growth and in the causation of abnormal 
growth is explored. Finally the emerging concept of a family 
of growth-promoting peptides is discussed highlighting the main 
features of each of the potential family members.
The importance of the end-organ response in determining 
the outcome of hormone action is emphasized by placing it as a 
separate subject in Chapter 6. Current knowledge concerning 
changes in end-organ responsiveness, with particular reference 
to cartilage, is reviewed.
To examine relationships between growth velocity, serum SM 
and end-organ responsiveness, an animal model was necessary.
The rabbit was chosen for a number of reasons. The rabbit is 
well suited to growth studies as it has a reasonably short growth 
period of about 6 months;litters are usually large, mothers 
tolerate interference with the young and the young are robust 
(Sawin 1950, Adams et al. 1966). Added to these favourable 
characteristics there is the relatively large size of the rabbit 
which provides workable quantities of serum and cartilage, even 
from foetal and neonatal animals. Furthermore, no complete 
longitudinal growth study appeared to have been made on the rabbit 
at the time this work was started (Tanner 1971, personal 
communication). It was envisaged that the growth data in itself 
would make a valuable contribution. No work has been published 
on the serum SM of the rabbit nor on the characteristics of its 
costal cartilage response to SM. In summary, the rabbit on 
theoretical grounds appeared to be a suitable choice of experimental
model. Chapter 7 describes the stock characteristics, housing, 
breeding and rearing procedures for the rabbits. Rats were 
used for one section of the work and the important features 
of the rats used are described.
After establishing a satisfactory breeding colony of rabbits 
a longitudinal growth study of body weight, body length and 
radiographically determined skeletal dimensions was executed 
during 1971/2/3. Norms of body weight growth were readily 
established by manual analysis immediately on completion of the 
study. All other measurements, viz. the skeletal dimensions, 
required development of a computerized method of analysis.
Chapter 8 presents the method, results and discussion of the 
longitudinal study of rabbit growth.
Rabbits growing at the established normal body weight 
velocities provided serum and costal cartilage for the 
determination of serum SM activity and cartilage responsiveness. 
Perforce these studies were of a cross-sectional nature, extending 
from foetal to adult rabbits.
Chapter 9 describes the SM bioassay method used. The 
validation and quality control of the method are given in full 
detail. Results and discussion of the assays of the rabbit sera 
complete the chapter.
The in vitro cartilage response studies are described and 
discussed in Chapter 10. Costal cartilage from groups of rabbits
between the foetal stage and adulthood was assayed for its ability
35 35 3 3to take up S-sulphate ( S0^) and methyl- H-thymidine ( HTdr).
The cartilage was stimulated by both a serum pool derived from
the donor animals of the cartilage and by a standard reference
pool of human serum. Dose-response curves were obtained and
time-sequence studies performed.
5Cartilage was chosen as the end-organ in which to study
end-organ responsiveness for a number of reasons. Linear
somatic growth velocity is chiefly determined by the growth
velocity of cartilage (Daughaday 1971b). The cartilage response
to SM is the most fully documented tissue response, and therefore
comparisons between the rabbit and other species would be of
value. Cartilage is readily maintained in vitro, is resistant to
hypoxia and consists of only one cell type; all factors favourable
to in vitro determination of responsiveness (Daughaday & Mariz 1962).
Costal cartilage is far more readily accessible than epiphyseal
cartilage and therefore less prone to trauma and incomplete
sampling during dissection. There is evidence to suggest that
cartilage from different sites in the same animal behaves similarly
during incubation. Thus costal, xiphoid, nasal and epiphyseal
cartilage display quantitatively similar responses (Murphy et al.
1956; Salmon & Daughaday 1957; Herbai 1971a). Finally, the fates 
35 3of the SO^ and the HTdr taken up by costal and epiphyseal
cartilage have been well established and are the same for the
35cartilage from different sites. SO^ is incorporated into
chondroitin sulphate (Dziewiatowski et al. 1949; Dziewiatowski
3
1962; Katsura & Davidson 1966). HTdr is incorporated exclusively
into DNA (Cleaver 1967) and this rate of incorporation correlates
very closely with mitotic rate (Mitchinson 1971). The rate of
uptake of these two isotopes therefore indicates the rate of
35synthesis of cartilage matrix ( SO.) and the mitotic rate of
3 ^the growing cartilage ( HTdr).
In order to obtain further evidence for changes in end-organ
responsiveness during growth costal cartilages from growing rats
were transplanted into age-matched and adult rats. The uptake by
transplanted and recipient costal cartilage of intraperitoneally 
35 3administered SO^ and HTdr is reported and discussed in
6Chapter 11. By this method the SM stimulus was held constant 
in vivo and growth-related changes in cartilage responsiveness 
assayed.
Chapter 12 describes the isolation and short-term culture of
rabbit costal cartilage chondrocytes. The cells were stimulated
by normal serum and heat-treated serum. The dose-response
3
characteristics of their uptake of HTdr and changes in uptake 
related to the growth-velocity of the donor animal are reported 
and discussed.
While this was primarily a study of normal growth, it was 
recognized that pathological disturbances of normal function 
can shed light on fundamental processes. Aspects of serum SM 
activity have therefore been studied in children with protein- 
energy malnutrition which is characterised by growth retardation. 
Serial changes in serum SM and GH in children recovering from 
malnutrition and the effects of exogenous GH infusion on serum SM 
are reported and discussed in Chapter 13.
Chapter 14 summarizes the main conclusions of the thesis.
7CHAPTER 2
THE NATURE OF GROWTH
There is no better starting point for this chapter than 
Sir D'Arcy Thompson's (1917)comment on the nature of growth:
"a somewhat vague word for a very complex matter", for in the 
words of this great student of growth lies the first issue, the 
definition of terms.
To early writers growth was essentially a quantitative 
phenomenon, an increase in the size and mass of the body, to be 
distinguished from qualitative changes such as alterations in 
shape and function. Thus Davenport (1899) wrote that
"....  organic growth is an increase in volume, ....  it is not
differentiation" and was followed by De Beer (1924) stating that 
"growing implies getting bigger and this increase in size is 
what should strictly be termed growth .... Growth alone cannot 
be responsible for the process of development." The concept was 
thus introduced that growth and differentiation are two distinct 
processes which together contribute to the overall development 
of an organism (Needham 1942). As investigation progressed 
into understanding the subcellular mechanisms the distinction 
between the quantitative aspect of development, growth, and the 
qualitative aspect, differentiation, became blurred, leading 
J.Z. Young (1950) to suggest that "growth is the addition of 
material to that which is already organized into a living pattern." 
To this rather non-specific definition must be added the concept of 
differential growth in which several levels of organization may
8be embraced, and which implies that the two processes are not 
mutually exclusive, but may occur concomitantly in the same tissue. 
Thus at cell-tissue level a population of identical cells may 
divide more rapidly (grow) in one direction than in another, 
leading to a change in organ shape (differentiation); whereas 
at the organelle-cell level an increase in the number of 
mitochondria would both increase cell size and modify cell function.
2.1. A Definition of Growth
To date no universally accepted terminology has emerged.
The distinctions between growth and differentiation drawn earlier 
this century pervade common usage and understanding.
In this thesis growth is regarded as progress towards final 
adult size, in the course of which the differentiation of function 
and shape of the growing organism plays an integral, but not 
total, contributory and sometimes regulatory role. This concept 
has both phylogenetic and ontogenetic validity as Needham (1964) 
has extensively argued.
2.2. Mechanisms and Spatiotemporal Patterns of Growth
There are three fundamental mechanisms by which the growth 
of a multicellular animal occurs. In the first, the animal's 
growth may be the result of an increase in the number of cells as 
a consequence of mitosis; that is multiplicative (Huxley 1932) or 
hyperplastic growth. In the second, growth occurs as a result of 
increase in size of individual cells, without increase in number; 
that is auxetic (Needham 1942) or hypertrophic growth. Whereas in 
hypertrophic growth cell products accumulate intracellularly, in 
the third mechanism cell products are secreted into the extra­
cellular compartment causing an increase in size. This occurs in 
cartilage matrix for example, by accretion (Huxley 1932).
9In the rat (Winnick & Noble 1965, Enesco & Leblond 1962) 
and in man (Cheek 1968) the chronology of the respective 
contributions of these three processes has been demonstrated.
For the rat the sequence is as follows: in utero and up to the 
time of weaning growth occurs predominantly by hyperplasia 
(phase I); after weaning hyperplasia and hypertrophy contribute 
about equally (phase II); and as adult size is approached hyper­
plasia gradually ceases and hypertrophy and accretion continue 
(phase III) until growth is complete. In man events appear to be 
similar to those in the rat, but studies are limited to skeletal 
muscle. In the rat various organs pass through the three phases 
at different times. The brain, for example, passes through 
phases I and II very rapidly, whereas the heart reaches phase III 
much later, and even well after the lungs.
While these generalizations concerning the mechanism and 
timing of cellular growth are most useful, sight must not be lost 
of the fact that growth also occurs at other levels of organization; 
by increases in size and/or number. This may range from molecular 
and organelle replication on the one hand to the hyperplastic 
growth of histological units such as acini on the other (Goss 1966).
2.3. Limitation of Further Considerations to Mammalian Growth
Much of our understanding of the nature of growth is based 
on the observation and analysis of the whole spectrum of animal 
life, exemplified in treatises such as On Growth and Form 
(D'Arcy Thompson 1917) and The Growth Process in Animals 
(Needham 1964). The literature is vast and continues to burgeon. 
Therefore in order to contain these introductory chapters and to 
relate them to the experimental work, further considerations are 
limited, with a few exceptions, to selected aspects of mammalian 
growth.
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CHAPTER 3
THE DESCRIPTION AND ANALYSIS OF SOMATIC GROWTH
"Hoc iterum incrementum miro ordine distribuitur, 
ut in principio incubationis maximum est; inde 
perpetuo minuatur"
Haller
Our knowledge of the mathematical description and analysis 
of somatic growth is predominantly based on the large number of 
studies made on children this century, rather than on observations 
in other mammals (Tanner 1962). The pioneering work of Boas (1897), 
Crampton (1908) and numerous others since was crystallised by 
Tanner (1951) in a classic synthesis. This and later works 
(Israelsohn 1960 and Tanner 1962, for example) laid the foundations 
for a thorough understanding of the description and analysis of 
growth data.
The oldest published study of the growth of a child was made 
between 1759 and 1777 by Count Philibert de Montbeillard on his son. 
The animal stature measurements on the boy from birth to 18 years 
of age were expressed both as stature achieved each year, or 
distance, and stature gained each year, or velocity (Scammon 1927). 
This study illustrates two fundamental aspects of growth analysis: 
the difference between cross-sectional and longitudinal studies and 
the relative merits of velocity and distance data. These aspects 
are discussed further.
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3.1. Cross-sectional and Longitudinal Studies
The Count's son was measured repeatedly over his entire post­
natal growth period. This longitudinal method contrasts with the 
alternative cross-sectional method, whereby groups of children of 
different ages are each measured only once.
The two methods have their individual merits, but the 
important difference is that they do not give the same information 
and cannot be analysed in the same way. Cross-sectional studies 
are more easily and more rapidly completed, and give the necessary 
information to construct clinical standards, stature attained by 
normal children at given ages, for example (Tanner & Whitehouse 1959). 
Of necessity, longitudinal studies take many years to complete but 
yield the vital information on the velocity of growth with far fewer 
subjects than a cross-sectional study would yield with an equal 
degree of accuracy (Shuttleworth 1937). Longitudinal studies are 
essential, however, for the derivation of the variability of 
velocity, which is often of prime importance in the clinical 
assessment of growth (Tanner 1952). The not inconsiderable 
difficulties of obtaining an adequately large pure longitudinal 
sample result in many surveys becoming mixed longitudinal; that 
is, where not all subjects are followed for the specified period 
and are replaced by others entering during the course of the survey. 
Although formulae are available to permit the analysis of mixed 
longitudinal data, Tanner (1962) points out that it is frequently 
simpler to extract and report the pure longitudinal element. The 
growth data in this thesis are of a mixed longitudinal nature 
(Chapter 8).
3.2. Distance and Velocity Descriptors
While the distance curve of the Count's son's growth yielded 
a picture to be found on the doorposts of many homes, namely a
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steady progression towards adult size, it was the velocity curve 
that showed the biologically significant features of his growth.
Like all normal children his growth velocity steadily decelerated 
from birth to about the age of three years, was fairly stable until 
12 years and underwent the characteristic adolescent growth spurt 
from 12 to 16 years of age. These changes in velocity, both 
positive and negative, are far more closely related to the under­
lying regulatory mechanisms and associated physiological and 
psychological changes than the distance achieved. Growth is a 
form of motion, and motion is clearly best characterized during 
progress, that is by velocity rather than by the final result; 
that is distance achieved.
Two further descriptors should be mentioned although their 
use has been minimal and the additional information they yield 
appears to be small (Tanner 1951). They are acceleration, which 
bears the same relationship to velocity, as velocity does to 
distance, and specific growth rate or multiplicative velocity.
The specific growth rate relates velocity to the size of the growing 
organism and, for man at least, shows parallelism with the ordinary 
velocity curves and therefore yields no further information.
3.3. Growth Curves
Since growth is a form of motion it may be subjected to 
precise (often over-precise?) mathematical analysis. Curves may 
be derived deductively and compared to observed points to test 
hypotheses, or they may be empirically fitted. The constants in 
the resulting polynomials must have biological meaning. There is 
no value in an nth-termed, perfectly fitting equation in which no 
interpretation can be placed on the constants. The fundamental 
assumptions that must be made to permit curve fitting are not yet 
fully settled on biological grounds. To obtain a curve that 
describes a given population of individuals for comparison with
other populations, or as a standard against which individuals may 
be judged, a mean-constant curve must be derived (Merrell 1931). That 
is to say, the average curve must be derived from the individual 
curves, separately fitted, and not from the averages of individual 
measurements.
Whatever the nature of the functions derived all must recognize 
the essentially continuous nature of growth and changes in velocity 
that occur during the growth period. Consideration of the extensive 
literature (Medawar 1945; Israelsohn 1960; Kowalski & Guire 1974, 
for example) on this subject is beyond the scope of this thesis.
3.4. Chronological and Physiological Criteria
Individual animals, including man, vary considerably in the 
degree of physiological development achieved at the same 
chronological age. Thus one rabbit of 15 days of age may weigh 
200g whereas another of the same strain, sex and nutritional status 
may weigh 250g. Alternatively one girl of 13 years may have passed 
her menarche, while another of that age has yet to reach this 
milestone. Crampton (1908) was one of the first to realise this 
phenomenon and introduced the term physiological age. The need 
for clearcut criteria of physiological age (also known as 
developmental maturity) has been increasingly recognized as the 
endocrine,biochemical and physiological aspects of growth have 
been explored.
Several systems of assigning physiological age have been 
developed. These have been developed mainly for clinical use and 
include:
Skeletal Age. To date this is the most widely used method 
for estimating physiological age. It is based on the radiological 
assessment of the numbers and shape of ossification centres in the 
hand and wrist (Greulich & Pyle 1959) or less commonly in the
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hemi-skeleton. The use of skeletal age in paediatric endocrinology 
is well established (Mellman et al. 1959), but exactly what its 
endocrine control is and what its relationship is to other measures 
of physiological age is not yet established. Other than man full 
skeletal age standards are available only for the rat (Hughes & 
Tanner 1970b).
Dental Age. Dental age is based on the same principles as 
skeletal age, namely, the stages of formation and eruption of each 
tooth. In areas other than orthodontic practice its greatest 
value lies in the fact that it appears to be predominantly 
genetically determined, with environmental factors playing a small 
role (Tanner 1962). Animal studies are very limited in this field.
Morphological Age. The size of the whole or parts of the 
growing animal is the most extensively studied aspect of 
physiological age in many species. Thus body length or weight, 
head length or facial breadth, femur length or leg circumference, 
and so on are well documented. One of the problems in evaluating 
these gross characteristics is that each in turn consists of 
several components. The leg circumference, for example, encompasses 
bone, muscle and fat compartments and each of these may have 
different growth rates. For certain situations the study of the 
growth of one of these component parts may be the most appropriate, 
or it may be their allometric relationship that is revealing 
(Huxley 1932).
When sizes of one component are measured simultaneously in two 
or three dimensions (Hiernaux 1968) or in the same dimension of 
several different components, shape and shape changes are assessed. 
The full potential of the concept of shape age has yet to be 
developed.
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Sexual Age. In view of the evolutionary significance of the 
age of achievement of reproductive ability the development of the 
sex organs and the outward pubertal manifestations in the secondary 
sex characteristics are of great importance, even though limited 
to a relatively brief period of the growth period. Testicular 
descent and vaginal opening in rats and breast development, pubic 
hair and genital development in man are biologically useful criteria 
which can be clearly related to sex steroid secretion and changes 
in end-organ responsiveness.
Functional/Metabolic/Biochemical Age. The preceding four 
categories of physiological age are all based on classical 
somatometric and somatoscopic techniques. To an increasing extent 
in the future physiological age will be assessed on functional, 
metabolic and biochemical criteria. The value of these approaches, 
which admittedly do not always span anything like the whole growth 
period, is exemplified in such studies as those on lung age in 
rabbits (Taeusch et al. 1972; Avery 1974), cartilage composition 
(Meyer 1969) and urinary creatinine excretion (Novak 1963).
Almost all functional age studies suffer from not being 
longitudinal in nature; from the labile nature of physiological 
measures compared to the stability of morphological measures and 
the error of reporting the few longitudinal studies in a cross- 
sectional fashion (Tanner 1962). Nevertheless, it must be 
recognized that many physiological studies are still contingent 
on invasive techniques that are incompatible with subsequent normal 
growth or on the sacrifice of the experimental animals, and are 
therefore cross-sectional. This is a problem encountered in this 
thesis, and as in other work there is no alternative at the present 
time.
3.5. Comparative Growth Studies
Growth studies in animals other than man are attended by a
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number of difficulties that make execution, interpretation and 
inter-specific comparisons difficult.
The technique of measuring animals is largely undeveloped 
and only recently fully described and evaluated for the rat 
(Hughes & Tanner 1970a). Animals have fur and also they cannot 
cooperate like children. The realization of standardized, optimum 
nutritional, housing and breeding conditions is difficult, expensive 
and plagued by lack of data on species and strain-specific optimum 
conditions. Littersize is an important determinant of pre- and 
post-natal growth rates because of insufficiency of uterine vascular 
supply (Eckstein et al. 1955) and shortage of milk for large litters 
(Schultze 1954). Furthermore weaning in laboratory animals often 
occurs around a time of peak growth velocity and may therefore 
have a greater effect than the equivalent event in man (Tanner 1962). 
Many laboratory animals have high morbidity and mortality rates, 
rendering pure longitudinal series difficult to achieve, and then 
leaving open the question as to whether these animals represent 
the norm. Lastly, the shorter lifespan of laboratory and domestic 
animals compared to man renders many species more subject to 
seasonal fluctuations in growth.
These difficulties have made good quality (as defined earlier) 
growth studies the exception, with that on the rat by Hughes and 
Tanner (1970a; 1970b) standing out as a model for future work.
Data is available, chiefly for body weight, in several species 
other than man (summarized in Tanner 1962). These species may be 
divided into two groups: the primates, which appear very similar 
to man, and the non-primates, a group including mice, rats, rabbits, 
guinea-pigs, cows and sheep.
In man, chimpanzees and Rhesus monkeys birth occurs after the 
peak in weight growth velocity. In the non-primates birth occurs
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shortly before the weight peak in guinea-pigs and sheep, and some 
considerable time before in rabbits, mice, rats and cows.
Comparisons in terms of weight velocities may not be the most 
appropriate. In the rat, for example, peak weight velocity occurs 
some two weeks later than peak length velocity (Hughes & Tanner 1970a). 
This phenomenon also occurs in the rabbit, as will be shown in 
Chapter 8. For truly meaningful comparisons some type of overall 
developmental scoring system is required, such as that of Otis &
Brent (1954), based on development of all organ systems in the mouse 
and man.
The differences between primate and non-primate are far more 
evident when the position of puberty, rather than birth, is examined 
in relation to growth rate. The primates attain puberty relatively 
much later than non-primates and undergo the adolescent growth spurt 
at this time. During this spurt the peak weight velocity may 
approach that of the intra-uterine peak. Although it is not nearly 
as dramatic as in man, there is some suggestion that the rat shows 
a pubertal growth change in that the decline in velocity of most 
linear measurements shows a diminution at or slightly after puberty 
(Hughes & Tanner 1970a).
A review of the details of published growth studies in the 
rabbit is-given in Chapter 8.
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. THE REGULATION OF GROWTH
CHAPTER 4
"The very molecules appear inspired 
with a desire for union and growth."
John Tyndall
A consideration of the factors and mechanisms regulating the 
rate of growth is constrained by the levels of organization that 
are examined. Ultimate control is centred in the genes through 
protein synthesis by replication, transcription and translation. 
Mitosis, tissue and organ growth and finally overall organism 
growth are the several levels at which further controls may be 
effected. This is a vast field and only a few topics germane to 
the overall theme of this thesis are elaborated.
4.1. Genes
Following gastrulation genes become progressively derepressed 
and their actions manifest, although our understanding is still 
largely based on accidents of nature rather than on normal 
development. Genes contribute to the regulation of early and late 
organogenesis (Danforth 1930) and also to the rate of early 
embryonic growth (Castle & Gregory 1929). The observations of 
Castle and Gregory are of particular interest to this thesis in 
that they were made on rabbits. They compared the ova, blastocysts 
and embryos of the large Flemish giant with those of the small Polish 
strain. In both strains ova were of the same size, but in the 
Flemish giant embryos cleave more quickly than in the Polish so that 
by 6 days the Flemish giant blastocyst is 47,8 ^ um in diameter
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compared to the Polish 40,5 yum. This differential rate of growth 
persists through foetal and postnatal growth with the smaller 
strain retaining a lower growth rate and stopping growth earlier 
than the larger strain (Castle 1931).
In man the genes on the Y chromosome are responsible for the 
sex differences in skeletal development. These genes retard male 
skeletal age, thus permitting a longer growth period and therefore 
greater male size (Tanner et al0 1959).
4.2. Organ and Tissue Growth
Theories of regulation of organ and tissue growth include 
auto-inhibition, exogenous stimulation, local self-control and 
systemic overall control.
Weiss (1955) and Bullough (1965) have explored the role of 
inhibitory substances being produced by the organs whose growth 
they control, postulating an intrinsic growth capacity that is 
auto-inhibited. Opposing this concept of local control is that 
of a central regulator, possibly in the brain, that monitors and 
controls the growth of other tissues (Tanner 1963). Systemic 
control undoubtedly exists through endocrine, vascular and 
neurotrophic mechanisms, but how these factors relate to local 
physical and chemical factors is not clear.
In addition to these theories there are two factors that 
contribute to regulation. The one is a degree of genetic 
predetermination of size and growth rate. This genetic component 
has phylogenetic significance and is independent of transient 
environmental influences. The other basic determinant of organ 
and tissue growth is the functional demands made on the structure. 
This force can clearly operate only once the structure has reached 
a critical size so as to be able to function and respond to feed-back,
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and so is superimposed on genetic and other control systems 
(Goss 1964).
4.3. Special Features of Local Regulation of Skeletal Growth
The great majority of our understanding of the local regulation 
of skeletal growth is derived from studies on long bone growth, 
whereas much knowledge of the endocrine and metabolic regulation 
derives from studies on cartilage from other sites, especially the 
costal region. A brief summary of the local factors influencing 
local bone growth is therefore included at this point and 
endocrine regulation is the subject of Chapter 5.
There is good evidence that the epiphyseal plates at each end 
of the long bones grow at rates determined by the local 
compression forces; growth being inversely related to longitudinal 
compression (Arkin & Katz 1956). Tension in the epiphyseal plate 
is also regulated by the overlying periosteum, which exerts a 
negative feed-back reaction force in response to being stretched 
by the proliferating underlying cartilage (Moss 1972).
4.4. Environmental Factors
Wolanski (1970) has stressed that writers frequently err by 
drawing too clear a distinction between genetic and environmental 
factors in the regulation of growth. The interface is usually 
blurred and little purpose is served by regarding factors as 
purely "nature" or purely "nurture", as it is the interplay of 
these factors and the adaptive responses of the organisms that 
are important.
In this context nutrition, day-length, ambient temperature, 
exercise, psycho-social environment and disease are relevant 
considerations in this thesis.
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Nutrition. The consequences of undernutrition and mal­
distribution of dietary constituents have long been recognized 
in man (Howe & Schiller 1952) and in animals (Acheson &
MacIntyre 1958). The effects of malnutrition are dependent on 
the phase of development during which it occurs and this phenomenon 
has been well documented in the rat (Widdowson & McCance 1960).
For laboratory and domestic animals the question of optimal 
nutritional conditions has already been alluded to above, and has 
been well-known for many years (Dunn et al. 1947). The only 
solution at present lies in carefully monitoring and reporting 
dietary constituents, feeding procedures and the resulting 
clinical and/or growth status of the animal colony.
Day-length. The stunting of rat growth following optic 
enucleation was shown by Browman in 1940. This and other evidence 
has been adduced to suggest that the seasonal fluctuations in 
growth of children are at least in part due to day-length 
(Marshall & Swan 1971). In chickens long hours of exposure and/or 
high intensities of illumination retard weight gain (Winchester 1964). 
In laboratory growth studies regular dark-light periods must there­
fore be maintained throughout the year.
Ambient Temperature. All other factors being equal extremes 
of ambient temperature retard growth in chicks (Brody 1945), cattle 
(Ragsdale et al. 1957) and rabbits (Johnson et al. 1957). The 
observations on rabbits provide yet another example of sexual 
differences in response to stress during growth in many species; 
the female always being more resistant (Tobias 1970; Williams 
et al. 1974). The body weight, body length and heart circumference 
of male rabbits reared at 28°C were 30% smaller than those reared 
at 9°C, whereas in the females there were no significant differences. 
Temperature plays an important role in determining the breeding 
patterns of rabbits as many strains have a low fertility during
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hot summers and cold winters (Sawin 1950). An ambient temperature 
of 10°C to 19°C seems generally accepted as the optimum for rabbit 
production (Portsmouth 1962), although no definitive studies appear 
to have been done.
Exercise. Few firm conclusions can be drawn about exercise
per se and its effects on growth (Tanner 1962). Whether it is
reduced exercise that is a contributing factor to the reduction
in growth that accompanies crowded living space is not clear in
mammals. In continuously exercising animals, such as fish, reduction
in opportunities for locomotion stunts growth (Brown 1946). The
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recommended floor surface area for rabbits is 0,23m /kg body weight 
(Adams et al. 1966).
Psycho-social Environment. Although the experimental evidence 
does not seem to be available for animals, the human growth response 
to an adverse psycho-social environment probably has analogies in 
other species. The classic observations of Widdowson (1951) showed 
that a congenial, loving atmosphere is more conducive to a child's 
growth than a rigid, hostile one, with other factors, including 
nutrition, being equal. Thus the handling and other environmental 
influences, such as noise and frequency of attendant's visits, to 
which animal colonies used for growth studies are exposed should 
be kept uniform, at least on theoretical grounds.
Disease. As in the previous paragraph, most experience 
concerning the effects of disease is based on human data. This is 
probably because animal studies are usually directed towards 
describing the normal situation, with diseased animals being 
excluded. In man acute illnesses, such as the exanthemata, have 
no detectable effect on growth (Tanner 1962). Chronic illness, such 
as congenital heart disease, retards somatic but not necessarily 
intellectual growth (Drash & Money 1968). Correction of the disease 
process results in varying degrees of "catch-up" growth depending
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on the duration, severity and timing of the period of retardation 
(Tanner 1970).
4.5. Hormones and Their Target Tissues, with Special 
Reference to Growth Hormone.
The evolution of the thyroid hormones provides a clear 
illustration of the importance of examining hormones and their 
target tissues as an integrated complex so as to obtain an under­
standing of the control processes involved. Iodothyronines, for 
example, are present in biologically active forms as early in 
evolution as the protochordates and have remained unaltered in 
molecular structure into the most recent vertebrates (Salvatore 1969). 
These millenia of molecular stability plus the wide range of 
metabolic activities that the molecules initiate and control, 
exemplified by the host of processes under thyroid control in 
anuran metamorphosis (Eaton & Frieden 1969), imply that it is 
often the target tissues that are the major determinants of the 
outcome of hormone action. This role of the target tissues has 
just as much ontogenetic significance as it has phylogenetic 
significance (Barrington 1971), and therefore the function of the 
end-organ in the regulation of growth is examined further in 
Chapter 6.
Most of our current knowledge of the endocrine regulation of 
normal growth is derived from naturally occurring or experimentally 
induced hormone deficiencies or excesses and the resulting growth 
abnormalities. This somewhat paradoxical situation is reflected 
in the space allocated to a consideration of the role of normal 
hormone secretion during normal growth in two major paediatric 
endocrinology texts. Hubble (1969) devotes approximately three in 
492 pages in his Paediatric Endocrinology and Wilkins (1965) two in 
619 pages in The Diagnosis and Treatment of Endocrine Disorders in 
Childhood and Adolescence to this subject. Accordingly much of the
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remainder of this chapter is based on pathological, rather than 
physiological, observations on growth hormone.
4.5.1. Growth hormone.
The importance of the pituitary gland in growth regulation 
was recognized at the beginning of this century when adenohypophyseal 
abnormality was linked to dwarfism and gigantism. In his book on 
the pituitary and its disorders Harvey Cushing (1912) suggested 
that the 'hormone of growth' was either over-secreted or under­
secreted by the pituitary in states of abnormal growth. Evans and 
Long (1921) and Smith (1930) conclusively demonstrated a pituitary 
growth factor by producing gigantism in rats injected with anterior 
lobe extracts. These observations were developed into the 
hypophysectomised rat tibial epiphyseal plate bioassay for GH 
(Evans et al. 1943; Greenspan et al. 1949); this was an improvement 
on the 10 day body weight gain test (Marx et al. 1942). The molecule 
responsible for this cartilaginous proliferation was then purified 
and isolated (Li & Evans 1944) and has subsequently been fully 
characterized in several species (Grindeland & Ellis 1966; Li 1972).
A peptide with GH-like activity has been synthesized (Li & Yamashiro 
1970) but a fully active "core" of the natural molecule has not been 
identified (Kostyo 1974).
Growth hormone has a wide array of metabolic and anabolic 
actions. The metabolic actions involve carbohydrate and fat 
metabolism. They are related to the anabolic, or growth-promoting, 
actions on nucleic acid and protein synthesis insofar as the metabolic 
effects are protein-sparing. Much controversy still remains 
concerning the exact nature and mechanism of GH-induced metabolic 
events. The problem lies in the differences between acute and chronic 
administration, in vivo and in vitro observations and results obtained 
in hypophysectomised and normal animals (Turner & Munday 1975).
A detailed consideration of the actions and regulation of GH is beyond 
the scope of this thesis, but some points are noted for comparison with 
somatomedin.
In liver and muscle from hypophysectomised animals GH 
stimulates both amino acid uptake and protein synthesis in vitro 
(Hjalmarson 1968; Clemens & Korner 1970; Kostyo 1968), whereas in 
muscle from normal animals only synthesis is stimulated (Reeds 
et al. 1971). Insulin stimulates both amino acids uptake and 
protein synthesis in normal muscle, but in muscle from 
hypophysectomised animals its effects on protein anabolism are 
minimal (Korner 1965). Furthermore, insulin and GH act 
synergistically on protein synthesis in normal muscle in vitro 
(Reeds et al. 1971). In vivo GH causes nitrogen retention in 
normal and hypopituitary subjects, with the earliest evidence of 
its effects being an increase in intracellular amino acids 
(Riggs & Walker 1960) and increased activity of liver Mg - activated 
DNA-dependent RNA polymerase (Janne & Raina 1969). These effects 
begin within one hour of administration of GH. The protein anabolic 
effects of GH act in the same direction as those of insulin and 
the two hormones are mutually interdependent in the feed-fast 
cycle for protein homeostasis.
In contradistinction, the actions of GH on carbohydrate and 
fat metabolism are opposite to those of insulin. In vivo GH 
results in glucose intolerance and mobilises free fatty acids, 
although there is a very transient fall in blood glucose and free 
fatty acids with intravenous administration (Bornstein et al. 1968). 
In general, during fasting GH preferentially induces fat rather 
than glycogen utilization, and this is probably a protein-sparing 
manoeuvre as it decreases the need for gluconeogenesis (Glick 1969). 
Paradoxically, in vitro GH enhances glucose uptake in fat cells 
from hypophysectomised animals, but this effect is blocked by 
pretreatment with GH (Goodman 1965), and is therefore probably 
not physiologically relevant.
Growth hormone secretion is regulated by neural, hormonal 
and metabolic factors (Hunter 1972; Martin 1973). Stress,
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exercise and slow-wave sleep result in bursts of secretion. In 
addition other apparently spontaneous day and night-time secretory 
peaks may occur and may be related to an underlying neural rhythm 
(Goldsmith & Glick 1970). A multiplicity of metabolic factors 
also influence secretion. Physiologically it is apparent that 
carbohydrate shortage stimulates and excess inhibits GH secretion.
A variety of acute stimuli provoke secretion and these include 
insulin hypoglycaemia and arginine, 2-deoxy-D-glucose and L-dopa 
infusion.
Control is mediated by two hypothalamic hormones, namely 
GH-releasing hormone (Schally et al. 1967) and somatostatin 
(Brazeau et al. 1973, 1974; Hall et al. 1973). In addition to 
the established short feed-back loop of endogenous GH inhibitory 
auto-regulation (Hagen et al. 1972), a long feedback loop of SM 
inhibition has been postulated (Tanner 1972), but as yet there is 
no experimental evidence to support this. In fact, in the 
admittedly unphysiological situation of protein-calorie malnutrition 
where GH is elevated and SM depressed, this inverse relationship 
does not hold strictly during recovery with adequate feeding 
(Grant et al. 1973; Chapter 13 of this thesis).
One of the major difficulties in evaluating GH secretion is 
the wide and rapid fluctuations that plasma levels undergo during 
a 24 hour period. These fluctuations mean that single determinations 
of plasma levels are of comparatively little value and that 
secretory rates should ideally be measured. But because GH, like 
other peptide hormones, is degraded very rapidly to unidentified 
products in the body the precise secretory rates cannot be 
determined with certainty. The metabolic clearance technique 
gives a half-life of human GH of 27 minutes in adult and 17 minutes 
in rabbits (Parker et al. 1962), suggesting a turnover of 5mg/day. 
Continuous venous sampling methods have yielded somewhat lower 
secretory rates of 0,5 - l,0mg/day (Frantz et al. 1969; Kowarski 
et al. 1971)
Although the association between growth and growth hormone 
has been recognized for over 60 years its exact role in regulating 
normal growth is still far from clear. The growth regulating role 
of GH is most easily considered during two phases: the intrauterine 
or antenatal phase and the postnatal phase of growth.
In 1947 Talbot and Sobel suggested on the basis of clinical 
observations in man that GH may not play an important function in 
growth during the first year after birth, and that growth occurred 
because of a carry-over of an intrauterine intrinsic growth capacity. 
While this view that human intrauterine growth proceeds independently 
of GH control has persisted largely unaltered until recently, 
there is good evidence concerning a definite role for GH in some 
mammalian species and little or no role in others. Evidence for 
a number of species will be reviewed.
Rat. Jost (1954) showed that decapitated foetal rats weighed 
5 - 15/S less than normal littermates, whereas brain aspiration, 
leaving the pituitary intact but removing the hypothalamus, results 
in 25 - 30% weight reduction (Swaab & Honnebier 1973). These 
ablation experiments must be interpreted with caution as radio­
immunoassay studies reveal the first appearance of GH on the 19th 
day of gestation (Birge et al. 1967). Jost decapitated his foetuses 
at 15 - 18 days and Swaab and Honnebier theirs at 18 - 19 days.
Equal circumspection must be applied to studies of pituitary 
content and concentration of GH, for these parameters simply 
reflect the nett balance of synthesis and secretion at one moment 
in time. Pituitary concentration rises from birth to approximately 
80 days of age (Dickerman et al. 1972), although Birge et al. (1967) 
report a continuing rise of male levels into old age. Plasma GH 
levels steadily increase from 21 to 64 days of age with no sex 
differences (Dickerman et al. 1972). In vitro culture of pituitary
glands has demonstrated that adult male pituitaries synthesize and
and release more GH than young male pituitaries, which in turn 
release more than weanling pituitaries(Burek & Frohman 1970). 
Pituitary GH synthesizing ability is inversely related to rat 
growth velocity. This illustrates the point that if GH 
secretion is causally related to growth velocity, then both 
secretory rate and utilization rate must be considered when 
evaluating this relationship.
Rabbit. Decapitation of rabbit foetuses on the 19th or the 
23rd day of gestation does not significantly reduce body weight 
at 28 days gestation (Jost 1961, 1966), but does affect some 
pituitary target organs such as the thyroid which is reduced in 
weight (Bearn 1966).
Cattle. Ablative techniques have not been applied to the 
foetal calf, but spontaneous apituitarism in Guernsey cattle is 
associated with marked retardation of growth in utero (Kennedy 
et al. 1957). In Holstein bulls, neither plasma nor pituitary GH 
concentration were closely correlated with specific growth rate of 
body weight between birth and 12 months of age (Purchas et al. 1970).
Sheep. Destruction of pituitary function by either electro­
coagulation (Liggins & Kennedy 1968) or stalk section (Liggins 
et al. 1973) results in foetal growth retardation. Measurements 
of plasma GH in the foetal lamb show no correlation with growth 
rate and fall rapidly at birth (Bassett et al. 1970). GH appears 
for the first time in the foetal pituitary at 50 days in the 147 
day gestation period (Stokes & Boda 1968).
Rhesus monkey. The only study of experimental hypopituitarism 
appears to be that of Chez et al. (1970). These workers implanted 
a Yttrium-90 source in the pituitary and measured birth weights. 
Although mortality was high and numbers small these authors 
concluded that foetal hypophysectomy had no effect on birth weight.
Pig. Pituitary GH content has only been measured by bioassay 
(Baird et al. 1952; Nalbandov 1963). These workers have shown 
pituitary GH concentration to be greater in a strain of rapidly 
growing pigs than that in a slower growing strain. Serum GH 
levels fall with increasing age, weight and length (Siers & Hazel 1970).
Man. Some light has been shed on the role of the human 
pituitary and hypothalamus by studying the various anomalies of 
development and function that occur. In all, except isolated GH 
deficiency, the cause of the maldevelopment may have direct, 
nonendocrine effects on the growth of the foetus, unrelated to the 
coincidental pituitary defect; thus caution must be exercised in 
concluding a causal relationship.
Spontaneous foetal decapitation by amniotic bands (4 documented 
cases) and apituitarism (4 documented cases) is usually associated 
with normal birth weight (Reid 1960; summarized in Liggins 1974).
In these cases adrenal and thyroid gland hypoplasia confirmed 
that the adenohypophyseal function was deficient. Many authors 
have long held that the human anencephalic achieves normal length 
and weight at term (Rimoin et al.1968). A recent careful assess­
ment of 122 anencephalic foetuses showed at 30% reduction in 
weight velocity in anencephalics compared to normals (Honnebier 
& Swaab 1973) and another study showed a 25$ weight reduction 
in anencephalics at 40 weeks gestation (Liggins 1974). Further 
evidence for abnormal growth in the anencephalic neonate is given 
by a quantitative histological study of the organs of 59 
anencephalic newborns (Naeye & Blanc 1971). In the 37 prematurely 
born infants all organs were subnormal in size and a diminished 
number of cells for gestational age. In the 22 term or post-term 
infants some organs were of normal size, but most had a diminished 
number of cells. The hypothalamus was absent in all these cases, 
but the pituitary was found in all those full-term infants in whom
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a careful search was made, but in only one of the premature 
infants. When found the anterior lobe ranged from one-tenth 
to one-half normal size and the concentration of acidophils 
was much lower than in the control infants. The finding of 
acidophils, at least in some cases, is in keeping with the 
detection of plasma growth hormone in anencephalics (Grunt & 
Reynolds 1970).
The anencephalic foetus, with multiple endocrine 
deficiencies, is a less suitable model for the study of GH 
dependent growth than the foetus with pure GH deficiency.
Laron and Pertzelan (1969) have shown that in both familial 
isolated GH deficiency and in the familial dwarfism with high 
GH levels syndrome (Laron et al. 1966a) the birth weights of 
12 of 14 cases were normal. It is of interest that 8 of the 14 
were significantly short at birth, suggesting that GH, if it 
plays any role, has a greater influence on skeletal than on soft 
tissue growth.
The human pituitary acidophils appear at about the 9th to 
10th week of gestation (Gitlin & Biasucci 1969) at which time 
the GH content becomes measurable by radioimmunoassay (Kaplan & 
Grumbach 1962; Matsuzaki et al. 1971). At this time GH can also 
be detected in the plasma (Kaplan et al. 1972). Pituitary levels 
rise to a term level of approximately l,5mg/gland.
Human GH does not cross the placenta (Gitlin et al. 1965; 
Laron et al. 1966b). Rimoin et al. (1966) report a GH-deficient 
mother bearing a GH-deficient infant of normal length and weight 
at term. Maternal GH therefore plays no direct role in foetal 
growth. Jost (1966) has reviewed the evidence for the action 
of maternally administered GH on the foetus and concludes that 
it has little or no effect.
Lastly, human placental lactogen must be considered. This
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peptide is synthesized by the placenta and has an amino-acid 
sequence very similar to growth hormone. At term umbilical 
venous serum has low levels compared to maternal serum and 
considerably higher concentrations are required for any 
growth-stimulating effects to be manifest (Kaplan & Grumbach 1965).
To summarize, the role of GH in the regulation of human 
foetal growth is probably significant when parameters such as 
cell number and size are considered and equivocal for parameters 
such as body length and weight. In other mammals such as the 
rabbit and monkey it appears to play no role, in rats a small 
role and in cows and sheep a significant role. However, all 
these studies have been based on body size, and observations 
on cell number and size are clearly needed before definite 
conclusions can be drawn.
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In contrast to the confusion surrounding GH, the role of 
thyroxine in intrauterine skeletal development is quite 
unequivocal. Deficiency retards bone maturation, but has a 
less clearcut effect on body weight. The human hypothyroidic 
foetus is larger than normal at term while the lamb is smaller 
than normal. This is probably because of a smaller placental 
transfer of thyroxine in the sheep (Fisher et al. 1964; Hopkins 
& Thorburn 1971). GH plays a permissive role for the growth- 
stimulating actions of thyroxine (Leblond & Carriere 1955).
In the postnatal phase of growth there is no doubt about 
the importance of normal GH secretion for normal growth. This 
statement is based, as in the antenatal situation, mainly on 
pathological and experimental situations; the exact relationship 
of postnatal growth hormone secretion to growth velocity is still 
far from settled.
By hypophysectomising rats at successive intervals after birth 
it was shown that growth rate declined, but did not cease after
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operation (Asling et al. 1950). Growth was restored by the 
injection of GH (Simpson et al. 1950). It is important to note 
that early hypophysectomy (6 days after birth) had less of an 
effect than late hypophysectomy (28 days after birth). In other 
words, factors regulating growth, other than GH, are relatively 
more important soon after birth than later in life. Identical 
conclusions can be drawn from Vezinhet's study on the rabbit (1968).
These experimental results are in agreement with observations 
on postnatal growth in GH-deficient children. Soon after birth 
grov/th retardation, although present, is slight and only becomes 
obvious at 2 or 3 years of age (Aarskog 1963). This progressive 
slowing of growth confused Seckel (1960) and caused him to conclude 
that GH was not necessary for normal growth in the first years of 
life after birth.
The postnatal ontogenesis of plasma GH levels is documented 
only in man. These measurements are beset by the difficulties 
of obtaining secretion rates and the lack of correlation between 
single plasma levels and secretory rate. All studies reported 
are cross-sectional. In the first year of life fasting levels 
are elevated above the subsequently similar prepubertal, pubertal 
and adult levels (Kaplan et al. 1968). The mean maximum rise in 
GH following insulin hypoglycaemia is three-fold higher in the 
adult (32,5ng/ml) than in the child (ll,5ng/ml) and appropriate 
sex steroid administration can convert the child's response to 
adult levels (Youlton et al. 1969; Abrams et al. 1971). At 
puberty GH response to hypoglycaemia is greater than during 
prepubertal growth (Kaplan et al. 1968). The work of Finkelstein 
and his colleagues(1972a) has provided the best evidence to date 
that GH secretion rate is related to growth rate. Both the mean 
24 hour secretion rate and the mean duration of secretory pulses 
were correlated with growth rate, but numbers were very small,
17 subjects ranging from 8 to 62 years of age, and the study was
cross-sectional. The half-life of GH in adults is about 25 
minutes and in children 12 minutes (Cornblath et al. 1965;
Glick et al. 1964).
The primate adolescent growth spurt (discussed in Chapter 3) 
is believed to be caused by increased androgen secretion, rather 
than by GH (Thompson et al. 1972) and although the spurt occurs 
in hypopituitarism (Rimoin et al. 1966), small amounts of GH 
appear to be necessary for this to occur (Scow & Hagan 1965).
In hypopituitarism GH and androgens act synergistically (MacGillivray 
et al. 1974) and in hypophysectomised rats GH and thyroxine act 
synergistically (Becks et al. 1946).
After all skeletal growth has ceased GH secretion and 
response to provocative stimuli persists, even into old age 
(Abrams et al. 1971), but its metabolic role is not clear. In 
the adult dog GH increases bone matrix turnover (Harris & Heaney 1969).
4.6. Concluding Remarks
This chapter opened with an heuristic quotation that suggested 
an underlying, inherent capacity for growth in the tissues of the 
living organism. The sections of the chapter have highlighted 
some of the numerous observations that have been made in efforts 
to understand the processes that regulate growth. It is 
abundantly clear that there is both a balance and an interplay 
between "nature" and "nurture". Within the organism controls 
exist at many levels - nuclear, cytoplasmic, intercellular, 
tissue, organ, hormonal, vascular and nervous and between each 
and all of these levels of control an intricate array of 
positive and negative feedback systems operates. A host of 
environmental influences act on, modulate and modify the internal 
controls. Ranging from physical influences, such as day-length 
and even gravity, through chemical factors, such as diet and 
air-pollutants, to psychological determinants, such as maternal
attitudes, these environmental influences must be excluded as 
far as possible when internal controls are being investigated.
The investigation of the enigmatic, often paradoxical, 
relationship between the so-called growth hormone and growth 
acquired a new dimension in 1957. In that year a new hormone 
that mediated the growth-promoting actions of GH was described 
(Salmon & Daughaday 1957). Subsequent studies sparked off by 
this discovery are now opening up an additional level of 
organization at which growth is regulated. The following 
chapter is devoted to a discussion of this new hormone and a 
family of associated hormones.
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CHAPTER 5 
SOMATOMEDIN
"I must apologise for sending you so an 
imperfect account of this substance .... 
it may induce others to examine the 
subject with more attention."
Dr. Bostock 1827
5.1. The Sulphation Factor Hypothesis
In 1957 Salmon and Daughaday showed that serum from GH- 
treated hypophysectomised rats stimulated the synthesis of 
chondroitin sulphate in cartilage in an in vitro incubation 
system, while serum from untreated hypophysectomised rats,
GH itself and a combination of both failed to stimulate synthesis. 
They postulated that a GH-dependent agent in serum was responsible 
for mediating the actions of GH on cartilage in vivo and named 
this agent "sulphation factor".
The work on which this hypothesis was based was preceded by
a number of important observations on cartilage sulphate
35metabolism. Dziewiatowski (1949) showed that S-sulphate was 
concentrated in the growing cartilage of young rats, and later 
showed that this concentration of sulphate was in the 
mucopolysaccharide, chondroitin sulphate (Dziewiatowski 1951; 
Dziewiatowski 1954). This sulphate incorporation into cartilage 
was then shown to be dependent on intact pituitary function, 
being drastically reduced by hypophysectomy, and restored by GH 
administration (Ellis et al. 1953; Denko & Bergenstal 1955).
Daughaday's laboratory examined the effects of hypophysectomy in
detail. In vivo uptake of radioactive sulphate fell progressively 
after hypophysectomy, reaching a nadir 20 days after operation.
Not only epiphyseal cartilage but also nasal septum cartilage was 
shown to actively take up sulphate in a GH dose-dependent manner. 
Most significantly, sulphating ability was shown not to be 
entirely specific to GH as thyroxine also stimulated sulphate 
uptake (Murphy et al. 1956).
These in vivo experiments were paralleled by in vitro work
on cartilage sulphate uptake. Layton demonstrated uptake of 
35S-sulphate by chondrosarcomatous tissue (1949) and chick
femoral cartilage (1950) in culture. In 1952 Bostrom and Mansson
35described a method for measuring S-sulphate incorporation into 
calf costal cartilage. It was a modification of this technique 
that Salmon and Daughaday used and developed into a formal 
bioassay (Daughaday et al. 1959).
The original sulphation factor hypothesis has been extensively 
examined and confirmed by others including Salmon (1960a; 1960b), 
Almquist (1960), Kogut et al. (1963), Hall (1970), Van den Brande 
et al. (1971) and Van Wyk et al. (1972).
The range of biological effects of sulphation factor has 
been shown to extend well beyond cartilage sulphation and to 
include' stimulation of thymidine incorporation into DNA 
(Daughaday & Rheeder 1966), uridine incorporation into RNA 
(Salmon & DuVall 1970a), proline incorporation into hydroxyproline 
of collagen (Daughaday & Mariz 1962), leucine incorporation 
into muscle and cartilage protein (Salmon & DuVall 1970b), 
glucose oxidation in fat (Hall & Uthne 1972) and to inhibit 
lipolysis (Underwood 1972). Purification procedures could not 
separate these activities into different molecular species. 
Therefore in 1972 the major workers in the field suggested a 
general term to replace the large number of different operational
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designations "sulphation factor", "thymidine factor" and so on.
The term suggested was "somatomedin"; "somato-" to connote the 
relationship with somatotrophin and also to the soma; and "-medin" 
to indicate that it mediates at least some of the actions of 
growth hormone (Daughaday et al. 1972). "Somatomedin" has now 
completely replaced "sulphation factor" in the literature.
5.2. Bioassay of Somatomedin
All current bioassay methods are modifications of the 
Salmon and Daughaday method (1957) which was based on the active 
incorporation of radioactive inorganic sulphate into chondroitin 
sulphate of cartilage in vitro.
As in all bioassays samples of serum (or plasma) of 
unknown, or relatively unknown, potency are compared with a 
standard preparation. For the purposes of the assay it is 
assumed that the unknowns differ only quantitatively from the 
standard. That is to say, it is assumed that the unknowns 
behave as dilutions, or concentrations, of the standard. Tests 
of this assumption, parallelism of standard and unknown dose- 
response curves, are part of the statistical evaluation of the 
assay.
A.standard preparation is needed in each assay because of 
the natural variability of biological responses of the 
experimental substrate and because of inter-assay variability 
in technique. Optimum bioassay results are obtained by using 
tissue from one animal and measuring its response to several 
symmetrically spaced dilutions of standard and unknowns.
Finney (1964)has fully defined the conditions and statistical 
evaluation of acceptable bioassays.
Somatomedin bioassays reported in the literature have not 
always been stringently ideal. The method of Daughaday et al. (1959)
used ten costal cartilage segments from each of eight rats and 
distributed these at random among the test samples. Chesley (1962) 
used but a single dilution by which to make comparisons between 
standard and unknowns. The comparison of statistically optimal 
assays of the same design from different laboratories is not 
possible because of the lack of an international reference 
standard (IRS). No IRS has been available up to the present time 
(Bangham 1975, personal communication) and so each laboratory sets 
its own local standard. This is usually a serum pool from one or 
more healthy, "normal" adults or from a blood bank, aliquotted 
and deep frozen. At least one author has used his own serum 
collected freshly for each assay run! (Chesley 1962).
These strict requirements for adequate design and analysis 
and the laborious and time-consuming nature of a SM bioassay have 
resulted in the development of a number of modifications of the 
assay. The important features of these are discussed, and 
summarized in Table 1.
The prototype assay used costal cartilage segments from rats 
hypophysectomised at 25 days of age. Uptake of labelled sulphate 
was shown to be linear in response to the logarithm of serum dose 
at concentrations between 1,7% and 10$. The index of precision for 
a reference pool used in the assay was 0,25 and 0,28 on two 
occasions (Daughaday et al. 1959). Almquist (1961) improved the 
precision of this assay by using one piece of cartilage from each 
of six hypophysectomised rats for each dose of serum to be assayed, 
so that each sample was assayed in sextuplicate. This reduced 
the index of precision to 0,14. A similar design was later used 
by Van Wyk et al. (1969) and Van den Brande et al. (1971).
The expense and problem of hypophysectomy was obviated by 
Yde (1968) who used 21-27 day old rats fasted for 48 hours before 
sacrifice and use in the assay. Sensitivity of fasted cartilage
TABLE 1 Summary of Current Approaches to Bioossoy of Somatomedin
Authors Tissue Isotope Total 
Incubation 
Time (hours)
Dauqhaday et al. 1959 Hypox. rat costal cartilage 3H 24
Almquist 1961 Hypox. rat costal cartilage 35S04 24
Van den Brands Hypox. rat costal cartilage 35so4 48
et al. 1971 3HTdr 48
Van Wyk et al. 1969 Hypox. rat costal cartilage 3HTdr 48
Yde 1968 Normal fasted rat costal 
cartilage
35so4 24
Alford et al. 1972 Normal fasted rat costal 
cartilage
88
Fujisawa 1964 Hypox. puppy costal 
cartilage
^SO.
4
24
Van den Brands & Normal pig costal cartilage 35s o4 48 or 73
Du Caju 1971 3HTdr 48 or 73
Hall 1970 Chick embryo pelvic 
leaflets
35 SO
4
6
Garland et al. 1972 Chick embryo pelvis 
isolated chondrocytes
3HTdr 24
Uthne 1973 Human glia-like cells . 3HTdr 48
Wasteson et al. 1973 Human foetal lung 
fibroblasts * » 4
6 to 50
Notes Hypox. indicates hypophysectomised
* obtained after rejecting non-valid assays 
n.q. indicates "not quoted" in reference paper.
Range of 
Sensitivity 
Serum)
Precision
(index of precision)
1,7 - 10 0,25 - 0,28
1 - 20 0,14*
0,1 - 8,3 0,38
0,1 - 8,3 0,47
0,25 - 18 
5 - 15
0,3
0,209*
5 - 20 0,18
5 - 40 n.q.
5,6 - 45,2 0,15
5,6 - 45,2 0,19
2,5 - 4 0 0,20
0,6 - 6,0 n.q.
3 - 50 n.q.
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was shown to be nearly equal to that of hypophysectomised
cartilage. After rejection of those assays which were not
statistically valid (22$ of all assays) the mean index of
precision was 0,209. Alford et al. (1972) simplified the Yde
technique by digesting the cartilage after incubation and
adsorbing the chondroitin sulphate onto paperstrips before
scintillation counting. The problem of inter-animal variation
was overcome using a single hypophysectomised puppy per assay
(Fujisawa 1964). However, expense and the shallow dose-response
curve have precluded further use of this technique. By preincubating
hypophysectomised rat costal cartilage for 24 hours before addition
of isotope Van den Brande et al. (1971) achieved maximum
sensitivity, with the linear portion of the dose-response curve
beginning as low as 0,1$ volume/volume serum dilution. This assay
35 3also introduced simultaneous measurement of S0^ and HTdr uptake.
The advantages of a single, non-hypophysectomised animal 
cartilage source, enhanced sensitivity from preincubation and dual 
isotope uptake were combined in the porcine costal cartilage assay 
(Van den Brande & Du Caju 1972, 1974). By using a schedule of 
post-incubation in isotope solution variations in endogenous 
sulphate and thymidine pools are rendered unimportant and the 
labour involved in the assay is reduced. This assay has been 
extensively evaluated recently by Phillips et al. (1974) and was 
the assay used for the majority of studies in this thesis.
The expense and length of the rat assays prompted Hall (1970)
to develop a simpler, less time-consuming assay. Hall used the
pelvic leaflets of 11 to 12 day-old chick embryos to measure the
35incorporation of S0^. This assay was based on the observation 
by Adamson and Anast (1966) that the variation in uptake between 
embryos of the same age was small and therefore, the precision of 
the assay compared favourably with others, the index of precision
being around 0,20f Hall's method was further simplified by the 
observation that omission of weighing of individual pelvic 
rudiments did not lower precision, and in fact actually seemed to 
improve precision for the overall mean of all assays in the 
laboratory of Schimpff and Donnadieu (1973).
The need for large quantities of homogeneous tissue to use in
the assay has led at least three groups of workers to examine
isolated cells in culture as possible substrates. Garland etal.
(1972) isolated chick embryo pelvis chondrocytes by enzymatic
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digestion and measured HTdr incorporation. Uthne (1973) used a
line of human glia-like cells, obtained at brain biopsy, to
3
measure HTdr incorporation. Wasteson et al. (1973) used the same 
glia-like line and pulmonary fibroblasts in culture to assay 
sulphated polysaccharide synthesis. Of these three systems only 
Othne's has been applied as a general assay system and has proved 
vital in the identification of the different SM species isolated 
to date (see below).
Of the several commonly used assay systems the hypophysectomised 
rat assay with preincubation has the greatest sensitivity, the 
porcine assay the greatest precision, and the chick pelvic assay 
is the least time consuming.
The SM bioassay technique has been applied successfully to a 
number of body fluids. Serum or plasma of several species has been 
investigated. In addition, serum extracts have been assayed for 
activity during purification procedures by several authors (see 
below). To date there have only been two reports on SM activity 
in other fluids; that of the author on adult cerebrospinal fluid 
(Beaton et al. 1975) and that of Anderson and Kastrup (1973) in 
human amniotic fluid. Attempts to show activity in urine extracts 
have been unsuccessful (Van den Brande 1972, personal communication).
All biossay systems are non-specific in that they measure the 
end-result of the addition of native plasma or plasma extracts to
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metabolizing tissue. Not surprisingly therefore, a wide variety 
of factors influence the assay. Some of these have been 
extensively investigated, amino acid content and composition of 
the medium, for example. This can be controlled by addition of 
optimum amounts of amino acids to the incubation medium. Other 
factors, such as possible cofactors or inhibitors have only recently 
been suggested and remain quite unknown in importance and influence 
on the assay systems.
Amino acids stimulate sulphate uptake. In the rat cartilage 
serine, glycine, glutamine, valine, and threonine are particularly 
important (Koumans & Daughaday 1963, Almquist 1961; Salmon & 
Daughaday 1958; Bostrom et al. 1955b). In the chick glutamine 
and serine seem to be the most important (Hall 1970). All these 
amino acids and others, cystine,methionine, phenylalanine, tyrosine, 
arginine, lysine, histidine, tryptophan, isoleucine and leucine 
are added in approximately the concentrations found in normal human 
serum (Daughaday & Reeder 1966; Hall 1970; Van den Brande 1973). 
There appears to have been no investigation of the effects of 
adding amino acids in concentrations appropriate to the species 
of serum being assayed. Van den Brande et al. (1974), for example, 
used the same amino acid composition in assaying sera of animals 
as different as turtles, pigeons and dogs.
Homocystine stimulates cartilage sulphation and this has 
been suggested as a possible mechanism of the skeletal abnormalities 
found in homocystinuria (Dehnel & Francis 1972).
Glucose is added to the incubation media of all assays. The 
work of Herington et al. (1972) suggests that glucose is not acting 
only as an energy source, but also as a substrate for polysaccharide 
chain formation in embryonic cartilage.
Most hormones at physiological concentrations, and some even 
at supra-physiological concentrations, have little effect on the
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SM assay. Salmon and Daughaday's (1957) original observations 
showed that GH in concentrations as high as 50 pg/ml had no effect 
on sulphation in vitro. At higher concentrations there is some 
effect of GH apparent on rat cartilage and more so on muscle 
(Salmon & DuVall 1970b). In chick pelvic leaflets human GH has 
no effect in concentrations up to 1,0 p g/ml (Hall 1970), but ovine 
GH stimulates significant sulphate incorporation in cultured chick 
chondrocytes in a dose-related linear response between concentrations 
of 0,01 and 1,0 pg/ml. (Meier & Solursh 1972). In spite of these 
apparently contradictory findings it must be stressed that at 
physiological concentrations GH does not stimulate SM (Daughaday 
1971a)0 Human placental lactogen and prolactin similarly have no 
significant effect (Murakawa & Raben 1968).
In rat cartilage insulin does cause significant stimulation 
of sulphate uptake, leucine incorporation into chondromucoprotein, 
uridine incorporation into RNA and thymidine incorporation into DNA 
(Salmon 1960a; Salmon et al. 1967; Salmon et al. 1968). Supra- 
physiological concentrations of insulin and failure of highly 
specific insulin antibodies to reduce sulphating potency of serum 
(Salmon & DuVall 1970b) add further support to the view that 
insulin has an insignificant effect in the bioassay. Chick 
cartilage is completely refractory to insulin stimulation 
(Hall & Uthne 1971). Glucagon has no effect on cartilage sulphation 
in vitro (Salmon et al. 1968).
Glucocorticoids inhibit sulphate incorporation (Layton 1951; 
Eisenbarth & Lebovitz 1974; Tessler & Salmon 1975) and hydroxyproline 
synthesis (Daughaday & Mariz 1962) by cartilage in vitro and 
in vivo (Ebert & Prockop 1967). Whilst testosterone stimulates 
sulphation in vivo it has very slight effects in vitro (Salmon 
et al. 1963). Oestrogens inhibit sulphate uptake by normal
cartilage (Herbai 1971b) but have no effect in cartilage from
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hypophysectomised animals (Herbai 1971b; Wiedemann & Schwarz 1972).
A variety of non-hormonal factors also act on sulphation 
in vitro. These include the ionic composition of the medium 
(Adamson et al. 1964), pH (Klebanoff et al. 1958), straight chain 
fatty acids which inhibit sulphation (Delcher et al. 1973;
Eisenbarth et al. 1973), heterocyclic compounds such as indoles 
(Liberti & Rogers 1970) and salicylates (Bostrom & Mansson 1955a). 
Manipulations of cyclic AMP activity, other than those acting 
directly on adenyl cyclase (discussed below), have resulted in 
contradictory results. Hall (1972) added dibutyrl-cAMP to chick 
pelvis and found no increase in sulphate uptake with increasing 
concentrations, while Adamson (1970) showed a 20-25% increase in 
amino acid transport, incorporation into protein and in sulphate 
incorporation in chick pelves. Uthne et al. (1974) blocked amino 
transport in muscle with the phosphodiesterase inhibitor 
theophylline, but showed that in the presence of a purified SM 
preparation this block did not occur.
The observation that free fatty acids inhibit SM in vitro 
is of considerable theoretical importance. If this effect can be 
shown in vivo it would suggest a mechanism whereby the lipolytic 
and glucose mobilizing effects of GH might be dissociated from its 
growth-stimulating effects. Thus stress, such as starvation, 
elevates GH levels resulting in lipolysis. This would, in turn, 
block SM activity so that substrate demands for growth are reduced. 
Protein-calorie malnutrition offers the opportunity to explore this 
relationship in vivo, and work in this field is reported in 
Chapter 13.
In recent years several authors have suggested that the reduced 
SM levels observed in fasting and malnutrition may be the 
consequence of a reduction of net serum activity due to inhibitors, 
rather than a reduction in absolute SM activity. Salmon (1972)
showed that there was a non-dialyzable heat-labile inhibitor in 
some but not all fasted rat sera. While Van den Brande has shown 
the presence of inhibitors in marasmic patients' serum (Van den Brande 
& Du Caju 1973; Van den Brande et al. 1974a)Grant et al. (1973) 
could not demonstrate inhibition by mixing experiments in two cases 
of kwashiorkor. A thermolabile inhibitor was demonstrated in 
normal adult human serum in the isolated chondrocyte system 
(Garland et al. 1972). Inhibitors of a molecular weight between 
25 000 and 50 000 have been isolated by ultrafiltration of the 
perfusate of GH-stimulated isolated liver preparations (Dehnel & 
McConaghey 1974). The nature, origin and possible physiological 
role of these inhibitors are not clear at the present time.
Finally, it has been suggested that the loss of SM activity 
during purification procedures may possibly be due to loss of 
cofactors necessary for full expression of activity, rather than 
loss or degradation of the SM molecule(s) (Van Wyk et al. 1974, in 
the discussion section). This hypothesis is supported by the 
observation that mixing purified fractions with native serum of 
known SM potency results in a synergistic rather than additive 
increase in potency of the mixture (Van den Brande 1974, personal 
communication).
In summary, the SM bioassay has been refined and facilitated 
in the past 18 years by a number of methodological and statistical 
modifications. The important characteristics of these bioassays 
have been analysed and the multitude of non-specific factors that 
may influence the assay discussed. All assays suffer from non­
specificity, relatively low sensitivity, variable precision and 
in being time-consuming. The lack of an international reference 
standard limits the value of comparison of results from different 
laboratories. Against all of these disadvantages must be weighed 
the fact that the bioassay yields unique information. The 
biological outcome of the net effects of serum can be accurately
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measured under precisely controlled in vitro conditions. As 
Daughaday (1971b) has pointed out "progress in characterizing the 
action of a hormone on a tissue demands the removal of the hormonal 
target from the complex environment of the whole animal to the 
controlled conditions of in vitro incubation."
The application of radioreceptor assays and radioimmunoassays 
to SM means much more sensitive, precise and rapid results.
However, these assays require the use of serum extracts or isolated 
membranes or measure only immunological activity of the molecule.
As in the case of GH, these assays will yield vast and invaluable 
quantities of information concerning secretion, control and actions 
of SM. However, they cannot provide the information regarding the 
action of native serum on intact tissue in culture that the bioassay 
can offer. While good agreement between membrane binding ability 
and biological action has been demonstrated for several polypeptide 
hormones (Cuatrecasas 1972, Lefkovitz 1973) this is not yet the case 
for SM. With the availability of the three different types of 
assay, measuring three different aspects of SM action, it is 
important to select the appropriate assay(s) for the investigation 
of a particular situation.
5.3. Physical Properties and Purification of Somatomedin
Purification of SM has been slow as a consequence of the low 
biological activity in serum and the time-consuming bioassays that 
are needed at every step to identify the purification products.
Early studies suggested that skeletal muscle and liver may be rich 
sources of SM (Bostrom et al.1955c; Hall & Bozovic 1969; Bozovic 
et al. 1970; Hall et al. 1969, 1970; Salmon 1972), but these 
findings were not confirmed by Daughaday(1971a) and have not been 
pursued. Plasma or serum are the richest sources of SM and all 
purification has been performed starting with these materials.
Early work showed that SM is remarkably stable, retaining
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activity after heating to 60°C for 15 minutes (Salmon & Daughaday 1957) 
and after prolonged storage at room temperature (Almquist 1961). 
Activity is lost in alkaline solution at 80°C for 30 minutes 
(Van den Brande 1973) but is retained at 100°C for 15 minutes in 
acid solution (Salmon & DuVall 1970b). Freezing, thawing and 
lyophilizing have no effect on activity (Daughaday & Kipnis 1966). 
Destruction of activity by pronase (Van den Brande 1973) or trypsin 
(Salmon 1972) digestion confirmed the peptide nature of the active 
molecule.
The first purification studies used small quantities of normal 
and acromegalic human and normal rat serum. Somatomedin was 
retained by both dialysis tubing (Salmon & Daughaday 1958) and 
ultrafiltration membranes with a pore size of 50 000 daltons 
(Van Wyk et al. 1971). Application of serum to Sephadex gels 
showed a higher molecular weight for SM than that of GH in serum 
(Bala et al. 1970; Van Wyk et al. 1969). In acid-ethanol SM 
activity appears at much lower molecular weights suggesting that 
it is normally bound to a carrier molecule (Hall & Uthne 1972;
Van Wyk et al. 1971). These heating and acidifying steps alone 
or combined with filtration or Sephadex chromatography, resulted in 
100-500 purification, but were quite unsuitable for large-scale 
purification. Acid-ethanol extraction was applied therefore as a 
first step and yielded satisfactory recovery of samples which 
paralleled the dose-response curve of the native plasma. Further 
purification of this acromegalic plasma by gel chromatography, ion- 
exchange chromatography,electrofocusing and high voltage paper 
electrophoresis continued to yield SM activity with progressive 
purity (Van Wyk et al. 1971).
Large scale purification of thousands of kilograms of outdated 
human plasma was therefore begun in 1971. In successive steps 
through Cohn fraction IV, acid-ethanol extracts and Sephadex G75 
chromatography a single peak of activity at Kd 0,64-0,77 with
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20 000 - 50 000-fold purification was achieved (Hall 1972). From 
this point two separate paths have been followed. Hall (1972) 
used ion-exchange chromatography on Dowex 50 followed by 
successive high-voltage electrophoresis on paper at pH 6,5, 
pH 3,6 and pH 2,0, achieving a 1- to 2-million-fold purification. 
This fraction stimulates chick pelvic sulphation, is a neutral 
peptide and is now termed somatomedin A (Uthne 1973). Iso­
electric focusing of this fraction yielded a more acidic second 
peptide of slightly different molecular weight, but markedly 
different biological activity. Uthne et al. (1973) named this 
somatomedin B and showed that it stimulated thymidine incorporation 
into human glia-like cells, whereas somatomedin A did not. In 
his laboratory Van Wyk followed another purification procedure.
The Sephadex G75 fraction of the acid-ethanol extracts was purified 
by continuous free-flow liquid electrophoresis followed by cation- 
exchange chromatography on carboxymethyl-cellulose. Electrofocusing 
between pH 7 and pH 10 of the most active fraction was followed 
by preparative electrophoresis at pH 2,2 on polyacrylamide gel 
and finally passage through Sephadex G75. Van Wyk's fractions 
yielded a basic peptide active on sulphation in rat cartilage 
but with no activity on chick cartilage. This is somatomedin C 
(Van Wyk et al. 1974).
Comparisons of the amino acid content of the most purified 
fractions of somatomedins A and C show differences. Whether 
these differences indicate two distinct peptides or simply 
chemical alterations as a result of the purification procedures 
is not known (Hall & Van Wyk 1974). Table 2 summarizes current 
concepts of the three somatomedins.
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TABLE 2 Summary of the Characteristics of Somatomedins A,B,and C.
Somato­
medin
Molecular
Weight
Peptide
Character­
istics
Bioassay Radio­
receptor
Assay
Radio-
immuno
Assay
A 7500 neutral chick pelvis 
sulphation
+ -
B 4500 acidic human glia-like 
cell thymidine 
uptake
+ +
C 7500 basic rat costal
cartilage
sulphation
+
Note : + denotes reported in the literature and
- not reported.
5.4. Radioreceptor and Radioimmunoassays for Somatomedin
The primary step in the action of polypeptide hormones is an
interaction between part of the hormone molecule and the target
cell membrane (Freychet et al. 1971). On the basis of this
interaction several polypeptides, including insulin, growth hormone
and adrenocorticotrophin, can be assayed by radioreceptor
techniques (Lefkovitz et al. 1970; Tsushima & Friesen 1973;
Freychet et al. 1971). A radioreceptor assay has been described
for both somatomedin A (Hall et al. 1974) and somatomedin C
(Van Wyk et al. 1974), based on the demonstration of competition 
125of SM and I-insulin for receptors in fat, cartilage and liver 
cell membranes (Hintz et al. 1972a).
Posner (1974) described a simple method for the preparation 
of particulate membrane fractions of human placenta, and the two 
radioreceptor assays use modifications of this preparation as
the binding substrate. The somatomedin A assay requires purified
125 125I somatomedin A and the somatomedin C assay I - SM - C for
competitive binding to the membranes.
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The availability of larger quantities of somatomedin B 
(Uthne 1973) has made the development of a radioimmunoassay 
possible (Yalow et al. .1975). Prepared from Cohn fractions of 
human plasma this assay detects somatomedin B in 1 : 20 000 
dilutions of human plasma, equivalent to concentrations of 
25 pg/ml. Although there is only a single publication on the 
radioimmunoassay to date a wealth of new information has been 
acquired that was previously not accessible with the bioassay. In 
unextracted plasma somatomedin B is associated with plasma proteins 
at least as large as the gamma-globulins and has an electrophoretic 
mobility similar to the alpha-globulins. It appears only in 
primate plasma being detectable in human plasma at 1 : 20 000 
and in monkey plasma at 1 : 5000 dilutions. There is no cross- 
immunoreaction at 1 : 20 in guinea pig, mouse, cow, rat, rabbit, 
dog, sheep or pig plasma. In other words there appears to be a 
species specificity similar to that for GH. This contrasts 
sharply with bioassay findings of no species specificity 
(Van den Brande et al. 1974b). The adult male fasting plasma 
concentration ranges from 4-20 /jg/ml (mean 9,8 - 1,5 yjg/ml). 
Although there is overlap with the normal range levels are high in 
acromegaly, and fall with therapy, and low in hypopituitarism, 
suggesting GH dependence.
Although antibodies have been raised against somatomedin C in 
the guinea pig, the titres of the antisera are too low to be useful 
for radioimmunoassay at present (Van Wyk et al. 1974).
5.5. Site of Production of Somatomedin
Based on the thesis that SM production is GH-dependent, the 
125localization of I-labelled GH after injection has been used to 
suggest sites of SM production. .A high concentration was found in 
liver, kidney, adrenal cortex and submandibular glands of 
hypophysectomised rats. Pretreatment with GH largely blocked
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uptake in liver and adrenal cortex, suggesting specific binding 
in these organs. Reassuringly GH was not taken up by epiphyseal 
plates of long bones (Mayberry et al. 1971).
As previously discussed tissue extracts have yielded 
equivocal results and the best evidence is derived from organ 
perfusion or culture.
Liver. Perfusion of isolated livers with GH-enriched 
medium results in the generation of SM activity (McConaghey &
Sledge 1970; McConaghey 1972; Williams & Hughes 1974). Rat liver 
slices (Hintz et al. 1972b) and liver microsomes (Hall & Uthne 1971) 
also release SM activity. Three different in vivo approaches 
also suggest that the liver is a source of SM or is at least 
necessary for full expression of SM activity. Partial hepatectomy 
in the rat results in a fall in serum SM activity which is followed 
by a gradual rise that parallels regeneration (Uthne et al. 1971; 
Uthne & Uthne 1972). In man catheterisation of the hepatic vein 
shows higher SM levels in the hepatic serum than in arterial 
serum (Girard et al. 1974). Hepatic insufficiency is associated 
with reduced serum SM in man (Wiedemann et al. 1974; Wu et al. 1974).
Kidney. Perfusion of the rat kidney with GH-enriched medium 
results in SM production (McConaghey & Dehnel 1972; Beaton &
Rabkin 1975, unpublished observations). As the kidney plays an 
important role in the degradation and excretion of GH (Wallace 
et al. 1972) the growth retardation of the nephrectomised lamb 
foetus has been attributed to interference with SM production 
(Thorburn 1974); although this has not been proven by serum assays. 
The recovery of growth rate and the closely correlated rise in 
serum SM that occurs in children after renal transplantation 
suggests an important renal contribution to serum SM activity 
(Saenger etal. 1974).
Reduction of normal growth rate in monkeys following
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extirpation of the submandibular glands (Narasimhan & Ganla 1968) 
and somatomedin-like activity in muscle extracts (Hall et al. 1970) 
suggests a possible role for these organs in somatomedin mediated 
growth.
For all of these organs identity between the SM of the organ 
perfusate or extract and serum SM has not been established and 
has been queried by at least one group for the liver (Hintz 
et al. 1972b). Only precise molecular characterization, by 
radioimmunoassay will permit proof of the exact origins of SM.
The possibility that SM may be a breakdown product or active 
fragment of the GH molecule has been investigated. Available 
evidence does not support this suggestion, but none is yet 
conclusive. Only precise identification of the amino acid 
sequence will finally decide this point. • Failure to cross-react 
with GH antisera (Daughaday & Kipnis 1966), induction in 
hypophysectomised rats by a non-GH factor from the tapeworm, 
Spirometra mansonoides (Garland et al. 1971) and complete 
temporal separation of related serum changes in SM and GH 
(Hall 1971) all make it unlikely that SM is derived from the GH 
molecule.
5.6, Factors Influencing Serum Somatomedin Levels
Serum SM levels may be affected by changes in the rate of 
production, rate of removal or degradation and the concentration 
of the serum binding-protein.
Hypophysectomy results in a fall in serum SM. In the rat 
the half-life is 3 - 4 hours (Daughaday et al. 1968) and in man 
it is 9 - 18 hours (Almquist & Falkheden 1961). Somatomedin 
activity is restored by injection of GH within 8 - 1 2  hours in 
the rat and mouse (Daughaday et al. 1968; Herbai 1971a) and 
within 3 - 6  hours in man (Hall 1971; Schimpff et al. 1974).
These hypophysectomy findings are confirmed by the half-life of
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3 - 4  hours of somatomedin A following partial hepatectomy in the 
rat (Uthne 1973). The response to GH in the hypophysectomised 
animal is an active process involving protein-synthesis as it is 
blocked by cycloheximide (Uthne 1973)0 The response is also 
blocked by oestrogen pre-treatment (Wiedemann & Schwarz 1972).
No consistent significant negative correlation has been 
shown between GH and SM, as may be expected from general 
endocrine principles of negative feedback control and as has been 
postulated (Tanner 1972). In normal children and acromegalic 
adults (Hall 1972) and in malnourished children (Grant et al. 1973) 
there is no correlation between basal GH levels and SM. These 
observations mean little in view of the different half-lives of 
the two hormones; minutes for GH and hours for SM. Adequate 
conclusions can be based only on secretion rates and dynamic 
studies with pure SM. There are two indirect items of evidence 
suggesting negative feedback. Hepatectomy in mice results in 
changes in the pituitary suggestive of increased GH synthesis 
and secretion (Zotter 1972) and in an increase in serum DNA 
synthesis-stimulating potency, identical to that caused by GH 
(Llanos et al. 1971).
There is much less information regarding removal of SM from 
serum. Successive incubations of cartilage in serum suggest 
inactivation or binding of SM and effective reduction in SM 
potency in the remaining fluid (Daughaday et al. 1968). This 
does not occur with the GH present in the medium, further 
indicating that GH and SM are separate molecules.
The role of binding-proteins in regulating the serum level 
of SM is purely speculative and there is no information on the 
nature, affinities or control of these proteins. It is possible 
that GH modulates the levels of and/or SM binding to these proteins.
That SM is not entirely GH-dependent has been recognized from
the outset. Children with no detectable immunoreactive GH almost 
always have low but measurable SM levels (Daughaday & Parker 1963). 
This incomplete dependence on GH has been highlighted by the 
finding that the spargana of the tapeworm Spirometra mansonoides 
contain a substance that induces SM production and subsequent 
growth (summarized in Daughaday & Garland 1972). This worm growth 
factor is not immunologically related to GH and does not act on 
cartilage directly. After 4 - 6  weeks antibodies against the 
factor develop, SM levels fall and growth slows (Steelman 1971).
A variety of physiological factors influence serum levels.
In the absence of measures of secretion rates the effects of the 
factors on production, utilization or protein-binding remain 
undetermined. Furthermore, all of the factors discussed below 
have been described using bioassay techniques. Therefore, the 
possible effects of inhibitors remain largely unexplored and 
these may be long- or short-term, cyclical or continuous.
Circadian rhythm. Daughaday et al. (1959) observed no
consistent diurnal variation in three adults, but Du Caju and
Van den Brande (personal communication) have some evidence to
suggest a pattern of diurnal variation that is significant, with
levels being highest in the early morning. These workers have
data also to show that SM levels are inversely correlated with
plasma cortisol levels. Further relationships have not been
35elucidated and await more data. The in vivo uptake of SO^ 
(Simmons 1968) and mitotic activity (Simmons 1964) in 
epiphyseal cartilage of mice shows a marked diurnal rhythm, 
being maximal between 15h00 and 18h00.
Fasting. Fasting for 48 hours or more results in a fall in 
serum SM in rats (Daughaday & Kipnis 1966; Salmon 1972). Salmon 
(1972) has shown this fall to be due to inhibitors appearing in the
serum.
Stress. Repeated bleeding causes a rise in serum SM in rats 
(Bostrom et al. 1971; Bozovic & Bostrom 1969). The significance 
of this finding is not clear as GH responses were not measured.
Nutritional status. Chronic malnutrition of the protein- 
calorie deficiency type results in a fall in SM in the face of 
elevated GH levels, as already discussed (Grant et al. 1973).
In childhood obesity SM is normal, while GH levels are often low 
(Du Caju & Van den Brande 1973; Van den Brande & Du Caju 1973).
Pregnancy. The early studies of Chesley (1962) and 
Daughaday et al. (1959) suggested that SM was unaltered in 
pregnancy, but the more precise assay used by Tato et al. (1975) 
recently has shown a reduction during pregnancy and an even 
further reduction during delivery. The values during delivery 
fall within the hypopituitary range. The authors suggest that 
oestradiol may be responsible for the low levels at delivery.
Age. Age-associated changes in SM are discussed later in 
this chapter.
5.7. Biological Actions of Somatomedin
Much of the work on the biological actions of SM has been 
conducted with whole serum or serum extracts of variable purity.
The only criteria for assigning the observed actions to SM have 
been GH-dependence of the activity and the failure of GH itself 
to cause similar effects.
In vitro cartilaginous actions. Since the early work of 
Daughaday which demonstrated cartilage sulphation, many other 
actions in cartilage have been ascribed to somatomedin.
^C-leucine is incorporated into chondromucoprotein (Salmon 
et al. 1968) and ^C-U-proline is converted into ^C-hydroxyproline 
collagen (Daughaday & Mariz 1962, Henneman 1971) under the 
stimulus of SM. The synthesis of both RNA and DNA is accelerated
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by SM (Daughaday & Reeder 1966; Salmon et al. 1968; Murakawa &
Raben 1968). In chicken cartilage transport of alpha-aminoisobutyric 
acid, cycloleucine and metabolizable amino acids is stimulated by 
SM (Adamson & Anast 1966).
When protein synthesis is blocked by actinomycin or puromycin, 
sulphation is also inhibited (Haba & Holtzer 1965; Salmon et al. 
1967), indicating that sulphation occurs as the terminal process 
in the synthesis of the sulphated proteoglycan molecule.
Several studies have shown that the various metabolic 
activities in cartilage are stimulated by one purified moiety 
(Salmon & DuVall 1970b; Van Wyk et al. 1969, 1971).
Whereas GH has no effect on all of these processes in vitro, 
the growth and metabolic activity of both mammalian and chick 
limb-buds is stimulated by GH in culture (Leong 1974, personal 
communication; Hay 1958; Renda & D'Este 1968).
In vitro non-cartilaginous actions. Somatomedin is insulin-
14like in its actions on adipose tissue, stimulating C-glucose 
conversion to (Hall & Uthne 1971) and inhibiting adrenalin-
induced lipolysis (Underwood et al. 1972). Hall and Uthne's 
study was one of the first to suggest that SM and soluble non- 
suppresible insulin-like activity (NSILAs) may be the same, or 
very similar, molecules. This similarity is discussed later. 
Partially purified preparations stimulate amino acid transport 
and protein synthesis in rat diaphragm muscle (Hall & Uthne 1972; 
Salmon & DuVall 1970b). Uthne's later studies (1973) confirmed 
the insulin-like effects of SM on protein synthesis in muscle, and 
convincingly showed that no lag period occurs as it does with GH, 
the effects of which are also anabolic (Kostyo 1968).
In vitro mitogenic actions.' Salmon and Hosse (1971) 
demonstrated that partially purified SM stimulated Hela cell growth, 
but stressed that not all the growth-promoting activity of serum
57
was resident in the SM fraction. Other authors have shown the 
stimulation of DNA synthesis and mitosis in a variety of cells 
including human glia-like cells (Uthne 1973), foetal rat liver 
cells (Leffert & Paul 1972), rat ovarian tumour cells (Clark 
et al. 1972), human skin and lung fibroblasts, meningocytes and 
cat lung fibroblasts (Westermark et al. 1973) and mammary gland 
epithelium (Hsueh & Stockdale 1974). Each of these groups has used 
only one or other of the somatomedins (usually impure), and whether 
the mitogenic effects in each tissue system can be ascribed to 
only one or to all the somatomedins is not known at present.
Cell membrane interactions. Because many of the actions of 
insulin and SM are similar, investigators examined the possibility 
that the two may compete for the same receptor site on the plasma 
membranes of responsive cells. Competitive binding, at physiological 
concentrations, occurs between insulin and SM in fat, liver and 
cartilage cell membranes (Hintz et al.1972a; Marshall et al. 1974). 
Moreover, the relative binding affinities reflect the biological 
potencies of the hormones in the responding cells. Thus in fat 
cells, for equivalent binding, the ratio of SM to insulin was 
50 microunits of insulin to one unit of SM, and for glucose 
oxidation 20 microunits to one unit. This contrasts with the 
situation in cartilage where small amounts of SM completely 
displace insulin from the binding sites, and for sulphation one 
unit of somatomedin is equivalent to 30 milliunits of insulin. 
Furthermore, in fat cells the effects of SM and insulin are 
strictly additive (Clemmons et al. 1974).
The conclusion that SM and insulin share common receptors 
and that this is the mechanism of the similarity of their biological 
actions is further strengthened by the demonstration that SM 
inhibits adenyl cyclase in several tissues including fat, liver, 
spleen lymphocytes and chondrocytes (Tell et al. 1973) and the
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observations that high concentrations of both exogenous and 
endogenous cAMP inhibit sulphation in chick pelvis (Rendall et al. 1972)
These findings heighten the paradox of a GH-dependent molecule 
having insulin-like actions in vitro while GH itself antagonizes 
insulin in vivo (Froesch et al. 1967). Until working quantities of 
pure SM are available for in vivo use this paradox will not be resolved.
In vivo actions. Shortage of pure SM has permitted only one 
very limited in vivo study. Somatomedin A induced tibial epiphyseal 
widening and skin thickening in hypophysectomised rats, but did not 
increase body weight (Hall & Uthne 1972). The failure to 
stimulate weight gain may be due to the use of Somatomedin A which 
is primarily active in chick cartilage and only slightly active in 
rat cartilage in vitro.
In spite of impressive in vitro evidence it remains to be 
rigorously established that GH mediates its effects on growth 
in vivo via the somatomedin mechanism.
5.8. Role of Somatomedin in the Regulation of Normal Growth
By examining changes in serum SM with age from birth to old 
age in a cross-sectional manner several authors have attempted to 
infer a role for SM in the regulation of growth velocity. Beyond 
describing a broad and somewhat variable trend such studies offer 
little information as they are based on single determinations on 
relatively small numbers of patients.
In cord blood SM has been described as approximately equal to 
that of the corresponding maternal serum (Daughaday et al. 1959;
Chesley 1962; Hintz et al. 1974) or significantly higher (Tato 
et al. 1975). In Tato and collaborators' study in the newborn, 
levels are low to undetectable, rising into the normal adult range 
by the 4th day of life and falling somewhat between 23 days and 15 
months of age. There is general agreement that from about one year
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of age to puberty SM rises progressively (Van den Brande & Du Caju 
1973; Kogut et al. 1963; Almquist & Rune 1961), although Daughaday 
et al. (1959) and Daughaday and Parker (1963) found no clearcut 
trend. Only one study has suggested a pubertal rise in SM, but 
the finding of a similar rise at 8 years makes the significance 
of the pubertal rise dubious (Almquist & Rune 1961). No 
difference between males and females has been shown. Adult levels 
persist into old age.
These age-associated changes in SM mean that clinical studies 
should always be related to age-specific control levels, yet only 
Van den Brande (1973) has consistently done this.
Recently serum SM has been related to growth velocity rather 
than to chronological or height achieved age (Hall & Filipsson 1975). 
As discussed in Chapter 3 this is the most meaningful correlation 
to seek on theoretical grounds. In this study no correlation was 
found between age and somatomedin A (r = - 0,11) but a highly 
significant correlation was shown between SM and gain in stature 
in the year prior to assay (r = 0,67).
The in vivo age-associated changes have been investigated in
35the rat and the mouse. Injected S0^ is maximally taken up by
the tissues at birth, after which there is a progressive decline
in uptake (Layton & Denko 1952). Dziewiatowski (1953) showed an
35increasing ability to incorporate SO, in rat embryos as they grew
4 35heavier. He also showed that postnatally S0^ was much more
rapidly and intensely concentrated in the femur by 10 day-old rats
compared to 30- or 300-day old animals (Dziewiatowski 1954). Herbai
35(1971a) demonstrated that the costal cartilage uptake of S0^ 
was highly correlated with the body weight gain in the preceding 
week in mice (r = 0,84 for males, r = 0,80 for females).
A possible explanation for the increase with age in serum SM 
is suggested by the observation that liver membranes of 3 day-old
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rats bind 5 to 6 times less GH than do those of 105 day-old rats. 
This increase in binding capacity is not due to changes in affinity 
but to an increase in the number of active binding sites (Du Caju 
& Desbuquois 1974).
All work to date that attempts to relate serum SM to somatic 
growth rate suffers from drav/ing on indirect evidence. Human 
serum SM, for example, is assayed by measuring sulphation of rat 
costal or chick pelvic cartilage. This activity is then correlated, 
in the best studies, with stature velocity over the past year; 
stature velocity being chiefly determined by hyperplasia in the 
epiphyseal plate, a mitotic rather than a matrix synthesis 
function. Ideally this question should be approached by a 
longitudinal study in which growth velocity of a particular 
tissue is correlated with the response of that tissue to SM.
5.9. Role of Somatomedin in the Causation of Abnormal Growth
Claude Bernard's "experiments of nature" and therapeutic 
intervention in a variety of diseases have yielded insight into 
the role of SM in the causation of abnormal growth.
Hypopituitarism. Somatomedin is low in hypopituitarism and 
after hypophysectomy or pituitary ablation (Daughaday et al. 1959; 
Daughaday & Parker 1963; Kogut et al. 1963; Hall 1970; Hall &
Olin 1972). GH administration causes a prompt rise in SM 
(Daughaday 1971a;Hall 1971). During long-term treatment there is 
a good correlation between growth rate and level of serum SM 
(Hall & Olin 1972). The initial growth rate and SM responses 
during the first year of therapy are usually not matched in 
subsequent years. This phenomenon was attributed to the 
development of GH antibodies by Parker et al. (1964), but the more 
recent work of Hall and Olin (1972) does not support this 
explanation. Experimentally GH antibodies can be shown to inhibit 
the growth of newborn rats (Duquesuoy & Good 1970).
Emotional deprivation dwarfism is associated with low GH 
secretion and low SM levels (Du Caju & Van den Brande 1973). 
Exogenous GH has little growth-stimulating effect (Tanner et al. 
1971; Frasier & Rallison 1972)j the added complication of 
malnutrition in many cases makes interpretation of the role of 
SM in the genesis of growth retardation in this syndrome difficult 
(Powell et al. 1967).
The syndrome of high immunoreactive GH levels and dwarfism 
illustrates a failure of SM generation, inherited on an autosomal 
recessive basis (Laron et al. 1966a; Daughaday et al. 1969;
Van den Brande et al. 1974a). Treatment of these patients with 
GH does not cause any increase in growth rate or in SM (Laron 
et al. 1971).
Acromegaly is usually accompanied by high SM levels 
Daughaday et al. 1959; Hall 1970), the degree of clinical activity 
correlating fairly well with the SM level (Hall 1972). Rats 
with GH-secreting tumours have elevated serum SM (Peake et al. 1968)
Somatomedin measurements in a variety of other conditions 
have yielded interesting, but as yet unexplained findings. In 
cerebral gigantism levels are low (Lecornu 1973; Du Caju &
Van den Brande 1973), in craniopharyngioma patients post-operative 
levels are normal (Du Caju & Van den Brande 1973) in spite of low 
GH secretion (Finkelstein et al. 1972b), and in Turner's syndrome 
levels are normal or elevated (Almquist et al. 1963) with normal 
GH secretion (Donaldson et al. 1968).
Short stature, normal GH and normal SM in the Congo pigmy 
suggest a diminished end-organ response compared to other 
genetically distinct, populations of greater stature with 
similar GH and SM levels (Rimoin et al. 1969; Daughaday et al. 1969) 
The role of nutrition in the causation of the pigmy short stature 
has not been carefully examined. Although SM studies have
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not been made in the Kalahari Bushman, nutrition may play a role 
in his short stature in view of the secular trend for increasing 
stature since 1900 that has been demonstrated (Tobias 1962).
5.10. Relationship of Somatomedin to Other Growth Peptides
In recent years a number of growth-stimulating factors have 
been described. This group has several features in common : all 
are peptides of fairly low molecular weight, they are tissue- 
specific to a greater or lesser degree, many are insulin-like 
in their metabolic actions, they evoke their responses by 
interaction with the cell membrane and they promote growth. 
Hershko et al. (1971) have termed this group of actions the 
"positive pleiotypic response."
Somatomedins A, B and C and a number of other peptides fit 
into this general grouping and a consideration of the features 
they share and differ in suggests a broader biological role for 
the somatomedins than was originally envisaged by the sulphation 
factor hypothesis.
Insulin. In 1945 Young showed insulin promoted protein 
anabolism and in hypophysectomised rats insulin and a 
carbohydrate-rich diet stimulates both body weight gain and 
skeletal growth (Salter & Best 1953). Further high doses of 
insulin can partially replace serum in stimulating DNA 
synthesis and mitosis in chick embryo fibroblasts in culture 
(Temin 1967). Evidence already discussed shows that insulin 
and SM are quite distinct molecules (Laron et al. 1972).
Nonsuppressible Insulin-like Activity (NSILAs). The 
immunoreactive insulin of serum contributes only 7% of the total 
insulin-like activity (ILA) in serum when assayed by glucose 
oxidation in the epididymal fat pad (Froesch et al. 1967; Jacob 
et al. 1968). That portion of the ILA which is soluble in
acid-ethanol (NSILAs) also stimulates thymidine uptake by rat
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cartilage (Raben et al. 1972) and some workers now believe that 
NSILAs and somatomedin C are the same or very similar molecules.
The additional observations that NSILAs is also partially GH- 
dependent and that it induces cartilage sulphate suggest that 
NSILAs should be classed as a somatomedin, or vice versa (see 
Froesch in discussion section of Van Wyk et al. 1974). On the 
other hand there are sufficient differences in amino acid 
composition to show that NSILAs and the somatomedins are distinct 
from each other (Labhart et al. 1972).
Nerve Growth Factor (NGF). A peptide purified from mouse 
submandibular glands stimulates growth in sympathetic nerve cells 
in vitro and in vivo (Levi-Montalcini & Angeletti 1968). This NGF 
stimulates RNA and protein synthesis and glucose uptake in these 
cells, and does not do so by stimulating adenylate cyclase 
(Hier et al. 1972). The close amino acid similarities between 
proinsulin and NGF and the fact that high doses of insulin mimic 
the actions of NGF suggest a possible common ancestral precursor 
molecule (Frazier et al. 1972). NGF has no sulphation activity 
(Hambley et al. 1974).
Multiplication-Stimulating Activity (MSA). A factor that 
stimulates chicken embryo fibroblast multiplication has been 
purified 6000-fold from calf serum and found also to have NSILAs- 
like activity on rat adipose cells (Dulak and Temin 1973).
MSA also stimulates DNA uptake in fibroblasts and competes with SM 
and insulin for binding sites in rat liver membranes (Smith &
Temin 1975). MSA is produced by rat liver cells growing in a 
serum-free medium and therefore does not appear to be GH-dependent 
(Smith & Temin 1975). Other recent reports suggest that MSA or 
MSA-like activity is GH-dependent for maximum stimulation of growth 
of fibroblasts of man (MacGillivray et al. 1975) and chicks (Cohen 
et al. 1975). Recently platelets have been shown to be a rich 
source of fibroblast growth-promoting activity (Kohler & Lipton 1974).
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Epidermal Growth Factor (EGF). EGF, like NGF, has been 
purified from mouse salivary gland tissue. This heat-stable 
protein of molecular weight 6400 stimulates growth of cells of 
ectodermal origin, amino acid transport and RNA synthesis 
(O'Keefe et al. 1974). It binds to cells at sites that are 
different from those GH, insulin and NGF. The increase in 
concentration in the submaxillary glands with age suggests a 
role in adult life as well as during the growth period (Bynny 
et al. 1972).
Erythropoietin. Erythropoietin is a partially GH-dependent 
peptide (Peschle 1972) that stimulates the growth of the erythroid 
cells both in vivo and in vitro (Gordon 1971).
Granulocytosis-inducing Factor. The mouse submaxillary gland 
contains a third distinct peptide that stimulates granulocyte 
proliferation in culture (Angeletti et al. 1965).
Other less well characterized factors have been described 
in serum (Paul & Walter 1975; Granstrom 1974; Pickart & Thaler 1973; 
Bradley & Metcalf 1966) and in the pituitary (Corvol et al. 1972; 
Malemud & Sokoloff 1974; Rudland et al. 1974) that are essential 
to or stimulate the growth of various cells in culture.
5.11. Concluding Remarks
The somatomedins fall into the broad grouping of growth 
factors. Whether the somatomedins should also be considered 
hormones, in the classical sense of the term, cannot yet be 
decided. When the exact origin of serum SM is identified and when 
the physiological in vivo role of the somatomedin group is 
elucidated the correct appellation can be decided upon. It is 
possible that each tissue produces its own self-specific 
somatomedin or somatomedin-like factor or factors and that these 
are GH-dependent. It is further possible that all the metabolic 
actions that have been identified and that are not related to growth
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are physiologically insignificant and that the only significant 
actions are those related to the growth of the somatomedin- 
specific tissue. Generalizations are difficult to make at the 
present because of the piecemeal nature of the information 
available about each of the somatomedins and other growth- 
promoting peptides, and the lack of evidence concerning their 
in vivo role.
On the basis of the facts reviewed in this chapter a broad 
definition of somatomedin can be suggested : A somatomedin is a 
peptide that is at least partially under the control of growth 
hormone, that is insulin-like in its actions and that stimulates 
growth in at least one tissue type. The omission of the 
requirement that sulphation be stimulated means that peptides 
that do not act on cartilage can also be included in this 
category.
On the basis of this definition somatomedins A, B and C, 
NSILAs and MSA must all be regarded as part of the "somatomedin 
family" (Van Wyk et al. 1974). As information concerning the 
precise structure of the somatomedins becomes available a more 
useful classification may be possible, as is the case with the 
prostaglandins.
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CHAPTER 6
THE END-ORGAN RESPONSE
"... our birth is nothing but our death begun"
Edward Young
In Chapter 4 brief mention was made of the necessity to 
regard hormone action as the net result of hormone-target or end- 
organ reaction. The role of the end-organ as an important 
determinant of endocrine function remains largely unexplored. In 
1953 Alfred Jost wrote that he was "unaware of any systematic
assays throughout development .... other than those concerned
with the gonadal response" that had investigated "the reactivity 
of the target organs." The early work of Moore and Morgan (1943) 
and of Joseph Gillman (1948) had demonstrated that the foetal 
genital organs pass through a period of a sensitivity during which 
their properties are irreversibly changed by hormonal influences. 
In recent years attention has remain focused on the maturation 
of sexual organs. Odell and others have shown that in the 
postnatal male rat the response of testosterone secretion to 
luteinizing hormone (LH) stimulation increases with age. This 
changing testicular responsiveness to LH is an important factor 
in determining sexual maturation (Odell et al. 1974).
In mammalian tissues other than the genital tract there are 
scattered reports of changes in end-organ sensitivity, indicating 
that the phenomenon has generalized applicability. For example, 
GH-stimulated alpha-aminoisobutyric acid transport in diaphragm 
occurs in young rats but not older rats (Kipnis & Reiss 1960). 
Similarly, GH induces 2-deoxyglucose uptake by rat diaphragm in
young but not in older rats (Riddick et al. 1962). The 
sensitivity of amphibian organs during metamorphosis shows that 
at any one time in the.same animal the prevailing concentration 
of thyroxine has dramatically different effects, depending on th 
responding target. The tail and gills undergo necrosis, while 
the limbs differentiate and grow (Schwind 1933). In the tadpole 
not only is the absolute direction of the response to thyroxine 
different in different targets, but the threshold also changes. 
Thus the dual controls of changing end-organ response and 
changing thyroxine concentration, result in an ordered sequence 
of differentiation and growth (Balinsky 1970).
In phylogenetic, rather than ontogenetic perspective the 
importance of the end-organ in determining the extent and 
direction of response to hormonal action is also clearly seen. 
The hypothalamic peptide arginine vasotocin, for example, is 
found in all classes of vertebrates except mammals. When the 
evolutionary step from water to land was heralded by the 
appearance of the amphibia, water balance was achieved by 
adaptation and specialization of end-organ response to arginine 
vasotocin; this peptide had been present since the time of the 
lampreys. The skin, kidneys and bladder of the amphibia evolved 
responses to the hormone not present in those forms which 
remained in the water (Barrington 1971).
Although much remains to be unravelled it is probable that 
changes in the response of the end-organ during development are 
major determinants of the patterns of growth and differentiation 
that occur. In the growing mammal the weight of evidence 
suggests that changes in cartilage sensitivity occur during the 
growth period; this is reviewed in the next section.
6.1. Cartilage
Cartilage and bone cells arise from a common stem cell and
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the differentiation of this ancestor appears to be intrinsically, 
that is genetically, determined. This differentiation is never­
theless triggered by microenvironmental factors (Hall 1970b) 
and the rate of division of chondroblasts appears also to be 
influenced, inter alia, by microenvironmental negative feed­
back controls (Jackson 1970). Skeletal organogenesis is also 
subject to local regulation (Lacroix 1951). Thus there is little 
evidence for pure, or primary, genetic regulation of skeletal 
growth, but there is reasonable evidence of local, or micro­
environmental, controls, acting by modifying the genome.
In vitro studies of cartilage segments indicate that age is
an important determinant of responsiveness. Two studies show
35that the uptake of S0^ in serum-free medium declines with 
increasing age in the rat (Heins et al. 1970) and in the pig 
(Phillips et al. 1974). The work of Heins et al. also showed 
that cartilage response to SM (as human serum) varies with age. 
Foetal rat costal cartilage was not stimulated by the addition 
of serum. The high uptake without serum suggests that the 
cartilage may be synthesizing chondroitin sulphate at maximum 
rates and therefore further stimulation is ineffectual. However, 
the only concentration at which serum was added was 10%, and the 
possibility remains that higher concentrations may have caused 
stimulation. The sulphation of costal cartilage from newborn 
rats and rats weighing lOg, 45g and 88g was significantly 
stimulated by the addition of 10% serum, in contrast to the 
refractoriness of foetal cartilage. Commenting on these 
observations Daughaday (1971a) states that "responsiveness in rat 
cartilage .... is greatest during the period of active postnatal 
... growth in the rat." While this study is unique in the SM 
and growth regulation literature it nevertheless does not take 
account of several important points. The first has already been
mentioned, namely the nature of the stimulus to which the cartilage
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was subjected. A range of serum concentrations would have
offered more information on the response characteristics of the
cartilage. The threshold and slope of the dose-response curve may
be of greater significance in interpreting age-related changes
than the stimulation achieved with serum at a single concentration.
Secondly, while the serum used retained its potency throughout
the experimental period, this potency was measured in the
hypophysectomised rat assay. It is possible that this serum
contained inhibitory material to which foetal cartilage, but not
postnatal normal and hypophysectomised cartilage, was sensitive.
Although the authors demonstrated that serum from hypophysectomised
rats also did not stimulate foetal cartilage, this serum was only
used in a single concentration and was not tried on cartilage
from older rats. Thirdly, cartilage response was related only
to body weight and not to any parameter of the velocity of growth.
Therefore, while Daughaday's comment, that responsiveness is
greatest during the period of active growth, may be a correct
generalization, it indicates that no further conclusions can be
drawn regarding the relationship between responsiveness and
velocity of growth. Fourthly, as stressed earlier, it is the
hormone-tissue interaction that is the most important determinant
of hormone action and therefore it is possible that in Heins'
study the serum of cartilage donor rats would have been a more
appropriate stimulus than human serum. Finally, the use of
chondroitin sulphate synthesis as the most appropriate index
of the responsiveness of growing cartilage is open to question.
3It is possible that mitosis and DNA synthesis, and therefore HTdr 
incorporation, is a more appropriate index when the whole span of 
the growth period is being considered.
The work on changes in cartilage sensitivity in pigs 
(Phillips et al. 1974) reveals only that the percentage response
to A0% human serum of foetal costal cartilage is greater than
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that of 6-9 month-old pigs. The cartilage of pigs older than two 
years cannot be stimulated under these conditions.
35Injection of S0^ into intact animals of different ages 
and measurement of uptake by growing cartilage is an index of 
cartilage responsiveness as modified by its metabolic and 
hormonal milieu. This technique demonstrates a declining uptake 
as age increases after birth in rat tibial epiphysis (Murphy et al. 
1956), rat femoral epiphysis (Dziewiatowski 1954) and rat costal 
cartilage (Salmon et al. 1963). In the mouse costal cartilage 
uptake rises in males until five weeks of age and then declines 
and in females falls off slowly from three weeks of age (Herbai 1971a).
By comparing the uptake of S0^ by normal and osteoarthritic 
human articular chondrocytes in culture in response to 
stimulation by normal and heat-inactivated sera Schwartz et al. 
(1974) have clearly shown that the biosynthesis of sulphated 
proteoglycans is controlled by both serum and cellular factors.
The direct experimental evidence for changes in end-organ 
responsiveness is therefore scanty, but the theoretical argument 
is strong and supported by many authors who write of "alteration 
in end-organ potential" (Daughaday et al. 1959), of "decreasing 
ability .... to respond to somatomedin" (Tanner 1972) and of 
growth depending on "both humoral growth factors and on the 
sensitivity of the individual to these factors" (Hall & Filipsson 
1975).
CHAPTER 7
EXPERIMENTAL ANIMALS
7.1. Rabbits
New Zealand white rabbits were used in the study. The breeding 
stock of 12 does and 3 bucks were purchased from a South African 
champion breeder who had maintained the strain in a large, closed 
colony for 18 years by line-breeding (Portsmouth 1962). The 
unusually long time for which the strain had been maintained and 
the similarity of the physical size and appearance of the 
breeder's herd suggested a high degree of homogeneity.
Housing. The experimental colony was housed in a brick- 
walled room 5m by 9m and 4m high. Overhead artificial lighting 
was used in a 12 hour light - 12 hour dark cycle. Temperature was 
maintained at 18 - 1°C by a reverse-cycle air-conditioner.
Humidity varied between 55$ and 70$.
Breeding stock were kept in galvanized mesh cages measuring
2
130cm x 7Qcm x 60cm, giving a floor surface of 0,91m . After 
weaning, growing rabbits were kept in galvanized mesh cages
2
measuring 70cm x 70cm x 45cm, giving a floor surface of 0,49m .
These cages sizes exceed the Universities' Federation for Animal 
Welfare (UFAW) recommended minima (Adams et al. 1966). Breeding 
and growing cages were built on mobile racks in tiers of four.
There were 12 breeding and 25 growing cages.-
Sawdust in the excreta trays was changed daily. Trays, 
cages and the house floor were washed down weekly with a Hycolin'~^- 
water mixture.
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Feeding, All stock were fed pelleted rations containing 18$ 
protein ( Delmas Milling Rabbit Pellets) which meet the recommended 
nutrient requirements of growing rabbits (National Research Council 
1954). Hoppers were filled twice daily. Adults were given just 
sufficient rations to ensure a steady body weight and all growing 
and lactating stock sufficient to ensure hoppers always contained 
some pellets. Fresh green carrot tops were supplied to all stock 
in the evening. Fresh water was provided by an automatic supply 
system.
Mating procedure. Does were introduced to the buck's cage 
and copulation observed. If the buck's ejaculation was successful 
the doe was examined 13 days later by abdominal palpation (Adams 
1960). If she was pregnant a wooden nesting box measuring 
60cm x 40cm x 40cm containing dry grass was provided on the 28th 
day of pregnancy. If the doe was not pregnant she was put to the 
buck again on the 13th day and the procedure repeated.
A random mating policy was adopted and records kept of all 
matings, pregnancies and litters' progress (Sawin 1950).
Does were considered sterile if 5 or more matings were 
unsuccessful and were destroyed. Three of 27 breeding does, 
including the original 12, were sterile (11$); this compares 
favourably with the figure of 18$ reported by Sawin and Curran 
(1952).
During the four years that the colony was maintained a total 
of 121 litters were born. Of these 104 were born on the 33rd day 
of gestation, 14 on the 32nd day and 3 on the 31st day. Ninety- 
nine litters were raised successfully, the remainder either being 
still-born (11), neglected (6), cannibalized (3) or dying because 
of maternal failure to lactate (2).
The sex ratio at birth was 1,02, as also found by Hammond 
(1925) with 331 female and 337 male rabbits being born.
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The average litter size was 5,5 at birth and in the successfully 
raised litters average size was 5,6 at weaning (Table 3).
TABLE 3 Summary of litters born and reared
Litter Size Number of Litters
At Birth At Weaning
1 1 -
2 4 2
3 4 1
4 19 16
5 31 28
6 33 30
7 17 16
8 8 5
9 3 1
10 1 -
total 121 99
average size 5,5 5,6
Rearing Procedure. All litters were born in the early hours 
of the morning and were inspected on the day of birth. The dead 
and runted babies were removed, all babies sexed and the normal 
ones marked and weighed. Marking was effected by staining either 
crown, neck or rump with gentian violet, mercurochrome or brilliant 
green solutions.
The young were weaned at eight weeks, which was at least two 
weeks after maternal milk supply started to diminish. At weaning 
colony serial numbers were tattoed into the left ears with Indian 
ink. Young were housed in pairs until 12 weeks and then separately.
Rabbits were handled for experimental purposes only by the 
author and the attendant.
For both the growth and endocrine studies only a doe’s second 
and subsequent litters of four to seven young born on the 33rd day
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of gestation were used. This reduced the well recognized 
variability that litter size and length of gestation have on birth 
size and neonatal growth (King 1915; Gates 1925; Spencer &
Coulombe 1965; Kumaresan et al. 1967; Duncan 1969; Park et al. 1971) 
and also reduced variability resulting from different numbers of 
animals per cage prior to weaning (Hughes & Nowak 1973). All other 
offspring were either raised for breeding stock or slaughtered at 
six weeks.
The rabbits of the colony maintained excellent health. There 
were no deaths due to disease and only five rabbits became ill in 
the four year period. Four pregnant does developed the "wet dewlap" 
syndrome, a suppurative skin condition from which no pathogen could 
be isolated and which responded rapidly to shaving of the affected 
area (Sandford 1957). One young rabbit developed non-specific 
diarrhoea which responded rapidly to a kaolin and pectin mixture.
7.2. Rats
The rats were a Sprague-Dawley strain supplied by the 
University of the Witwatersrand Central Animal Unit.
The breeding colony is housed at ambient temperatures with 
natural lighting. A random mating policy is applied.
Litters were raised in 45cm x 20cm x 20cm aluminium cages 
until weaning. Thereafter males and females were housed separately 
in groups of ten in 60cm x 60cm x 20cm aluminium cages. The diet 
was standard rat pellets. All experiments were performed within 
a six week period. Only litters of five to eight animals were used. 
Rats were delivered on the day of experimentation.
CHAPTER 8
A LONGITUDINAL STUDY OF THE GROWTH OF THE RABBIT
Rabbits of all ages are extensively used for laboratory 
experiments and rabbit husbandry is a rapidly expanding 
agricultural industry. In spite of this interest in the rabbit 
little is known of the precise characteristics of rabbit growth 
and no thorough longitudinal growth study has been carried out.
Previous work includes that on body weight by Minot (1908), 
Castle (1929), Lowrance (1953a,b) and Sawin and Crary (1960). 
Waterman (1943) has measured body weight and crown-rump lengths 
of a series of foetuses from 17 to 31 days gestational age. Over 
very limited age ranges data is available for metacarpal and 
metatarsal length and breadth (Crary & Sawin 1949), tibial and 
calcaneal lengths (Crary & Sawin 1949) and skull length for a 
single rabbit (Selman & Sarnat 1953). Ear length growth has been 
reported by Bronson (1958). The only work on skeletal maturation 
describes the number of epiphyseal centres in the hind- and fore­
limbs of.foetal rabbits (Kotas et al. 1971). Several papers 
describe external and dry skeletal dimensions of fully grown 
rabbits (Baumgartner & Sawin, 1943; Latimer & Sawin, 1959, 1962, 
1963). In none of these studies, all of which were on adults, was 
the reproducibility of the measurements reported. Furthermore, 
most of the work of Sawin and his collaborators was on highly 
inbred and mutant strains of rabbit and therefore not of general 
applicability.
This chapter presents reliable techniques for measuring the 
body length on a specially designed measuring board and numerous 
skeletal dimensions by radiography. Further, a novel method of
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deriving distance and velocity statistics is described and 
validated.
8.1. Materials and Methods
Animals. The rabbits used in this study were the New Zealand 
Whites described in Chapter 7. Fourteen litters of 14 proven does 
sired by four different bucks and born on the 33rd day of 
gestation were studied. Litter sizes ranged between four and 
seven. A total of 78 (40 male and 38 female) newborn rabbits 
entered the study. Sixty nine (37 males and 32 females) completed 
the study. Those not completing the study either died under 
anaesthesia (5), all as neonates, or as a result of falling from 
their cages (2) or were excluded because they became permanently 
ataxic after anaesthesia (2). During the course of the study some 
animals were not measured on every occasion for technical reasons 
(omission from the transport list and poor x-ray exposure, for 
example) or one or more measurements could not be made on the 
x-ray plate for technical reasons (animal too lightly 
anaesthetized and raising its head, for example). The study was 
thus a mixed longitudinal one and the group is referred to as the 
'mixed longitudinal group1.
Control series. All other animals in the colony were 
routinely weighed at birth and every sixth day thereafter until 
used for experimental purposes or breeding, or culled because of 
pressure for accommodation. The weights of 134 animals (63 males 
and 71 females) that reached 180 days post-copulation (PC) age 
were extracted from the colony records. These weights served as 
a control series both to assess possible effects of anaesthesia 
and to check the validity of the method of analysis of the 
radiologically studied group. This control series is referred 
to as the 'pure longitudinal group1.
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Examination frequency. All litters were examined on the day 
of birth, usually between 23h00 and OlhOO. Thereafter litters 
were examined on Tuesdays or Wednesdays between 19h00 and 22h00 
at weekly intervals until approximately 90 days PC and at 
fortnightly intervals until approximately 200 days PC.
The examination schedule was determined by the availability 
of the radiological facilities. The apparatus was a Siemens unit 
with 0,6mm focal spot and Tridoros 5s generator at the Johannesburg 
Hospital. The facilities were only available after normal 
working hours and because large numbers of rabbits had to be 
transported several kilometers to and from the Hospital this 
could be organized only on prearranged days of the week. An 
exception was made for the newborn litters which were always 
examined within 24 hours of birth.
Examination Technique. Each rabbit was weighed and then 
anaesthetized with ether. Up to 80 days PC the animal was firmly 
held between the anaesthetist's forearm and body and an 
appropriate sized beaker with ether-damped gauze in the bottom 
held over nose and mouth. Older animals were placed in a 
converted balance box to which a flow-meter and ether vapourizer 
were attached. This modification of Sherrard's (1966) box 
induced anaesthesia which was of slow onset and produced no 
struggling. It thus permitted several rabbits to be under 
induction of anaesthesia simultaneously. Anaesthesia was 
induced before the evening feed and in suckling rabbits at least 
two hours after removal from the mother.
Apparatus. A lever-arm balance calibrated in lg divisions 
up to 5kg was modified by adding a grocer's scale pan to hold 
the rabbits. The balance calibration was checked with standard 
weights at weekly intervals.
Body length was measured from nose tip to tail tip on a
78
specially constructed measuring board, illustrated in Figure 1.
Figure 1. The measuring board used for body length on anaesthetized 
rabbits. A black rabbit is shown for photographic clarity.
Initial experiments showed that the rabbit could be far more 
consistently positioned and that measurements were more 
reproducible in a supine rather than prone position. The 140cm x 
40cm laminated wood base carries the perspex V-shaped body 
holder. The holder has an angle of 110° and is 58cm long. The 
head of the holder is closed with a perspex sheet and at the foot 
is a guide-hole for the sliding rod. The body holder end of this 
steel rod is fixed to a triangular plate which fits exactly into 
the bottom third of the V of the body holder. The other end 
slides in a groove alongside a brass metric rule calibrated in mm. 
When the plate of the rod is against the head of the body holder 
the other end of the rod is opposite zero on the rule.
Although rabbits that are frequently handled can be measured 
while conscious, more consistent results are obtained when they 
are anaesthetized. The anaesthetized animal is placed supine in 
the holder, the neck extended and the nose tip pushed against 
the head board by pressure of the left thumb and forefinger of 
the examiner being applied to the angles of the mandible. The 
right hand ensures that the body of the animal lies symmetrically, 
and then grips and gently pulls the tail out parallel to the
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base of the holder. An assistant slides the rod up to the tip of 
the tail and the examiner indicates when the pressure is adequate 
to have made bony contact. The assistant then reads off the 
body length.
The still anaesthetized animal was then transferred to a 6mm 
thick clear perspex sheet on which were scored fine vertical and 
horizontal lines to guide positioning for x-ray. The animal was 
placed on its ventral surface and held in the position shown in 
Figure 2 with cellotape across limbs, head and tail. Foam rubber 
wedges were used to secure the symmetrical positioning of the body.
Figure 2. Position of the rabbit for radiographic examination.
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The left manus was placed prone, with digits separated, on the 
perspex so that the humerus was approximately at right angles to 
the body axis and to the forearm bones. The right manus was 
pulled caudally at 45° to the main body axis and fixed in a 
supine position. The left foot was positioned with its lateral 
border uppermost in such a way that approximate right angles were 
formed between femur and body axis, femur and tibia and tibia 
and foot. The right hind limb was pulled caudally at 45° to the 
body axis and fixed with the sole of the foot uppermost. The 
snout and tail were fixed in the axis of the body.
The perspex plate was then placed on the 91 x 36cm film 
cassette, the beam centred on the mid-lumbar spine at 130cm 
from the film and exposure made. A Halsey cassette with a Titan 
grid was used throughout. Films were identified by leaded 
figures giving the rabbit number and the date. Exposures 
varied from 50 Kv, 3,2 mAs for 0,01 sec in the newborn to 55 Kv,
5 mAs for 0,015 sec in large animals. Films were developed by an 
automatic processing unit.
At the completion of the study, measurements were made on 
the radiographs with a caliper reading to 0,1mm (Tanner & 
Whitehouse 1955) obtained from British Indicators, Herts,
England. . The following skeletal dimensions were measured 
(Craigie 1948):
Skull length: from the tip of the nasal bones to the 
posterior border of the foramen magnum.
Humerus length, right: from the most proximal point of the 
articular surface of the head to the most distal point of the 
articular surface of the trochlear.
Humerus breadth, right: the diameter of the narrowest point
of the shaft.
Radius length, right; from the most proximal point of the 
articular surface at the elbow to the most distal point of the 
articular surface at the wrist.
3rd metacarpal length, right: the distance between the 
articular surfaces.
5th lumbar vertebra: the length was considered the distance 
between the articular surfaces of the body in the sagittal plane 
and the breadth the diameter of the body at its mid-point.
11th rib length; the rib was divided into two or more 
segments, the inferior borders of which were reasonably straight, 
from the vertebral articulation to the costo-chondral junction. 
Each segment was measured along its inferior margin. The segment 
lengths were summed to give total bony length. The curvature of 
more proximal ribs was too great to permit measurement of their 
lengths.
Ilium length, right; from the tip of the iliac crest to the 
ilio-ischial junction.
Ischium length right: from the ilio-ischial junction to the 
distal tip of the ilium.
Bi-iliac width; the maximum distance between the most 
lateral points of the iliac crests.
Bi-acetabular width: the maximum distance between the 
articular surfaces of the acetabula.
Bi-ischial width: the maximum distance between the distal 
points of the ischia.
Femur length, right: from the most proximal point of the 
articular surface of the head to the most distal point of the 
articular surface of the condyles.
Tibia length, right: from the most proximal point of the
articular surface at the knee to the most distal point of the 
articular surface at the ankle.
Calcaneus length,~left; from the tip of the tuberosity to 
the articular surface with the cuboid.
In young rabbits these landmarks could not always be 
precisely defined as radiographic appearances were blurred due 
to incomplete calcification. Where a reasonable estimate of the 
landmark could not be made by the observer the measurement was 
not recorded.
8.2. Reliability of the measurements
Body length. To estimate the reliability of the method of 
measuring body length ten 38 - 43 days PC and ten full-grown 
rabbits were measured five times by the author and by a second 
observer. The animals were completely removed from the measuring 
board and repositioned for each measurement. For adults the 
within-observer maximum difference was 0,6$ and between observers 
1$. For the young rabbits the maxima were 1$ and 1,4$ 
respectively.
Radiographic measurements. To estimate the reliability of 
the radiographic measurements the author remeasured a 10$ random 
sample one year after the first measurements and a second 
observer measured the same 10$ sample. The reproducibility of a 
measurement is expressed as the mean for all ages of :
lOO x difference between measurements of a given age . 
mean of measurements at that age
The reliabilities are shown in Table 4.
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TABLE 4. Reliabilities of within- and between observer
measurements
Measurement Within- observer Between observers
Skull length 4,7 5,1
Humerus length 5,7 6,1
Humerus breadth 11,6 14,2
Radius length 6,3 7,0
3rd Metacarpal length 7,0 7,9
5th Lumbar vertebra length 2,8 3,6
5th Lumbar vertebra breadth 2,9 3,4
11th Rib length 4,7 5,3
Ilium length 5,6 7,3
Ischium breadth 5,2 6,9
Biliac width 2,1 2,4
Biacetabular width 3,6 4,0.
Bi-ischial width 2,0 2,1
Femur length 2,3 2,8
Tibia length 2,5 3,0
Calcaneus length 6,3 9,8
8.3. Data analysis
Because of the constraints placed on the times when 
radiographs could be taken rabbits were examined on day 33 PC 
and on varying days at the predetermined intervals thereafter.
For example, litter A may have been examined on days 33, 40, 47, 
54, etc., whereas litter B may have been examined on days 33, 38, 
44, 51, etc. This variability made direct calculation of the 
distance and velocity statistics impossible and interpolation 
was necessary.
Two approaches to interpolation in this situation have been 
reported (Goldstein 1970). The first, developed by Patterson 
(1950), depends on using the measurements of the whole sample in
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the region of the target date to derive a suitably weighted 
adjustment for the unknown values of the individual. The second 
method considers the observed measurements available for each 
individual near the target date and the desired value can be 
obtained by the application of standard interpolation formulae. 
This second method of individual adjustment avoids introducing 
biased estimates for individuals whose growth curves are 
different from the one representing the group. The analysis of 
the data in this study is based on this principle of individual 
adjustment.
All data was encoded on computer punch-cards; each card 
holding the data for one dimension, e.g. body length, of one 
rabbit from birth to completion of the study.
A frequency table of the days on which examinations were 
made was derived and from this the days at which interpolations 
were to be effected were selected. The selection was such as to 
have as many actual examination days coincide with interpolation 
days as possible and to give approximate 7 day intervals until 90 
days PC and 14 day intervals between 90 and 200 days PC. On this 
basis days 33, 39, 45, 53, 60, 67, 74, 80, 88, 101, 118, 132, 156, 
171 and 199 were chosen. In applying interpolation formulae 
caution must be exercised when dealing with the end-points of the 
data. In this study the results for days 33 and 199 were not 
used due to lack of necessary information about these end-points, 
respectively for the periods before and after each. However, 
distance results for day 33 could be obtained directly from the 
raw data as all rabbits were examined on day 33 PC.
Interpolations at each of the chosen points were then made 
for each rabbit. The interpolation method used was a spline fit 
described by Pennington (1965). This method fits a section of a 
third-order polynomial through adjacent points which constitute 
the interval containing the point, or points, at which the
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interpolation is to be made. Appendix A contains a listing of 
the general form of the computing programme and the 2 subroutines 
used to accomplish the.interpolation. The means of each 
measurement at each age were calculated from the interpolated 
data to provide the coordinates from which the 'distance curves' 
were plotted. In addition standard deviations and t-test 
statistics for differences between males and females were 
calculated.
The ordinates from which the 'velocity curves' were plotted 
were obtained as follows. The interpolation formula used for 
the spline fit was differentiated and this first derivative 
formula was then used to obtain velocity estimates at the desired 
points. It should be noted that the nature of the spline fit 
used constrains the first and second derivative of the 
interpolating function to be continuous.
For body weight and body length velocities were also 
calculated as 'actual increments'; that is, the increment from 
one examination to the next was calculated for each individual 
rabbit and these increments used to compute the velocities.
In the pure longitudinal group control series body weight 
velocities were calculated as 'actual increments'.
8.4. Results
Body weight (Figures 3, 4, 5, 6; Table 5)
The velocities of body weight growth, determined for the pure 
longitudinal group as 'actual increment' velocity and for the 
mixed longitudinal group as both 'actual increment' and 'first 
derivative' velocity, for males and females are shown in 
Figures 3 and 4. Inspection shows that there is no difference in 
either shape or variability between the curves of the pure and 
mixed longitudinal groups. Further examination shows that the 
two different techniques of analysis of the velocity of the mixed
longitudinal group yield the same curve and degree of variability
Figure 3. Body weight velocity of male rabbits of both the 
mixed longitudinal and pure longitudinal series.
Figure 4. Body weight velocity of female rabbits of both the
mixed longitudinal and cure longitudinal
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Females are largex than males from birth onwards, with the 
difference becoming more marked from 100 days PC onwards (Figure 5).
Figure 5. Body weight of male (•— • ) and female (o--o) rabbits.
Increase in body weight continues well beyond the point at which 
this study was terminated and colony records showed a mean adult 
weight of 4,8kg for females and 4,2kg for males. At no age does 
the sex difference achieve statistical significance (p)>0,05).
The shape of the velocity curve is similar in both sexes, 
rising sinusoidally after birth to a peak at 67 days PC. It then 
declines, more slowly in females, with a definite arrest in the 
rate of decline between about 85 and 130 days PC. This 'shoulder' 
is most clearly seen in Figures 3 and 4. It coincides with 
testicular descent in the male which occurs between 90 and 110 
days PC. There is no clearcut pubertal event in the female 
rabbit, but the timing is similar in the two sexes (Templeton 
1968).
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TABLE 5. Body weight distance and velocity data (means with
standard deviation below and coefficients of variation).
AGE
(days 
pc ) n
DISTANCE
MALE
mean
SD C.V.
(g)
n
FEMALE
mean
SD C.V.
VELOCITY (q/day) 
MALE FEMALE 
mean mean 
SD C.V. SD C.V.
33 37 60,1
6,2
10,3 32 60,4
7,3
12,1 - -
39 37 136,0
32,0
23,5 32 143,0
39,9
27,9 13,1
3,2
24,4 13,8
4,2
30,1
45 37 210,0
33,7
16,1 32 225,1
44,3
19,7 13,7
3,8
27,4 15,1
5,7
38,0
53 37 336,2
53,7
16,0 32 357,3
74,9
21,0 20,1
6,4
31,6 19,9
8,7
43,7
60 37 519,9
74,0
14,3 32 533,8
107,3
20,1 31,8
6,8
21,4 31,5
7,8
24,7
67 37 751,8
118,7
15,8 32 766,1
122,9
16,0 32,3
9,4
29,2 32,9
8,4
25,4
74 37 962,1
187,3
16,0 32 988,2
165,6
16,8 30,0
8,9
29,6 32.6
10.7
32,7
80 37 1130,6
255,7
22,6 32 1177,2
216,7
18,4 28,4
8,6
30,4 30,3
9,3
30,6
88 37 1350,9
321,4
23,8 32 1403,1
272,8
19,4 29,3
8,2
28,0 29,2
103
35,1
101 37 1701,4
317,3
18,7 32 1762,8
316,3
18,0 23,2
6,4
27,5 25,5
8,2
32,2
118 37 2134,9
296,4
13,9 32 2193,5
361,0
16,5 25,1
6,8
27,0 26,2
10,1
38,3
132 37 2432,0
318,6
13,1 32 2522,6
310,0
12,2 18,6
6,3
34,0 18,9
6,2
32,7
156 37 2799,1
305,1
10,9 32 2963,0 
'357,6
12,1 12,7
5,4
42,4 18,8
8,0
42,2
171 37 3021,7
283,2
9,4 32 3168,0
345,5
10,9 11,4
4,6
39,8 15,8
6,7
42,2
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rabbits.
Body length (Figures 7, 8, 9; Table 6)
Body length is greater in the female throughout the growth 
period, but not statistically so (p^.0,05). Growth ceases around 
171 days PC with the female being 3% longer than the male. (Figure 7).
AGE DAYS POSTCOPULATION
Figure 7. Body length velocity of both sexes combined of the mixed 
longitudinal series.
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TABLE 6.
standard deviations below and coefficients of variation).
AGE DISTANCE (cm) VELOCITY (cm/day)
MALE FEMALE MALE FEMALE
(days mean mean mean mean
pc) n SD C.Vo n SD C.V. SD C.V. SD C.V.
21,433 37 15,2
3,4
22,4 32 15,4
3,3
39 37 18,1
6,2
34,3 32 20,2
7,0
45 37 21,6
8,7
40,3 32 24,5
7,8
53 37 26.3
11.4
43,3 32 29,2
10,8
60 37 30,1
13,0
43,2 32 33,6
13,4
67 37 34,3
14,0
40,8 32 37,5
14,2
74 36 37,4
13,8
36,9 32 41,1
13,7
80 36 40,0
13,7
34,3 32 43,6
13,5
88 37 43,1
12,7
29,5 32 46,1
11,4
101 37 46,8
11,2
23,9 32 48,5
11,7
118 37 49,8
9,9
19,9 32 51.3
10.4
132 37 51,9
9,6
18,5 32 53,6
9,4
156 37 54,5
10,8
19,8 32 56,2
10,7
171 36 54,9
10,6
19,3 32 56,8
9,7
34,7 0,64
0,59
92,2 0,68
0,26
38,2
31,8 0,61
0,45
73,8 0,66
0,20
30,3
37,0 0,58
0,24
41,4 0,65
0,10
15,4
39,9 0,56
0,13
23,2 0,62
0,13
21,0
37,9 0,52
0,14
26,9 0,55
0,10
18,2
33,3 0,47
0,18
38,3 0,52
0,11
21,2
31,0 0,41
0,18
43,9 0,43
0,13
30,2
24,7 0,33
0,15
45,5 0,38
0,15
39,5
24,1 0,26
0,11
42,3 0,32
0,13
40,6
20,3 0,23
0,12
52,2 0,25
0,10
40,0
17,5 0,13
0,07
53,8 0,14
0,08
57,1
19,0 0,09
0,07
77,8 0,10
0,06
60,0
17,1 0,07
0,05
71,4 0,07
0,06
85,7
The velocity curve for both sexes combined was calculated by 
both 'first derivative' and 'actual increment' methods. Figure 8 
shows that the two methods again yield curves of very similar 
shape, position and variability.
Figure 8. Body length of male (o— • ) and female (o— o) rabbits.
Both males and females show a slowing in the rate of decline 
in velocity at the time of puberty, with female velocity being 
significantly greater than male at 101 days PC (Figure 9).
Skull length (Figures 10, 11; Table 7).
The female skull is longer than the male from birth until 
growth is complete, but the difference does not reach statistical 
significance (p)> 0,05).
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Figure 9. Body length velocity of male (©— ») and female (o— o) rabbits.
Figure 10. Skull length of male (*— • ) and female (o— o) rabbits.
TABLE 7. Skull length distance and velocity data (means with 
standard deviation below at each age).
AGE
(days
pc) n
DISTANCE 
MALE n
(cm)
FEMALE
VELOCITY (cm/day) 
MALE FEMALE
33 32 2,59 27 2,65
1,19 1,08
39 32 3,17 27 3,32 0,094 0,101
1,37 1,26 0,033 0,031
45 36 3,59 32 3,75 0,079 0,079
1,43 1,28 0,035 0,038
53 37 4,11 32 4,24 0,074 0,066
1,56 1,41 0,049 0,029
60 37 4,56 32 4,68 0,067 0,071
1,70 1,52 0,034 0,039
67 37 4,89 31 5,10 0,052 0,058
1,88 1,64 0,035 0,029
74 37 5,18 32 5,43 0,057 0,061
2,04 1,74 0,031 0,039
80 36 5,44 32 5,69 0,058 0,062
2,13 1,85 0,026 0,035
88 36 5,80 32 6,08 0,047 0,053
2,26 1,95 0,047 0,039
101 36 6,19 32 6,39 0,040 0,036
2,43 2,28 0,022 0,029
118 36 6,37 31 6,60 0,022 0,027
2,47 2,31 0,017 0,021
132 36 6,54 31 6,94 0,014 0,023
2,55 2,40 0,015 0,015
156 35 6,71 31 7,11 0,016 0,018
2,76 2,59 0,028 0,018
171 35 6,73 30 7,09 0,015 0,017
2,94 2,73 0,016 0,043
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The velocity curve shows a rapid fall after birth with a 
small, early puberty 'spurt' in both sexes between 75 and 85 
days PC.
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Figure 11. Skull length velocity of male (0— 0 ) and female (o— o) rabbits.
5th lumbar vertebral length and breadth (Figures 12, 13; Table 8).
In both dimensions the female 5th lumbar vertebra is larger 
than the male at birth and remains so through to adulthood, but at 
all ages p y  0,05 . There is no obvious pubertal change in velocity.
11th rib length (Figures 14, 15; Table 9).
The female rib is longer than the male from birth and this 
becomes more marked after 80 days PC, but at all ages p^0,05 .
Pubertal velocity changes are more marked in the female, where a 
reversal of the progressive fall occurs, while male length velocity only 
plateaus for the duration of puberty. Female velocity is significantly 
greater than male at 88 and 101 days PC.
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Figure 12. 5th lumbar vertebra length and breadth of male (c— *©) 
and female (o— o) rabbits.
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Figure 13. 5th lumbar vertebra length and breadth velocity of male 
(«— ») and female (o— o) rabbits.
TABLE 8. Lumbar vertebra length and breadth distance and velocity data (means with standard
AGE
(days
pc)
deviations below at each age group). Numbers of animals in each group are the same
as tho
DISTANCE
M
se in Table 9 
LENGTH
(cm)
F
VELOCITY (cm/day) 
M F
BREADTH
DISTANCE (cm)
M F
VELOCITY ( 
M
cm/day)
F
33 0,17 0,19 0,38 0,42
0,38 0,35 0,45 0,42
39 0,27 0,30 0,024 0,029* 0,52 0,56 0,019 0,016
0,39 0,35 0,010 0,009 0,46 0,41 0,008 0,008
45 0,42 0,48 0,027 0,031 0,60 0,63 0,011 0,012
0,43 0,39 0,012 0,009 0,48 0,43 0,006 0,007
53 0,60 0,66 0,026 0,021 0,66 0,70 0,012 0,012
0,49 0,44 0,010 0,007 0,50 0,45 0,007 0,008
60 0,77 0,82 0,026 0,027 0,73 0,75 0,011 0,010
0,54 0,48 0,008 0,010 0,52 0,46 0,006 0,006
67 0,91 0,98 0,022 0,023 0,75 0,80 0,014 0,012
0,61 0,54 0,010 0,012 0,55 0,48 0,012 0,008
74 1,04 1,10 0,020 0,019 0,78 0,84 0,008 0,009
0,66 0,58 0,011 0,008 0,58 0,50 0,005 0,006
continued overleaf
TABLE 8. Continued
AGE LENGTH
(days
pc)
DISTANCE
M
(cm)
F
VELOCITY (cm/day) 
M F
80 1,13 1,21 0,017 0,018
0,70 0,61 0,007 0,007
88 1,24 1,30 0,016 0,012
0,75 0,67 0,011 0,005
101 1,37 1,40 0,011 0,009
0,80 0,73 0,011 0,007
118 1,50 1,52 0,009 0,010
0,86 0,77 0,008 0,010
132 1,57 1,63 0,006 0,007
0,89 0,81 0,005 0,005
156 1,59 1,69 0,004 0,005
0,92 0,82 0,003 0,002
171 1,58 1,73 0,002 0,002
0,96 0,84 0,005 0,004
* female mean significantly different from male
BREADTH
VELOCITY (cm/day) 
M F
DISTANCE (cm) 
M F
0,80 0,87
0,59 0,51
0,83 0,88
0,61 0,55
0,87 0,92
0,63 0,59
0,90 0,94
0,64 0,59
0,91 0,96
0,65 0,60
0,91 0,98
0,68 0,60
0,91 1,01
0,69 0,61
0,007
0,006
0,007
0,008
0,007
0,005
0,009
0,005
0,006
0,005
0,007
0,007
0,005
0,006
0,005
0,003
0,004
0,004
0,004
0,003
0,004
0,004
0,004
0,004
0,001
0,004
0,003
0,007
at 5%
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Figure 14. 11th rib length (right) of male (•——«) and female (o— o) 
rabbits.
Figure 15. 11th rib length velocity of male (*— ®) and female (o— o)
rabbits.
TABLE 9 11th rib length distance and velocity data 
(means with standard deviations below).
AGE
(days
pc) n
DISTANCE (cm) 
MALE n 7EMALE
VELOCITY (cm/day) 
MALE FEMALE
33 37 0,90 32 0,92
. 0,64 0,60
39 37 1,22 32 1,38 0,062 0,068
0,75 0,72 0,036 0,038
45 37 1,49 32 1,60 0,059 0,061
0,78 0,74 0,024 0,022
53 37 1,92 32 2,01 0,062 0,064
0,91 0,83 0,028 0,041
60 37 2,23 32 2,34 0,060 0,062
0,99 0,91 0,026 0,028
67 37 2,61 32 2,72 0,056 0,054
1,17 1,03 0,020 0,031
74 36 2,89 31 3,03 0,044 0,044
1,28 1,12 0,024 0,036
80 37 3,08 31 3,26 0,036 0,041
1,36 1,18 0,020 0,033
88 37 3,37 31 3,50 0,031 0,044*
1,47 1,27 0,015 0,030
101 37 3,63 30 3,79 0,030 0,044*
1,57 1,47 0,018 0,028
118 36 4,01 31 4,24 0,031 0,034
1,71 1,60 0,014 0,031
132 36 4,28 31 4,48 0,017 0,020
1,80 1,67 0,014 0,012
156 37 4,49 30 4,72 0,017 0,020
1,98 1,75 0,011 0,015
171 36 4,54 31 4,93 0,016 0,013
2,07 1,81 0,011 0,013
* female mean significantly different from male mean at' 5%
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Pelvic dimensions (Figures 16 to 25; Tables 10,11).
In all dimensions females are either slightly greater than or 
similar to males between birth and 101 days PC, but differences do 
not achieve statistical significance (p^0,05). Thereafter the 
female pelvic measurements become progressively larger than the 
males, ranging from a 19% difference for iliac length to 4% for 
bi-acetabular width at 171 days PC when growth has ceased.
All the female velocity curves show a distinct pubertal 
slowing in their rate of decline. In the male this pubertal 
phenomenon is clearcut only for bi-iliac and bi-ischial width.
Figure 16. Ilium length (right) of male (©—-«) and female (o— o) 
rabbits.
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Figure 17. Ilium length velocity of male (•— #) 
rabbits.
AGE DAYS POSTCOPULATION
Figure 18. Ischium length (right) of male (©-—-€>
rabbits.
200
and female (o— o)
200
and female (o— o)
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Figure 19. Ischium length velocity of male (o— •) and female (o— o) 
rabbits.
Figure 20. Bi-iliac width of male (®— ®) and female (o— o) rabbits
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Figure 21. Bi-iliac width velocity of male (•— • ) and female (o— o) 
rabbits.
Figure 22 Bi-acetabular width of male (©— *) and female (o— o) rabbits
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Figure 23. Bi-acetabular width velocity of male (•— • ) and female 
(o— o) rabbits.
Figure 24. Bi-ischial width of male (®— -e) and female
TABLE 10 Pelvic dimensions distance data in cm, (mean and standard deviations at each age)
Numbers of animals in each group are the same as in Table 9.
BI-ACETABULAR
AGE
(days
Pc)
ILIUM LENGTH ISCHIUM LENGTH BI-ILIAC WIDTH WIDTH BI-ISCHIAL WIDTH
M F M F M F M F M F
33 0,57 0,63 0,54 0,52 0,85 0,84 0,49 0,47 0,41 0,43
0,64 0,58 0,54 0,54 0,65 0,65 0,52 0,61 0,38 0,40
39 0,84 0,91 0,80 0,77 1,23 1,16 0,59 0,52 0,57 0,59
0,70 0,60 0,57 0,55 0,73 0,69 0,51 0,59 0,50 0,48
45 1,12 1,23 1,02 1,05 1,49 1,49 0,71 0,64 0,74 0,77
0,81 0,70 0,66 0,64 0,81 0,77 0,55 0,63 0,51 0,56
53 1,49 1,63 1,36 1,39 1,86 1,90 0,92 0,84 0,85 0,91
0,94 0,82 0,76 0,74 0,93 0,90 0,64 0,71 0,60 0,71
60 1,82 1,96 1,63 1,69 2,23 2,30 1,10 1,04 1,07 1,09
1,07 0,92 0,86 0,84 1,05 1,03 0,69 0,79 0,68 0,73
67 2,08 2,22 1,87 1,91 2,57 2,61 1,27 1,19 1,21 1,24
1,24 1,03 1,00 0,93 1,23 1,16 0,78 0,87 0,77 0,89
74 2,41 2,56 2,23 2,26 2,85 2,89 1,48 1,42 1,89 1,91
1,40 1,18 1,13 1,01 1,35 1,27 0,87 0,95 0,89 1,00
80 2,72 2,89 2,54 2,47 3,13 3,14 1,60 1,57 1,50 1,52
1,56 1,29 1,28 1,16 1,47 1,36 0,93 1,02 0,76 0,79
continued overleaf 105
TABLE 10 continued
AGE
(days
pc)
ILIUM LENGTH ISCHIUM LENGTH BI-ILIAC
M F M F M
88 3,07 3,20 2,95 2,80 3,40
1,78 1,54 1,47 1,39 1,62
101 3,45 3,55 3,30 3,21 3,70
2,01 1,69 1,64 1,57 1,83
118 3,52 3,97 3,43 3,49 3,84
2,20 1,84 1,76 1,69 1,96
132 3,54 4,10 3,40 3,62 3,83
2,37 2,08 2,00 2,00 2,25
156 3,57 4,17 3,42 3,65 3,86
2,52 2,20 2,11 2,19 2,42
171 3,53 4,21 3,40 3,68 3,82
2,71 2,32 2,38 2,04 2,57
WIDTH
BI-ACETABULAR
WIDTH BI-ISCHIAL WIDTH
F M F M F
3,42 1,81 1,79 1,63 1,64
1,61 1,04 1,18 0,78 0,81
3,71 1,94 1,94 1,75 1,77
1,77 1,16 1,35 0,80 0,96
3,94 2,03 2,05 1,95 1,93
1,84 1,24 1,41 0,90 0,91
3,98 2,00 2,07 2,08 2,01
2,11 1,36 1,54 1,00 1,03
4,14 2,05 2,05 2,10 2,03
2,30 1,46 1,66 0,97 0,99
4,15 2,01 2,10 2,01 2,11
2,39 1,61 1,70 0,93 1,10
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TABLE 11 Pelvic dimensions velocity data in cm/day, (mean and standard deviations at each age)
Numbers of animals in each group are the same as in Table 9.
BI-ACETABULAR
AGE
(days
pc)
ILIUM LENGTH ISCHIUM LENGTH BI-ILIAC WIDTH WIDTH BI-ISCHIAL WIDTH
M F M F M F M F M F
39 0,057 0,061 0,045 0,045 0,061 0,060 0,019 0,020 0,021 0,020
0,013 0,015 0,015 0,020 0,015 0,027 0,010 0,011 0,011 0,010
45 0,056 0,060 0,049 0,047 0,061 0,059 0,028 0,027 0,027 0,027
0,014 0,011 0,015 0,018 0,017 0,023 0,017 0,012 0,019 0,018
53 0,052 0,056 0,053 0,059 0,057 0,061 0,027 0,028 0,029 0,031
0,022 0,025 0,017 0,095 0,017 0,027 0,011 0,011 0,013 0,016
60 0,058 0,057 0,056 0,050 0,054 0,056 0,031 0,034 0,028 0,029
0,025 0,024 0,019 0,025 0,021 0,021 0,017 0,021 0,020 0,017
67 0,056 0,057 0,050 0,063 0,051 0,051 0,032 0,029 0,031 0,032
0,025 0,027 0,021 0,028 0,021 0,022 0,017 0,001 0,012 0,019
74 0,056 0,059 0,060 0,054 0,051 0,050 0,034 0,030 0,032 0,031
0,042 0,044 0,037 0,043 0,035 0,049 0,028 0,019 0,026 0,030
80 0,060 0,055 0,061 0,052 0,042 0,041 0,032 0,029 0,024 0,024
0,052 0,050 0,050 0,046 0,057 0,049 0,028 0,026 0,021 0,019
continued overleaf
TABLE 11 continued
AGE
(days
pc)
ILIUM LENGTH ISCHIUM LENGTH BI-ILIAC
M F M F M
88 0,052 0,049 0,046 0,047 0,035
0,040 0,041 0,036 0,050 0,030
101 0,041 0,039 0,036 0,038 0,033
0,017 0,027 0,023 0,019 0,022
118 0,017 0,038 0,018 *0,036 0,022
0,011 0,028 0,010 0,020 0,060
132 0,012 0,019 0,009 0,017 0,017
0,010 0,013 0,015 0,005 0,028
156 0,013 0,018 0,009 0,018 0,015
0,009 0,014 0,006 0,022 0,009
171 0,010 0,016 0,005 0,016 0,013
0,006 0,023 0,004 0,009 0,007
* female mean significantly different from male mean at 5%
WIDTH
BI-ACETABULAR
WIDTH BI-ISCHIAL WIDTH
F M F M F
0,036 0,028 0,029 0,019 0,020
0,023 0,025 0,023 0,020 0,021
0,031 0,025 0,027 0,019 ' 0,020
0,028 0,016 0,011 0,021 0,023
0,025 0,019 0,020 0,017 0,014
0,019 0,022 0,013 0,016 0,010
0,019 0,008 0,012 0,007 0,009
0,017 0,005 0,005 0,006 0,005
0,022 0,007 0,011 0,006 0,008
0,008 0,008 0,012 0,006 0,006
0,021 0,004 0,006 0,004 0,010
0,009 0,009 0,008 0,006 0,009
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Figure 25. Bi-ischial width velocity of male («— • ) and female 
(o— o) rabbits.
Humerus length and breadth (Figures 26, 27; Table 12).
Females are larger than males throughout, although not 
statistically so (p)>0,05). A small rise in length velocity is 
seen in both sexes between 67 and 80 days PC.
Radius length (Figures 28, 29; Table 13).
Females are larger than males throughout, although not 
statistically so (p^0,05). No clearcut change in velocity occurs 
in relation to puberty.
3rd metacarpal length (Figures 30, 31; Table 14).
Again females are larger than males throughout, although not 
statistically so (p)>0,05). Soon after birth velocity falls off 
steeply with two episodes of a decline in the rate of fall, at 
60 - 74 and 95 - 110 days PC.
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Figure 26. Humerus length (right) and breadth of male (•— o) and 
female (o— o) rabbits.
Figure 27. Humerus length and breadth velocity of male (• ■ o) and
female (o— o) rabbits.
TABLE 12 Right humerus length and mid-shaft breadth distance and velocity data (means with standard 
deviations below at each age group).
AGE
(days
pc) n
DISTANCE
M
(cm)
n
LENGTH
F
VELOCITY (cm/day) 
M F
DISTANCE
M
BREADTH
(cm) VELOCITY (cm/day) 
F M F
33 30 1,30 26 1,44 0,05 0,08
0,78 0,77 0,34 0,31
39 31 1,75 28 1,92 0,172 0,131 0,10 0,13 0,008 0,008
0,93 0,89 0,039 0,030 0,33 0,30 0,004 0,005
45 36 2,27 30 2,30 0,174 0,121 0,15 0,18 0,010 0,010
• 1,03 1,00 0,049 0,032 0,36 0,31 0,004 0,005
53 37 2,88 32 2,96 0,110 0,112 0,21 0,24 0,007 0,007
1,19 1,10 0,034 0,032 0,36 0,33 0,003 0,004
60 37 3,40 32 3,42 0,080 0,081 0,24 0,28 . 0,007 0,006
1,35 1,20 0,039 0,041 0,38 0,34 0,004 0,003
67 37 3,74 32 3,87 0,061 0,064 0,27 0,30 0,006 0,007
1,51 1,33 0,030 0,044 0,40 0,35 0,003 0,004
74 37 4,07 32 4,20 0,064 0,066 0,28 0,32 0,004 0,003
1,65 1,44 0,047 0,034 0,41 0,36 0,003 0,003
80 37 4,38 31 4,56 0,064 0,060 0,29 0,32 0,003 0,004
1,78 1,53 0,026 0,035 0,42 0,36 0,002 0,003
continued overleaf
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TABLE 12. continued
AGE LENGTH
(days DISTANCE (cm) VELOCITY
pc) n_____M_____n_____F________M
88
101
118
132
156
37 4,82 32 4,92 0,053
1,92 1,64 0,032
36 5,19 32 5,30 0,030
2,09 1,92 0,022
36 5,59 31 5,80 0,042
2,22 2,06 0,023
37 • 5,89 32 6,06 0,017
2,33 2,15 0,011
36 6,07 32 6,38 0,019
2,51 2,23 0,012
37 6,09 31 6,54 0,002
2,63 2,28 0,008
(cm/day) 
F
0,058
0,024
0,034
0,020
0,047
0,019
0,026
0,008
0,023
0,009
0,015
0,013
171
BREADTH
DISTANCE (cm) VELOCITY (cm/day)
M F M F
0,31 0,34
0,44 0,39
0,32 0,34
0,44 0,41
0,35 0,37
0,45 0,42
0,37 0,39
0,46 0,42
0,36 0,41
0,48 0,42
0,36 0,42
0,50 0,43
0,005
0,003
0,004
0,002
0,003
0,003
0,004
0,003
0,003
0,003
0,002
0,001
0,002
0,002
0,002
0,002
0,002
0,002
0,002
0,002
0,001
0,002
0,002
0,002
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Figure 28. Radius length (right) of male (©— • ) and female (o— o) 
rabbits.
Figure 29. Radius length velocity of male (•■— ••) and female (o— o)
rabbits.
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TABLE 13. Riqht radius lenqth distance and velocity data
AGE
(days
pc)
(means with standard deviations below at each aqe).
n
DISTANCE 
MALE n
(cm)
FEMALE
VELOCITY
MALE
(cm/day) 
FEMALE
33 32 1,09 23 1,14
0,69 0,69
39 33 1,52 29 1,49 0,061 0,051
0,78 0,73 0,032 0,030
45 37 2,02 31 2,13 0,082 0,065
0,91 0,86 0,021 0,029
53 37 2,52 31 2,66 0,054 0,060
1,07 1,00 0,029 0,022
60 37 2,86 31 3,01 0,070 0,068
1,18 1,10 0,028 0,037
67 35 3,20 30 3,30 0,060 0,068
1,34 1,20 0,030 0,032
74 34 3,49 32 3,62 0,067 0,075
1,45 1,32 0,041 0,049
80 36 3,80 32 3,93 0,051 0,051
1,58 1,40 0,036 0,050
88 37 3,98 32 4,19 0,050 0,052
1,66 1,51 0,124 0,028
101 36 4,32 32 4,30 0,043 0,035
1,78 1,65 0,053 0,013
118 36 4,82 32 4,99 0,030 0,034
2,22 1,84 0,051 0,024
132 36 5,07 32 5,22 0,023 0,021
2,37 1,93 0,015 0,018
156 37 5,34 31 5,51 0,018 0,023
2,21 2,02 0,012 0,010
171 36 5,36 31 5,57 0,002 0,019
2,31 2,04 0,015 0,017
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AGE DAYS POSTCOPULATION
Figure 30. 3rd metacarpal length (right) of male (»-■ ») and 
female (o— o) rabbits.
Figure 31. 3rd metacarpal length velocity of male (»— o) and
female (o— o) rabbits.
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TABLE 14. Right 3rd metacarpal length distance and velocity data 
(means v/ith standard deviations below at each age)
AGE
(days
pc) n
DISTANCE 
MALE n
(cm)
FEMALE
VELOCITY (cm/day) 
MALE FEMALE
33 28 0; 39 16 0,41
0,50 0,56
39 33 0,64 19 0,62 0,036 0,036
0,57 0,58 0,021 0,020
45 36 0,86 28 0,93 0,039 0,036
0,58 0,55 0,017 0,019
53 36 1,11 32 1,20 0,031 0,036
0,66 0,59 0,013 0,045
60 36 1,28 32 1,39 0,027 0,026
0,71 0,63 0,010 0,017
67 36 1,43 31 1,51 0,028 0,027
0,78 0,68 0,012 0,014
74 36 1,57 30 1,65 0,026 0,028
0,84 0,73 0,010 0,016
80 36 1,68 30 1,78 0,019 0,022
0,89 0,77 0,010 0,010
88 36 1,75 32 1,89 0,012 0,017
0,93 0,84 0,006 0,011
101 36 1,89 32 2,00 0,013 0,014
0,98 0,91 0,018 0,005
118 36 2,00 32 2,08 0,007 0,071
1,01 0,94 0,015 0,003
132 36 2,04 31 2,11 0,007 0,053
1,02 0,94 0,007 0,004
156 35 2,02 30 2,16 0,003 0,003
1,07 • 0,96 0,004 0,003
171 35 2,00 30 2,16 0,004 0,004
1,10 0,95 0,003 0,005
Femur length (Figures 32, 33; Table 15)
Females are larger than males throughout, although not 
statistically so (p>0,05), and there is no clear change in 
velocity at the time of puberty.
Figure 32. Femur length (right) of male (»■ —«) and female (o- 
rabbits.
Tibia length (Figures 34, 35; Table 16)
Females are larger than males, but not statistically so 
(p^0,05), and between 80 and 100 days PC the fall in velocity 
declines in both sexes.
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TABLE 15. Right femur length distance and velocity data
AGE
(days
pc)
(
n
means with standard deviations below at each age)
DISTANCE (cm) 
MALE n FEMALE
VELOCITY
MALE
(cm/day) 
FEMALE
33 31 1,32 27 1,24
0,80 0,78
39 35 2,00 30 1,92 0,105 0,104
0,95 0,87 0,043 0,041
45 37 2,57 32 2,67 0,104 0,103
1,09 1,00 0,027 0,053
53 37 3,34 32 3,51 0,092 0,103
1,32 1,22 0,030 0,033
60 37 3,94 32 4,11 0,110 0,098
1,50 1,36 0,023 0,041
67 37 4,42 31 4,62 0,105 0,101
1,73 1,53 0,038 0,037
74 36 4,87 31 5,04 0,090 0,090
1,90 1,66 0,035 0,028
80 37 5,21 32 5,52 0,067 0,074
2,05 1,79 0,025 0,027
88 37 5,57 32 5,77 0,055 0,056
2,21 1,96 0,025 0,028
101 37 6,04 32 6,26 0,044 0,048
2,36 2,21 0,037 0,027
118 37 6,81 31 6,89 0,041 0,031
2,73 2,38 0,038 0,019
132 36 7,10 31 7,10 0,023 0,026
2,87 2,46 0,017 0,014
156 36 7,24 32 7,53 0,014 0,019
2,92 * 2,58 0,008 0,014
171 36 7,30 32 7,67 0,013 0,018
3,07 2,62 0,010 0,016
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Figure 33. Femur length velocity of male (•■— «) and female (o— o) 
rabbits.
Figure 34. Tibia length (right) of male (•— ®) and female (o— o)
rabbits.
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TABLE 16. Distance and velocity data for right tibia
(means with standard deviations below at each age)
AGE
(days
pc) n
LENGTH (cm 
MALE n
)
FEMALE
LENGTH
MALE
VELOCITY (cm/d 
FEMALE
33 32 1,58 27 1,60
0,89 0,81
39 35 2,30 32 2,35 0,113 0,100
1,03 0,90 0,031 0,025
45 37 3,13 32 3,27 0,112 0,109
1,26 1,15 0,018 0,020
53 37 4,14 32 4,30 0,126 0,118
1,56 1,41 0,016 0,021
60 37 4,89 32 5,07 0,110 0,114
1,79 1,61 0,016 0,024
67 37 5,52 31 5,74 0,110 0,115
2,07 1,81 0,030 0,030
74 37 6,13 31 6,32 0,105 0,098
2,31 2,01 0,021 0,024
80 37 6,56 32 6,80 0,081 0,079
2,49 2,14 0,020 0,017
88' 36 7,07 32 7,39 0,069 0,078*
2,71 2,43 0,017 0,029
101 36 7,79 32 8,04 0,066 0,055
2,97 2,73 0,062 0,020
118 37 8,81 31 8,87 0,044 0,038
3,56 3,00 0,057 0,013
132 36 9,19 31 9,29 0,032 0,030
3,72 3,12 0,011 0,010
156 37 9,28 31 9,76 0,014 0,016
3,64 ■ 3,26 0,010 0,008
171 36 9,34 32 9,88 0,011 0,011
3,83 3,31 0,014 0,009
* female mean significantly different from male mean at 5%
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Figure 35. Tibia length velocity of male (•——•) and female (o— o) 
rabbits.
Calcaneus length (Figures 36, 37; Table 17)
The female is larger than the male from birth onwards, but 
there is no statistically significant difference (p^0,05) and 
growth ceases after 120 days PC. Velocity declines rapidly soon 
after birth and no pubertal phenomenon is observed.
Shape changes
Shape changes developing during grov/th may be shown by plotting 
the mean distance values of pairs of measurements against each 
other at successive ages (Hiernaux 1968). Using this technique 
sex differences in shape in addition to those already shown for 
size have been sought (see Figure 38 for an example). For all of
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the following plots (not shown) no changes in relationship have 
been demonstrated: skull length: body length, humerus length: 
radius length, radius length: 3rd metacarpal length, femur length: 
tibia length, femur length: humerus length, ilium length: ischium 
length, ilium length: body length, iliac length: bi-iliac width, 
bi-iliac width: bi-ischial width.
Figure 36. Calcaneus length (left) of male (o— • ) and female 
(o— o) rabbits.
8.5. Discussion
Methods.
The techniques of anaesthesia, body length measurement and 
radiography developed by Hughes and Tanner for the rat (1970a) have 
been successfully modified for the rabbit in this study.
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TABLE 17. Distance and velocity data for left calcaneus length 
(means with standard deviations below at each age)
AGE
(days
pc) n
LENGTH (cm) 
MALE n FEMALE
LENGTH VELOCITY (a 
MALE FEMALE
33 33 0,33 28 0,33
0,43 0,42
39 34 0,64 29 0,64 0,067 0,063
0,51 0,47 0,016 0,019
45 37 1,03 31 1,14 0,068 0,071
0,62 0,61 0,017 0,018
53 37 1,49 32 1,56 0,053 0,057
0,76 0,69 0,009 0,009
60 37 1/77 32 1,85 0,037 0,039
0,84 0,77 0,010 0,013
67 37 1,96 31 2,03 0,033 0,033
0,94 0,83 0,013 0,015
74 36 2,13 31 2,17 0,025 0,031
1,02 0,88 0,013 0,010
80 35 2,22 31 2,34 0,019 0,023
1,06 0,93 0,012 0,015
88 35 2,32 31 2,41 0,018 0,019
1,12 1,02 0,014 0,013
101 34 2,41 32 2,51 0,013 0,010
1,14 1,11 0,011 0,007
118 34 2,52 31 2,62 0,009 0,009
1,19 1,11 0,009 0,006
132 34 2,53 32 2,61 0,006 0,005
1,20 1,11 0,005 0,004
156 36 2,53 32 2,62 0,001 0,001
1,23 1,11 0,007 0,004
171 36 2,54 31 2,61 0,001 0,001
1,31 1,29 0,007 0,006
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AGE DAYS POSTCOPULATION
Figure 37. Calcaneus length velocity of male (•— • ) and female 
(o— o) rabbits.
ILIAC LENGTH cm
Figure 38. Bi-iliac width plotted against iliac length for male 
(•— ■©) and female (o— o) rabbits.
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Ether anaesthesia is remarkably safe, except in neonatal 
rabbits, with a 6,4$ mortality and 2,6% morbidity in the 78 rabbits 
that underwent a total.of 1064 anaesthetics. Comparison of the 
body weight velocities of the pure and mixed longitudinal groups 
reveals no differences between them. This is taken as evidence 
that anaesthesia, to which only the mixed longitudinal group was 
exposed, has no effect on growth. A similar observation has been 
made by Hughes in rats (1970, personal communication). Anaesthesia 
permits precise body measurement and simplifies radiography as 
the restraining methods used by other authors are unnecessary (Crary 
& Sawin 1949; Selman & Sarnat 1953). The within- and between 
observer errors in body length measurement are low and compare 
favourably with those reported for the rat (Hughes & Tanner 1970a).
Body weight at birth varies considerably with length of 
gestation and litter number in the rabbit. This variability is 
greatly reduced by using only litters born on day 33 of gestation 
and numbering four to seven animals. These two manoeuvres reduce 
variability more than expressing ages in days to permit the use 
of litters irrespective of gestation length and artificially 
reducing litter size as has been done by others (Crary & Sawin 1949; 
Hughes & Tanner 1970a). The procedures used in the animals in this 
study gives a coefficient of variation of 11%> for birth weight of 
both sexes combined, compared to that of 18$ for all other litters 
born in the colony.
Radiographic definition was adequate to allow measurement 
of all the skeletal dimensions described except in a few neonatal 
x-rays. However, definition was not adequate to accurately 
describe shape changes in epiphyseal centres and the construction 
of a bone age scale was not possible.
Data analysis had to overcome the problem of unequally spaced 
observations at varying ages. Most classical interpolation methods 
require equally spaced data observations and therefore could not
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be used. The other classical formulae which admit unequally 
spaced data are cumbersome from a computational point of view; 
therefore, a spline fit interpolation formula was used.
By inspection the velocity curves of body weight and body 
length obtained from the first derivative of the interpolation 
equation appear to be identical v/ith those obtained by the more 
conventional method of increment analysis (Figures 3 & 4); strongly 
suggesting that the first derivative method offers a reliable 
description of the growth velocity curve. This is further 
supported by the comparison of the body weight velocities of 
this study with those in the literature (Figures 39 & 40).
Figure 39. Body weight velocity of male rabbits from the present 
study compared with 3 other studies.
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AGE DAYS POSTCOPULATION
Figure 40. Body weight velocity of female rabbits from the present 
study compared with 3 other studies.
The curves for Minot's unspecified strain and Lowrance's mixed 
Himalayan strain were derived from the published distance means 
and therefore are not mean constant curves (Merrell 1931, discussed 
in Chapter 3). The curves of Sawin and Crary are true mean- 
constant curves from a pure longitudinal series of New Zealand 
White rabbits and therefore are strictly comparable with those of 
the present study. Waterman's foetal weight velocities have been 
calculated from his cross-sectional data for "average"-sized 
foetuses. The male curves and the female curves of the present 
study are identical in shape and duration to those of Sawin and 
Crary, but of somewhat lower peak intensity.
Results
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The important features of the rabbit growth curve may be 
summarized by smoothing a selection of curves of various linear 
dimensions. Figure 41 shows the smoothed velocity curves in males 
of body length, skull length, pelvis (i.e. ilium plus ischium) 
length, 11th rib length and tibia length.
AGE DAYS POSTCOPULATION
Figure 41. The smoothed velocity curves of male body length, 
skull length, pelvis length, 11th rib length and tibia length.
The basic pattern is a rise in velocity from some time before 
birth to a peak in the weeks following birth, and then a gradual 
decline. The peak velocity is reached at different ages by 
different parts of the body. As in other animals the skull peak 
appears to occur at or shortly after birth. There is no clear 
cephalocaudal gradient for the other skeletal dimensions, either
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within the limbs, between the limbs or between the axial and 
appendicular skeletons. A marked difference does exist, however, 
between body length with a well-defined peak between 40 and 50 
days PC and body weight between 60 and 70 days PC. The female 
peak intensity is greater than the male in body weight, skull 
length, lumbar vertebra length, rib length, ilium length and 
humerus length. This greater peak plus generally greater 
velocities in the females contributes to the overall larger size 
in the female.
The declining slope of the growth curve is halted temporarily 
at a time related to testicular descent, which is the only 
external indicator of puberty in the rabbit. The dangers of 
drawing conclusions about the host of changes associated with 
puberty from only one event are well recognized (Marshall 1970), 
but there can be little doubt that the relative growth spurts 
observed in many of the bodily dimensions of the rabbit are a 
pubertal phenomenon. In man and other primates this growth spurt 
occurs at a time when the preceding velocity is relatively lower, 
and the spurt appears as a marked rise in velocity (Tanner 1962).
In the rabbit, as in the rat, (Hughes & Tanner 1970a; Swanson & 
van den Werff ten Bosch 1963), the spurt is usually relative, being 
a slowing in the decline of velocity. In some dimensions in the 
rabbit a true spurt is seen, for example, skull length in both 
sexes (Figure 11) and 11th rib length in females (Figure 15).
Where this spurt can be unmistakably discerned there is little 
difference in intensity between males and females, except in the 
11th rib where that of the female is significantly greater. In 
respect of the timing of the spurt there also appears to be no 
difference between males and females.
Sex differences, including those in the pelvis, are purely 
in size and not in shape. This contrasts sharply with the 
situation in man (Tanner 1962), but is similar to that in the rat 
(Hughes & Tanner 1973).
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It is noteworthy that at no age do differences in size 
achieve statistical significance and on very few occasions do 
differences in velocity achieve statistical significance. This 
contrasts with the observations in the rat where the sex 
difference (male larger in this case) becomes significant in all 
dimensions after puberty (Hughes & Tanner 1970a). This difference 
between the two studies is probably caused by the larger number 
of rats studied and the fact that the growth statistics were 
calculated directly from the data without need to resort to 
interpolation. Lack of statistical significance of differences 
in this situation does not preclude biological significance being 
attributed to the differences. For a given dimension of the 
rabbit the pattern of sex difference is highly consistent, females 
always being larger than males, and where changes in difference 
occur these are smooth and progressive. Both of these facts 
strongly suggest biological significance must be attributed to 
the observed sex differences, even in the face of lack of 
statistical significance.
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CHAPTER 9
RABBIT SERUM SOMATOMEDIN
Somatomedin activity in human serum has been widely 
investigated and there have been several reports on rat serum SM 
(reviewed in Chapter 5). Van den Brande and co-workers (1974b) 
have investigated SM in other species including monkey, pig, horse, 
cow, dog, turtle, pigeon and fish. Only in man has a systematic 
study been made of age-related changes in serum SM (Van den Brande 
& Du Caju 1973).
This chapter reports the results of investigation of serum SM 
in the rabbit at all ages from foetal to adult life. The serum 
activity bioassayed is shown to be growth hormone-dependent by 
both porcine and chick cartilage assay systems. The effects of 
fasting on serum SM are also described.
9.1. Assay techniques
Porcine cartilage assay. The method described by Van den 
Brande and Du Caju (1974) was used. A brief outline of this 
method follows:
The costal cartilages and adjacent sternum of a freshly 
slaughtered pig were obtained from the Johannesburg Abbatoir. 
Cartilage was selected personally from a pig weighing 30 to 45kg, 
after slaughter and removal of the viscera. The criteria of 
suitability were a smooth, shiny cut surface and marked resilience 
on bending. Like Phillips et al. (1974) I have observed that 
cartilage that is macroscopically calcified and has a roughened 
cut surface, has an irregular and shallow dose-response curve.
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The excised tissue was placed in saline at ambient temperature and 
transported to the laboratory. Muscle was cleaned off the 4th to 
8th cartilages and each cartilage dissected free. The 2cm zone 
adjoining the rib of each cartilage was discarded. Cartilages 
were then sliced into 2mm transverse sections on a commercial meat 
slicer. From each section between one and five cylinders 2mm in 
diameter were punched by means of the stainless steel punch 
illustrated in Figure 42.
Figure 42; Line drawing of the cartilage punch. The mounting and 
lever portions are a Bosch electric drill holder. The punch (A) is 
machined from hardened stainless steel ana1 has an externally tapered 
end of 2mm internal diameter. A stainless steel rod (not shown) lies 
inside the punch to expel the cartilage cylinder as the handle is 
raised against the stop (B). The hatched cube (C) is of Teflon.
Cylinders were taken from the central and peripheral portions of 
the section, but not closer to the margin than 2mm.
The cartilage cylinders, about 230 in number, were placed in 
a beaker containing 50ml of incubation medium in a shaking water- 
bath at 37°C for 20 hours (overnight). The incubation medium 
was that described by Daughaday and Reeder (1966) and contained:
1. amino acids: cystine 0,05mM, methionine 0,03mM,
phenylalanine 0,05mM, tyrosine 0,06mM, arginine 0,lmM,
lysine 0,2mM, histidine 0,08mM, tryptophan 0,05mM, isoleucine 0,07mM, 
leucine 0,13mM, threonine 0,12mM, valine 0,25mM, glutamine 0,57mM, 
serine 0,llmM and glycine 0,21mM. (All amino acids L-isomers from 
BDH, Johannesburg and Merck, Darmstadt).
2. Krebs phospho-saline buffer (Krebs & Eggleston 1940) 
adjusted to give Na 158,6mM, K 4,56mM, Mg 0,73mM, Cl 118,7mM,
HPO^ 22,2mM and S0^ 0,73mM„ (All salts AR, BDH, Johannesburg).
3. Dextrose (BDH, Johannesburg) lOmM.
4. Antibiotics: streptomycin sulphate (Novo, Johannesburg) 
100/jg/ml,Na benzylpenicillin (Novo, Johannesburg) 100 units/ml 
and kanamycin (Bristol, Johannesburg) lOOyug/ml.
Incubation of the cartilage segments was performed in a 
specially designed rack, shown in Figure 43. The standard and 
unknown sera were diluted with the incubation medium to give 40, 20, 
10, 5 and 2,5$ dilutions and 1ml of each dilution was added in 
triplicate to the pots of the rack. Two cylinders of cartilage 
were placed in the bottom of each tube and the supporting frame 
positioned. The covered rack was placed in an incubator 
(Gallenkamp) for 46 hours without shaking.
In these 10-point assays six unknowns and one reference 
standard filled 105 places in the rack. The remaining three places 
were filled with incubation medium only.
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Figure 43: Line drawing of the incubation rack. The base consists 
of a perspex block into which 108 holes were machined. Teflon 
pots, 1,2cm internal diameter x 1,3cm depth were pressed into 
these holes. The supporting perspex frame (A) holes 108 Teflon 
tubes, 1,0cm internal diameter x 4,3cm depth which have 9 1mm 
perforations in the base. In position the base of each tube lies 
1mm above the base of the corresponding pot. Individual tubes can 
be removed from the frame for cleaning. The whole rack is covered 
with a 27cm x 23cm x 15cm lid.
After 46 hours the frame was removed, lowered into a bath of
normal saline so that the bottom third of the tubes was immersed,
agitated briefly, removed and shaken. Next it was placed in a
35perspex bath, 22cm x 17cm x 2,5cm, containing 2 /jCi/ml of Na„ SO,
3 2 4
(carrier free, Amersham) and 2yuCi/ml H-methyl-thymidine
3
(17 Ci/mmole, Amersham ( HTdr) in incubation medium. Again the 
depth was such that the base of each tube was 1mm from the bottom 
of the bath and the cartilages completely immersed. Incubation was 
continued for 4 hours at 37°C.
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Next the frame was transferred to a siphon bath. The tube 
bases were washed once with water at ambient temperature and then 
heated in water at 80°C for 10 minutes. Thereafter the water level 
was raised and lowered in the bath, with complete emptying of the 
bath after each cycle, for 20 minutes to wash off all unincorporated 
isotope. Measurement of the activity in the effluent was checked 
in a series of assays and found to be at background levels after 
6 to 7 washings. In the 20 minute washing period at least 15 
washings occurred.
The cartilage pairs were then added to labelled glass isotope­
counting vials containing 0,5ml 23N formic acid (Protea, Johannesburg). 
Polyethylene caps were lightly screwed onto the vials and the 
vials heated at 80°C in a water bath for 30 to 60 minutes until 
complete solution had occurred. After cooling 10ml Instagel 
(Packard) was added to each vial.
Activity was determined in a Packard 3390 liquid scintillation
counter with automatic activity analyser (AAA). The AAA setting
3 J.4was adjusted weekly using H and C standards.
Somatomedin potency ratios were calculated on a Hewlett -
Packard 9100 B calculator with plotter and extended memory. Semi-
3
log transformation of HTdr data and log-log transformation of 
35S0^ data yielded linear dose-response curves. The computation 
programme, generously provided by Dr. J.L. Van den Brande, permits 
visual selection of the linear portion of the curve. Linearity is 
then statistically checked at the 95$ level, regression analysis 
performed and the index of precision calculated. The standard and 
unknown responses are analysed for linearity, preparation 
differences, regression, parallelism and heteroscedasticity.
Finney's £ is calculated and finally the potency ratio with 95$ 
confidence limits is calculated. The statistics are those 
developed for classical bioassays (Finney 1964).
136
Chick cartilage assay. The method described by Hall (1970) 
was used to check the validity of the porcine cartilage assay 
for rabbit serum (see 9.2. below). The method used was slightly 
modified from Hall's technique as follows.
Pelvic leaflets of 11-day old White leghorn chick embryos 
were dissected and cleaned by gentle rubbing with gauze. The 
incubation medium was the same as that used for the porcine assay.
The leaflets were preincubated for 2 hours in medium at 37°C.
Three pairs of leaflets were then added separately to 4ml of
each of the 4 dilutions of the standard and unknown sera
(40, 20, 10 and 5%) in 10ml Erlenmeyer flasks. Each dilution
35contained 2yuCi/ml Na£ S0^. Incubation was continued in a 
shaking water-bath (Gallenkamp) at 50 cycles/minute for 6 hours 
at 37°C.
Incubation was stopped by rinsing out the flasks with a 
saturated ^£30^ solution and then heating them at 80°C for 10 
minutes. After standing overnight in a saturated ^£30^ 
solution cartilage pairs were dessicated over ^2^5' we^9hed to 
0,00001g, digested in 23N formic acid and counted in the same way 
as the porcine cartilage.
Reference serum. Three fasting healthy adult males each 
donated 500ml of serum. The pool of sera was aliquotted into 4ml 
lots and frozen at -30°C. Two pools were used in the course of 
the work. The potency ratio of pool 2 compared to pool 1 was 0,98, 
with 95$ confidence limits of 0,89 to 1,07. Correction for this 
difference was made.
Serum S0  ^ concentrations. Although a post-incubation schedule 
was used for the porcine assay, the serum S0^ concentration of the 
rabbits was investigated.
Serum inorganic S0^ was measured by the benzidine colorimetric 
method of Kleeman et al. (1956). The method was shown to have a
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linear response between 10 and 40 ^ ug/ml. Rabbit sera were diluted 
2- or 3-fold with DD h^O before assay. Table 18 shows the results 
of these assays. No sex difference was demonstrated. The over­
all mean concentration was 70,4^ug/ml, and incubation medium 
concentration was therefore adjusted to this concentration, 
i.e. 0,73mM.
TABLE 18. Serum inorganic SO, concentrations in the rabbit
Age Number of Inorganic S0^ ( pq/ml)
(days PC) sera assayed mean (& range)
30 1 (pooled) 74,8 -
37 2 68,4 (61,8 - 75,0)
48 4 73,0 (64,7 - 81,3)
53 3 64,4 (61,7 - 70,2)
88 4 69,8 (65,0 - 73,4)
114 4 77,2 (64,3 - 91,4)
400 5 68,4 (59,3 - 86,9)
Serum amino acid concentrations. Because amino acid
concentrations are critically important in the SM bioassay, serum 
amino acids in the rabbit were measured and compared to those in 
the human reference pool and published values in the literature. 
Amino acid concentrations were determined, after 5% TCA 
precipitation of proteins, in a Beckman auto-analyser. 
Determinations were made on fasting serum from three adult rabbits 
(two female, one male) and three young rabbits aged 43 days PC 
(two males, one female).
Table 19 shows the results of these determinations and 
compares them with published concentrations for human serum 
(Albritton 1952), fasting rabbit serum (Bromer & Chance 1969) and 
the incubation medium (Daughaday & Reeder 1966).
TABLE 19. Amino acid concentrations (mM) in human and rabbit serum
Human Serum
Reference
Pool-
Present study
Normal
Range
(Albritton 1952)
Arginine 0,07 0,06 - 0,2
Cystine 0,06 0,03 - 0,08
Glutamine 0,60 0,41 - 1,16
Histidine 0,06 0,07 - 0,12
Isoleucine 0,04 0,07 - 0,17
Glycine 0,19 0,17 - 0,31
Leucine • 0,15 0,10 - 0,19
Lysine 0,19 0,14 - 0,26
Methionine 0,03 0,02 - 0,04
Phenylalanine 0,04 0,03 - 0,13
Serine 0,09 0,11
Tyrosine 0,07 0,04 - 0,12
Valine 0,27 0,19 - 0,30
Tryptophan 0,04 0,03 - 0,07
Incubation Rabbit Serum
Medium 
(Daughaday & 
Reeder 1966)
Adult 
n = 3
43 days 
n = 3
PC Adult
(Bromer & 
Chance 19< 
n = 8
0,10 0,20 0,19 0,26
0,05 0,11 0,14 -
0,57 0,48 0,63 -
0,08 0,09 0,12 0,14
0,07 0,09 0,08 0,11
0,21 1,14 1,19 1,27
0,13 0,10 0,13 0,17
0,20 0,24 0,30 0,26
0,03 0,05 0,05 0,07
0,05 0,10 0,08 0,09
0,11 0,36 0,29 0,32
0,06 0,14 0,20 0,15
0,25 0,26 0,20 0,29
0,05 0,04 0,03 0,05
139
To determine whether altering the normal (i.e. those described 
by Daughaday and Reeder) amino acid concentrations in the 
incubation medium to match those of the mean concentrations of all 
six rabbit sera measured affected SM activity in the bioassay, a 
porcine cartilage assay was conducted with the results shown in 
Table 20.
TABLE 20. Effect on the bioassay of altering amino acid concentrations
Specimen
in the medium 
Incubation Potency Ratio Index of
Reference
Medium 
amino acid 
composition
normal*
(- 95% limits ) 
standard = 1,00
precision
0,16
Pool
Reference rabbit means 1,06 (0,88 - 1,19) 0,18
Pool
Adult normal 0,67 (0,53 - 0,82) 0,22
rabbit A 
Adult rabbit means 0,73 (0,59 - 0,86) 0,11
rabbit A 
Adult normal 0,54 (0,47 - 0,60) 0,14
rabbit B 
Adult rabbit means 0,55 (0,43 - 0,65) 0,21
rabbit B 
40 day PC normal 0,34 (0,27 - 0,45) 0,23
rabbit pool 
40 day PC rabbit means 0,31 (0,26 - 0,39) 0,17
rabbit pool
* i.e. those described by Daughaday and Reeder (1966). 
Thus alteration in amino acid concentrations, chiefly in glycine
and serine, had no measurable effect on SM activity in the bioassay.
Therefore, in the present study the amino acid concentrations used
in the incubation medium were those described by Daughaday and 
Reeder (1966).
Collection of serum. In post-natal rabbits blood was collected
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by cardiac puncture during light ether anaesthesia between 06h30 
and lOhOO after a 4 - 6 hour fast. In foetal rabbits blood was 
collected from the neck after decapitation. Foetuses were 
delivered by hysterotomy under ether anaesthesia after a 6 hour 
fast.
Blood taken by cardiac puncture was usually venous in 
colour, but occasionally arterial or mixed samples were obtained.
Possible effects of ether anaesthesia and possible 
differences between venous and arterial serum SM were investigated. 
Three adult female rabbits were restrained and venous blood taken 
from the ear. Ether anaesthesia was induced and after 10 minutes 
blood was taken from the ear vein and femoral artery and by 
cardiac puncture, simultaneously. All three cardiac punctures 
yielded venous colour blood. The results of SM assays on 
these sera are shown in Table 21.
TABLE 21. Somatomedin assay of sera before and during ether 
anaesthesia and of venous and arterial sera
Specimen Potency ratio Index of
n = 3 mean (& range) precisioi
Ear vein- 
unanaesthetized
0,59 (0,51 - 0,72) 0,19
Ear vein- 
anaesthetized
0,69 (0,60 - 0,77) 0,17
Femoral artery- 
anaesthetized
0,65 (0,60 - 0,69) 0,23
Cardiac puncture- 
anaesthetized
0,70 (0,58 - 0,79) 0,20
Removal of serum somatomedin inhibitors. Putative SM
inhibitors were removed from sera for some experiments
(Chapters 9, 12 and 13). The pH was adjusted to 5,5 with IN H Cl
and the solution heated at 80°C for 15 minutes. The precipitate 
was removed by centrifugation, the supernatant lyophilized and 
reconstituted to the original volume (Salmon 1972; Cohen et al. 1975).
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9.2. Specificity of the porcine assay.
Hypophysectomy and GH treatment. By definition serum SM 
activity is at least partially GH-dependent (Van Wyk et al. 1974; 
Hall & Van Wyk 1974). The GH-dependence of the activity assayed 
in rabbit serum by the porcine cartilage system was shown by 
treating hypophysectomised rabbits with human GH as follows.
Eleven 80 to 90 days PC rabbits from three litters which had 
been gaining body weight normally from birth were subjected to 
hypophysectomy by the transbuccal approach (White 1933). Under 
ether anaesthesia the soft palate was incised and separated 
with a small intra-oral spring retractor. The now visible nasal 
mucosa was infiltrated with a 2% adrenalin solution and compressed 
until completely blanched, at which time the cavernous foramen 
in the basi-sphenoid became visible. The mucosa was incised in 
the midline from the foramen for a distance of 3 or 4mm rostrally. 
Bone wax was pushed into the foramen. Using a 2mm dental burr 
the bone from the rostral edge of the foramen was carefully 
removed for a distance of 3mm. The underlying fibrous sheet was 
slit open precisely in the midline with an iridectomy knife and 
the pituitary gland bulged into sight. The gland was removed 
by negative pressure through a fine glass pipette. The cavity 
and burr-hole were plugged with bone wax and the mucosal incision 
pulled together but not sutured. The soft palate incision was 
closed with interrupted sutures. Post-operatively animals were 
given 25mg of hydrocortisone intramuscularly and supplied with 10% 
dextrose drinking water.
The peri-operative mortality was high with six animals dying 
within 6 hours of operation. Three further animals died 3 to 5 
days after operation. The remaining two rabbits made excellent 
recoveries and their body weight velocity declined compared with 
their sham-operated litter mates (Table 22).
Ten days post-operatively each rabbit was given lmg of human GH
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(van Rooyen et al. 1974) intramuscularly on two successive days 
and sacrificed 12 hours after the second injection. Scrapings of 
the sella turcica were examined histologically (haematoxylin and 
eosin) and no pituitary tissue was observed. Three littermates 
were given control saline injections and also sacrificed by 
cardiac exsanguination.
Table 22 shows the body weights and serum SM assays 
(sulphation) obtained during this specificity experiment.
TABLE 22. Effects of hypophysectomy and GH-treatment on
rabbit serum somatomedin activity by poreine
assay ( \  is the index of precision)
BODY WEIGHT
10 days 
postop.
% of controls
Pre-op.
\
10 days 
postop. 
\
After
GH-treatment
\
Litter-
mate
control
mean
100 0,46
(0,16)
0,40
(0,19)
0,49
(0,11)
Hypox 
rabbit A
79 0,36
(0,24-0,44)
(0,14)
0,21
(0,16-0,28)
(0,14
0,34
(0,26-0,43)
(0,21)
Hypox 
rabbit B
84 0,48
(0,35-0,61)
(0,13)
0,14
(0,08-0,23)
(0,22)
0,39
(0,30-0,46)
(0,13)
Rabbit serum SM, as determined by the porcine cartilage 
assay, is clearly GH-dependent.
Comparison of porcine and chick assay results. These results 
were confirmed by assaying in the chick cartilage system. There 
was insufficient serum available for a full comparison and so 
pooled sera were used. In addition sera from normal rabbits of 
different ages were also assayed. The excellent correlation 
between the porcine and chick cartilage results is shown in 
Figure 44.
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Figure 44: Comparison of somatomedin activity in the same serum 
determined by both the porcine cartilage and chick cartilage 
methods. Numerals refer to the following sera: 1: - hypox pool 
10 days postoperative; 2: - GH-treated pool; 3: - littermate 
control pre-operative pool; 4: - littermate control GH-treated 
pool; 5: - 36 days PC normal pool; 6 and 7 adult normal pools, 
male and female; 8: - 84 days PC normal pool; 9: - 63 days PC 
normal pool.
Reproducibility of the porcine assay results. The repro­
ducibility of the porcine assay results and the stability of 
rabbit somatomedin at -30°C (relative to the human reference 
standard) was investigated by pooling 5 adult male rabbit sera, 
aliquotting the pool and assaying an aliquot in each of six assays 
at approximately monthly intervals (Table 23).
The method is thus highly reproducible with the variation in 
the six month period falling well within the confidence limits 
of the assay.
S M
TABLE 23. Reproducibility of rabbit serum somatomedin assay 
(sulphation)
Assay date
Date of 
collection
Potency Ratio 
(- 95% limits)
2.6.74
0,63
(0,54 - 0,74)
28.9.74
3.8.74
0,50
(0,46 - 0,55)
15.10.74
19.9.74 
0,59
(0,51 - 0,66)
14.11.74
0,55
(0,49 - 0,60)
0,61
(0,53 - 0,70)
0,60
(0,54 - 0,67)
9.3. Results
Effects of fasting on somatomedin. Twelve adult male 
rabbits were fasted, six for 12 hours and six for 48 hours. Access 
to water was allowed. At the end of the fasting period and again 
after 24 hours free access to food blood was obtained by cardiac 
puncture under ether anaesthesia. Half of each serum specimen 
was heated and acidified (see above) and the resulting four 
specimens from each rabbit were assayed in the same porcine 
assay (sulphation).
Prolonged (48 hour) fasting consistently depresses serum SM 
but overnight (12 hour) fasting has no effect (Table 24).
Heating and acidification consistently depresses the 12 
hour fasting and all fed levels. The effect on the 48 hour 
fasting samples is variable; three remaining unchanged, two 
being depressed and one being elevated (Table 24). Similar 
heating and acidification treatment of the reference pool serum 
depresses its activity to 76% of the untreated level.
Variation of somatomedin with age. Forty eight sera or 
serum pools were assayed for SM activity. In the younger age 
groups the volume was not sufficient for assay of individual 
sera and pooled sera from the same litter were used. Serum
TABLE 24 Effects of fasting on somatomedin
12 hour fast 
heated &
Rabbit normal acidified .
\l» change
A
B
C
D
E
F
G 0,63 0,47 (-25)
H 0,52 0,44 (-19)
I 0,78 0,61 (-22)
J 0,88 0,70 (-20)
K 0,64 0,58 (- 9)
L 0,70 0,62 (-11)
Mean 0,69 0,57 (-16)
normal
0,26
0,74
0,62
0,30
0,42
0,36
0,45
48 hour fast Fed state
heated & 
acidified
{% change) normal
heated & 
acidified
{% change
0,27 (+ 4) 0,43 0,39 (- 9)
0,63 (- 15) 1,13 0,87 (-23)
0,50 (- 19) 0,95 0,81 (-15)
0,32 (+ 7) 0,57 0,43 ' (-25)
0,44 (- 5) 0,49 0,39 (-20)
0,96 (+167) 0,54 0,48 (-11)
0,69 0,56
0,71 0,67 (- 6)
0,59 0,48 (-19)
0,61 0,57 (- 7)
0,73 0,58 (-21)
0,62 0,53 (-15)
0,71 0,63 (-13)
0,52 (+ 16)
0,66 0,58
0,67 0,57
(-19)
(-18)
(-18)
from litters used for the experiments in Chapter 10 was always 
assayed as a pool. Only sera from rabbits gaining body weight at 
the normal rate were assayed. The mean indices of precision of 
the reference standards in the 17 assays were 0,14 for sulphation 
and 0,23 for thymidine. For the unknowns the index means and 
ranges were 0,19 (0,09 - 0,28, n = 48) and 0,28 (0,14 - 0,40, 
n = 47), respectively.
Figures 45 and 46 show the variation with age of SM assayed 
by its sulphation-and thymidine uptake- stimulating potencies 
respectively. By both parameters SM rises progressively from 
low foetal levels to a plateau reached about 150 days PC. There 
is no difference between males and females at any age. The degree 
of variation of the SM level at a given age increases with 
increasing age so that by the time adulthood is reached the range 
is 0,36 to 1,01. It is important to note that SM in serum pools, 
consisting of variable amounts of serum from six or more rabbits 
of both sexes, falls within the range of SM of the individual 
rabbits at all ages. Neither birth (33 days PC) nor puberty 
(approximately 100 days PC) is associated with any clearcut change
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Figure 45: Serum somatomedin (sulphation) variation with age.
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Figure 46: Serum somatomedin (thymidine uptake) variation with 
age.
There is an excellent correlation between the potencies 
estimated by the two different isotopes (r = 0,87).
A plot of the body weight velocity, over the 5 or 6 days 
prior to the serum assay for the individual rabbits and for the 
groups of rabbits used as the source of costal cartilage in the 
experiments in Chapter 10, against serum somatomedin shows no 
correlation, r =“0,39 (sulphation) and r =~0,36 (thymidine),
(Figure 47).
The statistical design of the bioassay permits the calculation
of a potency ratio only when the standard and unknown dose-
response curves are parallel. Non-parallelism occurred with both
3
isotopes in seven samples and with HTdr in one additional sample. 
The age distribution of these non-parallel samples is of interest 
(Table 25).
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Figure 47: Relationship between serum somatomedin and body weight 
velocity in the preceding 5 or 6 days. The velocities described 
by Waterman (1943) have been used for the foetal rabbits - see 
Figures 39 and 40.
TABLE 25. Age distribution of sera giving non-parallelism 
in the assay
Age (days PC) Number
30 1
33 - 37 4
49 - 56 3
9.4. Discussion.
Assay technique and specificity. GH-dependence of the serum 
activity assayed in any cartilage incubation system is a sine 
qua non for the stimulating effects of the serum to be ascribed
to SM (Van Wyk et al. 1974). The specificity of the SM activity
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in rabbit serum was unequivocally proven in both the porcine and 
chick cartilage assays. Treatment of two GH-deficient children with 
GH (Crescormon, Kabi), the details of which are shown in Chapter 13, 
also resulted in a marked rise in SM assayed in the porcine system.
The excellent indices of precision ('X) for both sulphate 
and thymidine uptakes confirms the high degree of precision for 
this assay reported by other authors (Van den Brande 1973). As 
others have also observed the thymidine precision is considerably 
lower than that of sulphate-uptake. Nevertheless 'X was less 
than 0,40 for all thymidine potency ratios. The good correlation 
between the sulphate and thymidine potency ratios has not been 
reported before. This correlation is further evidence, in 
addition to the purification data reported in Chapter 5, that 
these two separate metabolic actions of SM on cartilage are 
resident in the same or very similar serum fractions.
Serum inorganic S0^ concentrations have not been reported 
in the rabbit. The results indicate no difference between males 
and females and no change with age. This latter observation 
contrasts with the finding of a decrease in sulphate in the rat 
with increasing age (Dziewiatowski 1954). Although the post­
incubation schedule in a common bath containing the isotopes in 
medium of fixed composition obviates the problem of a variable 
sulphate pool, the S0^ concentration in the medium was lowered 
to match that of the rabbit serum. This was nevertheless some 
3-fold greater than the human reference pool S0^ concentration 
of 0,19mM.
Serum thymidine estimation was not attempted as this can 
only be achieved accurately by radioimmunoassay (Hughes et al.
1973). Human and mouse serum thymidine concentrations are in 
the order of 10 ^M.
The possibility that the different serum amino acid
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composition of rabbit serum may significantly alter the bioassay 
incubation medium requirements was investigated. In spite of 
major differences in the glycine and serine concentrations and 
other smaller differences, no difference in response was 
obtained when amino acid concentrations v/ere changed from a 
normal human to a normal rabbit profile.
Few authors have reported the times and conditions of 
collection of samples for assay. This work has shown no 
difference between venous and arterial serum and no effect of 
acute ether anaesthesia. It is possible that minor differences 
do exist, but the precision of the assay is not sufficient to 
detect them. These findings are consistent with the concept of 
stability of serum SM acting as a modulator of fluctuating GH 
levels (Daughaday 1971b). Somatomedin does appear to rise in 
response to chronic stress such as repeated venesection (Bozovic 
& Bostrom 1969) and as with other hormone measurements it would 
be wise to define and standardize the conditions under which 
samples are collected.
Finally, the porcine assay provides highly reproducible 
results over a period of time and the stability of rabbit SM 
appears to match that of human origin in the deep-frozen state.
Serum somatomedin variations. As in the rat (Salmon 1972) 
prolonged fasting causes a fall in serum SM in the rabbit. The 
mechanism of this decrease is not entirely clear, but at least 
in one rabbit (F) it was unequivocally due to a thermolabile 
inhibitory factor. In the other five rabbits the decline may 
also have been due to inhibitors, but their removal was either 
not as dramatic as in the case of rabbit F or an equivalent 
portion of the stimulatory fraction was also destroyed by the 
heat-acid treatment, resulting in little net change. This latter 
explanation is favoured because in the other sera, viz. 12 hour 
fast, fed state and reference standard, in which inhibitors were
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presumably not present, the treatment uniformly resulted in a 
modest fall in SM activity.
The role of this inhibitor in the fasting state remains 
unresolved. Since inhibitors, but not necessarily the same ones, 
have also been demonstrated in serum from patients with protein- 
energy malnutrition it is possible that they play a protein­
sparing role by blocking the insulin-like action of SM.
The changes with age of SM in the rabbit are similar to 
those seen in man (Van den Brande & Du Caju 1973). These serum 
SM levels give no indication of the rate of turnover of the 
hormone. In view of the observation that SM is either removed 
from or inactivated in the serum (Daughaday et al. 1968) it is 
possible that the low levels in early life reflect a high rate 
of utilization by rapidly growing tissues. As the growth rate 
slows so the serum level would then rise to a steady plateau 
when growth ceases. This hypothesis is attractive and warrants 
further investigation.
The failure to detect a change in SM levels around birth, 
as has been observed in man (Tato et al. 1975), and during 
puberty may indicate a true lack of importance of these events 
for SM or may again be due to inadequate precision of the assay.
The lack of correlation between serum SM and body weight 
velocity contrasts, at first impression, with the clear 
correlation in children between somatomedin A and stature 
velocity. Even when the correlation coefficient is recalculated 
only for rabbits under 100 days PC, i.e. those growing rapidly, 
no correlation is found, r = 0,41 (sulphation), r = 0,33 (thymidine). 
Hall & Filipsson (1975) only studied children between the ages 
of 7 and 16 years and their correlation was with stature, a 
predominantly skeletal dimension, rather than body weight which 
has many components.
152
INTRODUCTION TO CHAPTERS 10, 11 AND 12
The velocity of growth of a tissue is dependent on both the 
micro-environmental stimuli and the responsiveness of the tissue 
to these stimuli. To quantitate the relative contribution of 
each of these two factors they must be experimentally separated 
and each studied with the other being held constant, insofar as 
is possible. This can only be achieved in vitro where the known 
variables can be controlled. The growth of cartilage is 
particularly suited to this type of in vitro study (Daughaday and 
Reeder 1966, Daughaday 1971a).
In Chapter 9 one aspect of the micro-environmental stimuli 
to cartilage growth, namely serum SM, was investigated. In 
Chapters 10, 11 and 12 aspects of the cartilage response to serum 
in vitro are described.
In Chapter 10 two indices of cartilage metabolism, the uptake 
of thymidine and of inorganic sulphate, by rabbit costal cartilage 
are shown to be age-dependent and closely correlated with the 
velocity of growth of the cartilage. By varying the serum SM 
source, the serum concentration and the duration of incubation 
it will be shown that both basal metabolism and dose-response 
characteristics are a function of cartilage age, not the SM 
stimulus.
Chapter 11 describes experiments that attempt to bridge the 
gap between the in vitro situations in Chapters 9 (serum stimulus) 
and 10 (cartilage response). The experiments consist in short­
term homotransplantation of rat costal cartilages. By both age­
matching the donor and recipient rats and transplanting cartilages 
from rats of different ages into adult rats the stimulus-response
153
conditions are varied in a controlled manner.
Chapter 12 describes the isolation of rabbit costal 
chondrocytes from the matrix and the age-dependency of thymidine 
uptake by the chondrocytes is examined. These cell cultures 
remove a further variable, namely the possible role of the matrix 
in modifying the response of chondrocytes to SM.
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CHAPTER 10
CHARACTERISTICS OF THE RESPONSE OF RABBIT 
COSTAL CARTILAGE IN VITRO
Few studies have been made of the variables that influence 
the response of cartilage to serum stimuli in vitro, and most work 
has concentrated on somatomedin and the host of factors that 
modify its action on cells (see Chapter 5). What little is known 
of the role of age, sex, anatomical site and species in the 
in vitro response of cartilage is discussed in Chapter 6.
In this chapter costal cartilage from rabbits over a wide 
range of ages (15 days PC to adults) is studied. The velocity of 
growth in both length and weight of the fourth to seventh costal
cartilages over this age range has been calculated. The uptake of
3 35thymidine as HTdr and of sulphate as Na£ S0^ in vitro is
quantitated. Aspects of the experimental technique are examined
and the putative serum SM to which the cartilage responds is
shown to be GH-dependent. The correlation between in vitro
cartilage responsiveness and growth velocity is described and
discussed.
10.1. Methods
Rabbit litters of standard size (see Chapter 8) were 
sacrificed between 07h00 and 08h00 under light ether anaesthesia 
by exsanguination. The serum from rabbits of each litter or group 
of litters was pooled and stored at 4°C for use later in the day.
The 4th to 7th ribs and adjoining vertebrae and sternum were 
dissected free. The lengths of the bony and cartilaginous portions
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of each rib were measured by placing a monofilament cotton thread 
along the greatest curvature of the rib, cutting the thread to 
give lengths representing the bony and cartilaginous portions, 
and then laying the threads along a ruler graduated to 0,5mm.
The cartilaginous portion was separated from the sternum and 
from the bony portion through the costochondral junction and 
stripped of adhering soft tissue and perichondrium. Cartilages 
from all rabbits assigned to the experiment were pooled by 
number, i.e. all 4th cartilages together, and when allocations 
were made each assay flask received an equal proportion of 4th, 
5th, 6th and 7th cartilages. Cartilages were placed in 
incubation medium at room temperature for 30 to 90 minutes prior 
to allocation.
Cartilages were incubated in groups in stoppered 25ml
Erlenmeyer flasks at 37°C in a shaking water bath (Gallenkamp)
at 30 cycles/minute. The solutions were dilutions of serum
(either standard human pool or cartilage donor pool) in
incubation medium (described in Chapter 9). After either 4 or 20
hours the cartilages were removed, blotted dry and transferred
35for a further 4 hours to medium containing 2yuCi/ml each of S0^ 
and 'Wdr. At all ages 2ml of solution per cartilage was 
provided. Incubation was stopped by washing the flasks through 
with a boiling saturated solution of ^£50^ for 5 minutes. 
Cartilages then stood overnight at ambient temperature in
saturated solutions of NaoS0..2 4
After rinsing in distilled water and being blotted dry each 
cartilage was divided into costal, middle and sternal thirds 
(zones), each of which was weighed to 0,lmg. Each zone was 
dissolved in 0,5ml 23N formic acid at 80°C for 30 - 40 minutes. 
After cooling 10ml Instagel was added and activity of both 
isotopes determined by liquid scintillation counting as described 
in Chapter 9. In cartilages from rabbits older than 100 days PC
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each zone had to be divided into half for solution in the formic 
acid.
10.1.1. Calculation of velocity of growth. To obtain 
an estimate of the mean length velocity of cartilage growth the 
following procedure was adopted. The lengths of all measured 
ribs (4th to 7th inclusive) of all rabbits of a given age were 
summed and a mean length for bony and for cartilaginous portions 
calculated. From the means at each age mean velocities for the 
intervals were calculated. By linear interpolation between the 
mid-points of these intervals, velocity at each of the ages 
studied was derived. Velocity at the first age studied, viz. 15 
days PC, was obtained by linear extrapolation from the two 
adjacent velocities.
The same method was applied to obtain velocity estimates 
for cartilage weight.
10.1.2. Autoradiography methods. Thymidine incorporation 
into cartilage was also studied by autoradiographic techniques.
Costal cartilages were dissected out as before, but not
stripped of perichondrium. They were incubated in 2ml medium/
3 orib containing 10^Ci HTdr/ml at 37 C for 3 hours. Half of the 
cartilages from each rabbit were processed for liquid 
scintillation counting as before and the other half processed for 
autoradiography.
The cartilages for autoradiography were washed in distilled 
water and fixed in fresh Carnoy's solution (3 : 1, 80/S alcohol : 
acetic acid) for 2 hours. Dehydration and embedding in paraplast 
was performed following Humason (1962). Sections of 4 yjm were 
cut and mounted on glass slides..
The slides were dipped in Ilford GS nuclear emulsion and 
stored in absolute darkness for 14 days at 4°C. Thereafter
Kodak Microdol-X was used for development and the slides were then 
lightly stained with haematoxylin. The details of the autoradio­
graphic technique are .those described by Rogers (1972).
Rabbits aged 34, 40, 47 and 54 days were studied. At each 
age both 4th and 6th ribs were examined in two animals. At each 
of the following sites 800 to 1000 cells were counted and the 
proportion of definitely labelled nuclei calculated : 1mm from 
the costochondral junction, the centre of the middle zone, 1mm 
from the sternal articulation. Perichondrial cells were not 
included in the counts.
10.2. Results
The mean lengths and weights and respective velocities for 
the 4th to 7th ribs are shown in Tables 26 and 27. For both 
dimensions the velocity reaches its maximum value just after birth 
(34 days PC), declining progressively thereafter. Length growth 
slows earlier than weight growth, tending to flatten off around 
70 days PC (Figure 48). The ratio bone velocity: cartilage 
velocity remains close to unity throughout the growth period.
4H
1- •
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CARTILAGE WEIGHT MG
Figure 48. Rabbit costal cartilages (4th to 7th inclusive) : 
mean length plotted against mean weight.
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TABLE 26. Mean length and mean length velocity of the cartilaginous
and bony sections of the 4th, 5th, 6th and 7th ribs in
the rabbit. "Ratio" indicates the bone■ : cartilage ratio
Velocity is derived by interpolation - see text.
AGE BODY n LENGTH LENGTH VELOCITY
(days WEIGHT (cm) (cm/day)
pc) (mean)
g Bone Cartilage Ratio Bone Cartilage Ratio
15 9 12 0,88 0,75 1,17 0,021 0,023 0,91
23 19 40 1,12 0,95 1,18 0,041 0,036 1,14
30 41 40 1,49 1,26 1,18 0,055 0,048 1,15
34 62 40 1,73 1,46 1,18 0,057 0,051 1,12
40 144 34 2,07 1,76 1,27 0,055 0,048 1,15
50 381 34 2,61 2,20 1,19 0,047 0,040 1,18
72 841 40 3,29 2,84 1,16 0,019 0,019 1,00
97. 1630 28 3,47 2,98 1,16 0,011 0,011 1,00
123 2224 24 3,86 3,34 1,16 0,014 0,014 1,00
365+ 3147 24 4,71 3,63 1,30 0,001 0,001
TABLE 27. Mean weight <□ nd mean weight velocity of the cartilaginous
sections of ■the 4th, 5th, 6th i□nd 7th ribs in the rabbit.
Veloc:i.ty is (derived by interpolation - see text.
AGE n WEIGHT WEIGHT VELOCITY
(days (mg) (mg/day)
pc)
15 12 2,25 0,32
23 80 6,09 0,64
30 56 11,44 1,45
34 52 18,12 1,68
40 74 28,43 1,56
50 40 40,96 1,27
72 74 67,88 1,33
97 32 103,07 1,22
123 72 129,92 0,90
365+ 24 141,65 <0,01
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TABLE 28. Experiment to demonstrate the lack of influence 
of the volume of incubation fluid on isotope 
uptake. Cartilages were incubated in 20/ 
standard pool serum with volumes of 1ml, 5ml and 
lOml/lOOmq wet cartilage for 4 hours, followed
by 4 hours in isotope - containing medium at the
same volume. "C/S" indicates the icostal zone -
to - sternal zone ratio of isotope uptake.
VOLUME n* dpm/mg AGE OF RABBITS
PER lOOmg 
OF RIB
(- so) 44 days PC C/S 113 days PC C/S
1 ml 12 3H 9630 (673) 2,7 2171 (298) 15,7
35s 967 (111) 1,3 484 ( 49) 1,4
5 ml 12 3H 8651 (910) 2,9 2214 (331) 16,1
35s 839 (214) 1,4 458 ( 74) 1,4
10ml 12 3H 9113 (1001) 2,4 2052 (357) 14,4
35s 908 ( 167) 1,2 427 ( 94) 1,7
*n denotes the number of cartilage segments assayed at each volume
160
The possible influence of variable stimulus, or variable 
substrate supply, per unit mass of cartilage, as a result of 
keeping solution volume constant per cartilage irrespective of 
size, was investigated. Cartilages from two sizes of rabbits,
44 and 113 days PC, were incubated in solutions of 1, 5 and 
lOml/rib cartilage and isotope uptake measured (Table 28). The 
results indicate no significant difference (p}0,05) for either 
isotope at any of the three volumes studied. A volume of 2ml/rib 
was therefore used to ensure that the larger cartilages were 
adequately immersed during incubation.
10.2.1. GH-dependence of SM effect on rabbit costal 
cartilage. To demonstrate that the serum-stimulus to cartilage 
is, at least in part, somatomedin-like in that it is GH- 
dependent the following experiment was performed. Serum from 
a 4 year old child with isolated GH deficiency (basal^GH 1,0 ng/ml 
and no response to adequate insulin hypoglycaemia; SM on porcine 
bioassay 0,14) and serum from a 32 year adult with untreated 
acromegaly (fasting GH 56 ng/ml and no suppression with glucose 
loading; SM on porcine bioassay 1,9) was obtained. The response 
of cartilage from 34 day PC rabbits to normal human serum 
(standard pool), the GH deficient serum and the acromegalic 
serum at 5/ and 20/ concentration was assessed (Table 29). In 
incubation medium and in normal serum responses were 
quantitatively similar to those obtained for 34 day PC cartilage 
in later experiments (see Tables 30 and 31). Stimulation 
occurred at both 5/ and 20/ concentrations. Uptake in the 
SM-poor serum was significantly lower than that in normal serum 
(p<0,05) and no stimulation occurred. On the other hand uptake 
in the SM-rich serum was significantly greater than in normal 
serum (p^0,05) and marked stimulation occurred.
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TABLE 29. The effect of normal adult (standard pool),
hypopituitary and acromegalic human serum on the 
uptake of sulphate and thymidine by rabbit costal 
cartilage,, aged 34 days PC.
Serum Sulphate uptake Thymidine uptake
moles x 10 ^/mg (-SD) moles x 10 ^/mg (-SD)
Incubation
medium
8 6,3
Normal adult 
serum
5% 8 8,4
20% 8 11,7
Hypopituitary
serum
5% 8 5,9
20% 8 6,3
Acromegalic
serum
5% 8 9,9
20% 8 17,6
(2,7) 9,8 (2,3)
(2.6) 13,7 (2,9)
(2.7) 17,9 (3,1)
(2,4)* 9,9 (2,6)*
(3,1)* 10,4 (2,8)*
(2,4) 14,8 (3,1)
(2,7)* 23,7 (4,4)*
n indicates the number of cartilage segments 
assayed in each solution
indicates that uptake is. significantly different from 
the uptake at the corresponding concentration of normal 
adult serum, at the 5% level.
TABLE 30. Uptake of sulphate, moles x 10 ^ m q  wet cai•tilaqe (-SD), by rabbit costal cartilaqe in incubation medium, 20$ standard
pool. serum, and 20$ serum from the cartilage donor rabbits.
AGE BODY n*
(days WEIGHT 4 HOURS INCUBATION 20 HOURS INCUBATION
PC) (mean)
9
Medium 20$ Standard Serum 20$ Donor Serum Medium 20$ Standard Serum 20$ Donor Seri
15 9 16(2)** 4,1(1,7) 5,8(2,3) 2,9(1,8) 3,4 (2,7) -
23 19 12(1) 4,2(2,6) 7,7(2,9) 6,8(2,7)+ 3,1(2,0) 5,0(2,6) -
30a) 8(1) 7,8(1,9) 10,3(2,3) 9,7(2,6) 5,3(2,9) 7,2(3,9) 6,2(4,1)
b) 8(1) 9,0(2,3) 13,4(3,4) 8,5(3,1) - - -
mean 41 8,4(2,2) 11,8(3,2) 9,1(2,9)
34 62 ‘ 8(1) 7,2(3,0) 9,6(3,0) 9,3(2,1) 6,8(4,1) 8,0(2,9) 7,2(4,3)
40a) 8(1) 2,1(0,9) 3,3(2,0) 3,2(2,1) 1,8(1,1) 3,1(1,3) 2,8(0,9)
b) 12(1) 3,8(1,4) 7,5(1,9) 4,9(2,0) - - -
mean 144 3,0(1,2) 5,4(2,0) 4,1(2,0)
50 381 8(1) 3,8(2,3) 5,0(1,8) 4,7(3,2) 3,1(1,7) 3,8(2,7) 3,2(2,7)
72 841 12(2) 1,9(1,2) 2,8(0,9) 2,7(1,3) - - -
97a) 8(1) 1,8(0,6) 1,9(0,7) 1,1(1,7) 1,3(1,4) 1,8(1,0) 1,0(1,2)
b) 8(1) 2,9(0,8) 3,7(1,2) 3,4(2,1) - - -
mean 1630 2,4(0,8) 2,8(0,9) 2,3(1,3) '
123 2224 8(1) 2,0(1,1) 2,1(1,2) 1,8(0,9) 1,2(1,0) 0,7(0,9) 1,0(1,3)
365+ 3147 8(1) 0,09(1,3) 0,2(0,9) - - -
Boiled
44 6(1) 0,008 0,007 - - -
*n indicates the number of cartilage segments iri each group, e.g. 4 hours incubation in medium
** figure> in brackets indicates the number of litters from which cartilage was obtained
+ for this experiment maternal serum was used
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10.2.2. Variation in cartilage responde with age and 
velocity of growth. The in vitro response of cartilage from 
rabbits aged 15, 23, 30, 34, 40, 50, 72, 97, 123 and more than 
365 days PC is shown in Tables 30 and 31. Stimulation was 
provided by 20$ solutions of standard pool and 20$ donor pool 
serum. There was insufficient donor serum in the younger foetal 
rabbits to incubate cartilage in.
At three ages, 30, 40 and 97 days PC, two assays were 
performed on separate occasions. For both sulphate and thymidine 
uptake there was reasonably close agreement at each age with no 
statistically significant difference between any of the pairs 
(p> 0,05).
Sulphate (Table 30). Irrespective of duration of incubation,
4 or 20 hours, or of incubating solution, medium, 20$ standard 
serum or 20$ donor serum, a general age-related pattern of 
uptake emerges. Uptake rises from 15 days PC to a peak at 30 
days PC just before birth. It then falls more or less regularly 
to very low levels in adulthood. Cartilage boiled for 10 
minutes prior to incubation shows no active uptake.
Up to and including 72 days PC 20$ serum stimulates uptake 
significantly (p^0,05). This is true for both standard pool and 
donor sera, except at 30 days PC with 20$ donor serum in the second 
litter (b) studied. In all cases, however, the stimulation by 
the donor serum is less than that caused by the standard pool 
serum. This ranges from a maximum difference after 4 hours 
incubation at 30 days PC of 75$ to a minimum at several ages of 98$.
At 23 days PC a 20$ solution of maternal serum was used as 
there was insufficient foetal serum. No difference in uptake 
compared to that occurring in 20$ standard serum was noted.
The remaining feature of the sulphate uptake is its 
dimunition after 20 hours compared to that after 4 hours incubation.
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This dimunition is consistent for all ages and all incubating 
solutions, ranging from 33$ to 97$.
Thymidine (Table 31). As with sulphate there is a general 
age-related trend for thymidine incorporation to rise from 15 
days PC, but in this case the peak is reached just after birth 
at 34 days PC. Incorporation then falls steadily reaching 
negligible levels in adulthood. Boiled cartilage shows no 
active incorporation.
Again 20%> serum, both standard and donor stimulates uptake 
significantly (p^0,05) at all ages up to and including 50 days PC. 
Thereafter although some stimulation does occur, it is not 
significant.
As with sulphate, the incorporation of thymidine is generally 
less in donor serum compared to standard serum. At 23 days PC 
uptake in 20$ maternal serum is not significantly different from 
uptake in 20% standard serum (p^0,05).
Thymidine, like sulphate, incorporation is also lower at 
20 hours compared to 4 hours except for 20$ standard serum at 
97 days PC. This difference ranges from 30$ to 89$ with a 
tendency for it to be larger at the younger ages when greater 
uptake is occurring.
The correlation between sulphate uptake (Figure 49) and 
thymidine uptake (Figure 50), stimulated by 20$ standard pool 
serum, and velocity of growth in length is excellent. The 
correlations between length velocity and uptake under other 
conditions are good, but the correlations between uptake and 
weight velocity are poor (Table 32).
TABLE 31. Uptake of thymidine, moles x 10
-14 +
/mq wet cartilaqe (-S0), by rabbit costal cartilaqe in incubation medium, 20$ standard
pool serum, and 20$ serum from ■the cartilaqe donor rabbits.
AGE
(days
BODY
WEIGHT
n*
4 HOURS INCUBATION 20 HOURS INCUBATION
PC) (mean)
Medium 20$ Standard Serum 20$ Donor Serum Medium 20$ Standard Serum 20$ Donor Serum
15 9 16(2)** 4,8(1,2) 11,2(1,1) - 3,6(1,1) 10,6(2,0)
23 19 12(1) 6,3(2,1) 16,9(2,1) 14,8(3,2)+ 6,0(1,7) 14,3(3,1) -
30a)
b)
mean .41
8(1)
8(1)
9,3(2,0)
8,6(1,9)
9,0(2,0)
18,7(1,6)
21,5(1,9)
20,1(2,0)
12,9(2,3)
16,3(2,9)
14,6(2,7)
9,0(1,8) 18,9(3,0)
34 - 62 8(1) 12,5(1,9) 20,4(2,4) 16,7(3,0) 9,6(1,6) 17,7(4,6) . 14,8(5,3)
40a)
b)
mean 144
8(1)
12(1)
8,6(1,8)
11,2(2,6)
9,9(2,1)
14,2(1,9)
18,4(2,3)
16,3(1,7)
13,6(2,0)
14,7(2,8)
14,2(2,6)
6,4(2,1) 11,4(2,7) 9,2(4,0)
50 381 8(1) 10,4(2,7) 14,0(1,8) 13,3(2,0) 8,3(3,1) 11,3(3,8) 12,4(4,6)
72 841 12(2) 5,6(3,0) 6,1(1,0) 6,2(1,3) 3,9(1,8) 3,5(2,7) -
97a)
b)
mean 1630
8(1)
8(1)
2,9(1,1)
3,8(1,3)
3,4(1,3)
3,3(0,8) 
5,1(1,2)
4,2(1,0)
2,8(1,5)
5,2(2,3)
4,0(1,8)
2,8(1,8) 3,6(1,7) 2,3(1,8)
123 2224 8(1) 2,6(1,9) 2,7(1,1) 2,7(0,9) 1,9(1,8) 1,8(1,3) 1,4(0,9)
365+ 3147 8(1) 0,03(0,4) 0,03(0,4) - - -
Boiled
44 6(1) 0,002 0,003 - - -
*n indicates the number of cartilage segments in each group, e.g, 4 hours incubation in medium
** figure in brackets indicates the number of litters from which cartilage was obtained 
+ for this experiment maternal serum was used
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Figure 49. Correlation between velocity of 
growth in cartilage length and sulphate 
uptake.
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TABLE 32. Coefficients of correlation between both 
length and weight velocity and uptake of 
35 3
sulphate ( S) and thymidine ( H) of rabbit 
costal cartilage
Length Velocity Weight Velocity
Medium 35s 0,65* 0,27
3h 0,91*** 0,60
20% 35s 0,73* 0,23
std.
serum 3h 0,94*** 0,30
20% 35s 0,69* 0,53
donor
serum 3h 0,97*** 0,72
Medium 35s 0,64* 0,16
3h 0,87** 0,31
20% 35s 0,65* 0,16
std. o
serum 3h 0,80** 0,05
20% 35s 0,69* 0,60
donor
serum 3h 0,86** 0,64
Note: asterisks indicate that the correlation is
significant at *p<0,05 **p<0,01 ***p< 0,001
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10.2.3. Dose-response characteristics of cartilage. 
Cartilage from rabbits aged 23, 42 and 90 days PC was incubated in 
serial dilutions of standard pool serum from 2,5/2 to 20/2 (Figures 
51, 52 and 53).
23 DAYS PC
r P m
• THYMIDINE 0,98 < 0,01 0,42
16- o SULPHATE 0,86 < 0,1 0,35
4
0
—r------------------------- 1
2,5 5
% STANDARD SERUM
10 20
Figure 51. Response of cartilage from 23 day PC rabbits to 
increasing concentrations of standard pool serum. Sulphate uptake
in this and Figures 52 and 53 expressed as moles x 10 /mg wet
cartilage and thymidine uptake as moles x 10 mg wet cartilage. 
The serum concentration in these three figures is shown on a 
logarithmic scale.
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Figure 52. Response of cartilage from 42 day PC rabbits to 
increasing concentrations of standard pool serum.
Positive correlations were obtained for both sulphate and 
thymidine uptake at all three ages.
With increasing age the slope of the dose-response curve 
tends to decline for both isotopes.
10.2.4. Investigation of sex differences in cartilage 
response. Cartilage from rabbits aged 41, 88 and 114 days PC was 
incubated for 4 hours with male and female segments kept separate.
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90 DAYS PC
' r P m
• THYMIDINE 0,30 n.s. 0,02
o SULPHATE 0,69 n.s. 0,07
4-
2,5 5 10
% STANDARD SERUM
20
Figure 53. Response of cartilage from 90 day PC rabbits to 
increasing concentrations of standard pool serum.
Incubation medium only, 20% standard pool serum, and at 88 days PC 
20$ donor serum were used. No sexual differences were noted at any 
age in any of the solutions (Table 33).
10.2.5. Ratio calculations. For both sulphate uptake 
and thymidine uptake after 4 hours incubation the costal zone : 
sternal zone ratios are shown in Figure 54. For sulphate the ratio
TABLE 33. Experiment to demonstrate the lack of ony sexual differences in sulphate and 
thymidine uptake by rabbit costal cartilage.
AGE Sex Serum n « « Sulphate uptake Thymidine uptake
(days PC) moles x 10 ^/ mg (^SO) moles x 10 ^/mg (iso)
41 male medium 8 2,7 (0,8) 9,9 (2,3)
female 12 2,9 (0,9) 9,6 (2,0)
male 20$(3^ 12 4,6 (2,1) 17,7 (2,3)
female 8 5,1 (1,8) 16,8 (2,9)
88 male medium 8 2,2 (0,7) 4,3 (1,8)
female 8 1,9 (0,8) 4,9 (1,3)
male 20$ 8 3,3 (0,9) 5,2 (1,6)
female 8 3,1 (0,9) 5,4 (1,7)
male 2 0 $ ^  donor 8 2,9 (1,1) 5,0 (1,3)
female 8 3,1 (0,9) 4,8 (1,1)
114 male medium 12 2,0 (1,0) 2,0 (1,1)
female 8 1,8 (0,9) 2,2 (0,9)
male 20$ 8 2,4 (0,8) 2,9 (1,3)
female 12 2,0 (1,2) 3,0 (1,5)
Note: (l)n indicates the number of cartilage segments in each group
(2) incubation medium only (3) solution of 20$ normal adult human serum (standard pool) 
(4) solution of 20$ serum from the cartilage donor rabbits 171
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remains near unity throughout the age range studied. For thymidine, 
however, the ratio rises from unity before birth to between 10 to 
15 around 100 days PC. Thereafter it declines reaching unity 
again in adulthood. The ratio in incubation medium only .mains 
consistently lower than the ratio in serum. No pattern of 
difference between standard pool and donor serum emerges.
Figure 54. Ratios of uptake of sulphate and thymidine in costal 
zone of the rib cartilage to uptake in the sternal zone.
The thymidine-sulphate molar ratio exhibits one feature of 
interest (Figure 55). Ranging between one and three before birth 
and in the immediate peri-natal period, it then rises slightly 
at 40 days PC before gradually falling towards unity at 123 
days PC and in adulthood.
10.2.6, Thymidine incorporation by autoradiography. The 
results of these experiments are expressed as the number of 
definitely labelled nuclei per 1000 cells counted (Table 34).
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Figure 55. Ratios of uptake of thymidine by the whole cartilage 
to uptake of sulphate on a molar basis per unit mass of cartilage.
TABLE 34. Autoradiographic measurement of thymidine uptake by
rabbit costal cartilage. The C/S ratio indicates the 
ratio of the number of labelled cells/1000 cells in the 
sternal zone.
AGE MEAN NUMBER OF LABELLED CELLS/1000 CELLS
(days PC)
Costal Middle Sternal Whole C/S ratio
Zone Zone Zone Cartilage
34 4th 26,0 12,9 17,7 18,9 1,45
6th 26,1 16,8 16,7 19,9 1,56
40 4th 31,7 3,6 12,4 15,9 2,56
6th 27,7 4,5 13,3 15,2 2,08
47 4th 32,0 5,0 11,1 16,0 2,90
6th 26,8 6,7 5,4 13,0 4,90
54 4th 21,0 2,6 2,2 8,6 9,50
6th 21,2 2,4 2,0 8,5 10,60
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These results show an age-related trend in thymidine 
incorporation in chondrocytes. From 34 days PC there is a fall 
in incorporation with age, so that three weeks after birth 
(54 days PC) the number of labelled cells is less than half the 
number immediately after birth. As conditions of incubation for 
autoradiography differed from those for liquid scintillation 
counting quantitative comparisons cannot be made between the 
results obtained by the two methods. Qualitatively, however, the 
two methods show a similar decline in incorporation from 34 days PC 
onwards, (cf. Table 31).
The costo-sternal ratio for thymidine incorporation shows a 
progressive rise from 34 days PC onwards, starting just above 
unity and reaching the region of ten at 54 days PC. In this 
situation direct comparison with the liquid scintillation is 
possible, and almost identical results were obtained (cf. Figure 54).
10.3. Discussion
The in vitro method of assessing cartilage responsiveness has 
unique advantages over in vivo methods. These advantages outweigh 
the technical difficulties and artificial conditions of the method 
(Chapter 6; Daughaday and Reeder 1966) and include controlled 
exposure to nutrients, stimuli and radio-isotopic labels.
The method used in these experiments is a modified version of 
that of Heins et al. (1970). The modifications improve on the 
method of these authors in several respects. The possible 
influence of variable volume of incubation fluid relative to the 
cartilage mass has been shown to be negligible (Table 28). The 
serum stimulus to cartilage has been shown to be GH-dependent 
(Table 29) and therefore, by inference, to be SM or SM-like 
(see Chapter 5.11). Direct proof of the exact nature of these 
serum fractions must await the availability of purified somatomedin. 
Further, the uptake of both sulphate and thymidine has been shown
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to be active since boiled cartilage exhibited no uptake (Tables 30
and 31). The final advantages of the present method are the range
of sera used, the use of both a standard serum and a donor serum
pool for stimulation and the use of the two time periods for
incubation, namely 4 hours and 20 hours. The biological fate 
35 3of the SO^and the HTdr has not.been examined in this present 
work. Previous authors have amply investigated this question and 
shown that chondroitin sulphate and nuclear DNA are the respective 
end-products of these molecules in cartilage (evidence summarized 
in Chapters 5 and 9). The autoradiographic observation that the 
labelled thymidine is incorporated in cell nuclei and the 
similarity of qualitative results for thymidine incorporation by 
the liquid scintillation and autoradiographic methods do offer 
some evidence from the present work that DNA synthesis is 
stimulated by SM.
A major problem that has largely been overlooked in the 
literature on end-organ responsiveness is the relationship of 
the responsiveness to growth velocity. Authors have used either 
chronological age or distance parameters, such as body weight or 
length, as yardsticks. Logically it is the velocity of growth of 
the tissue being studied that should be the yardstick. In this 
study an attempt has been made to estimate the velocity of growth 
of the costal cartilages. By measuring a large number of 
cartilages at each age the errors resulting from the derivation 
of velocity by linear interpolation may have been offset to a 
degree. The absence of longitudinal data for costal cartilages 
precludes validation of the method used here. However, comparison 
of the length and length velocity obtained by longitudinal study 
of the bony portion of the 11th rib (Table 9 in Chapter 8) with 
that of the mean of the bony portion 4th to 7th ribs (Table 26 
in this chapter) shows values of a similar order. This similarity 
suggests that the cross-sectional method used in this study is a 
valid one.
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At this point it is worth noting why the 1st to 3rd and 8th 
to 12th ribs were not used for assay purposes. The small size of 
the cranial ribs and the extreme thinness of the caudal ribs 
presented many technical difficulties that made rapid preparation 
for incubation impossible. This delay and the additional trauma 
to which small cartilages were subject greatly increased the 
variability of uptake in early experiments and they were therefore 
excluded from the work reported here. In these early experiments 
where all 12 cartilages were included no evidence of a cranio- 
caudal gradient was found, in contrast to the observations of 
Herbai in the mouse (1970a).
The most important result of this work is the demonstration 
of a significant correlation between the responsiveness of 
cartilage and its velocity of growth in length (Figures 49 and 50 
and Table 32). This significant correlation occurred irrespective 
of whether cartilage was incubated for 4 or 20 hours in medium 
only, in 20$ standard serum or in 20$ donor serum. The 
correlation coefficients were consistently higher for thymidine 
(p <0,001 or p<0,01) than for sulphate (p<0,05). The 
correlation with weight velocity did not achieve significance 
under any conditions. These results may be interpreted to mean 
that the major determinant of growth in length is cell 
multiplication and that chondroitin sulphate synthesis is of 
lesser importance. The fact that neither DNA synthesis nor 
sulphation correlate with the growth in weight suggests that other 
metabolic processes are more important in this respect. Studies 
of the rate of collagen and chondromucoprotein synthesis are 
more likely to yield significant results since these constituents 
contribute the greatest bulk in cartilage. The thymidine-sulphate 
ratio does, however, provide one item of evidence suggesting that 
sulphation may contribute substantially to weight growth. This 
ratio falls progressively after birth (Figure 55) indicating that
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mitotic activity slows down more rapidly than chondroitin 
sulphate synthesis. The start of this decline and the point at 
which growth in weight continues after growth in length has all 
but ceased (Figure 48) are similar (70 days PC). The origin of 
the SM stimulus does not appear to influence the outcome of the 
stimulus-tissue interaction since there is no difference in the 
correlation coefficients for standard and donor sera.
The slopes of the dose-response curves also provide evidence 
that the responsiveness of the cartilage varies as a function of 
age (and growth velocity) and not of stimulus. Over this wide 
range of serum concentrations consistent age-specific trends in 
both sulphate and thymidine uptakes were observed (Figures 51-53). 
As cartilage ages and velocity of growth declines the response to 
stimulation diminishes until at 90 days PC the slopes are very 
shallow indeed. This suggests that the number of growing cells 
is diminishing with age and this is corroborated, at least for 
thymidine, by the results obtained by autoradiography (Table 34), 
and for both sulphate and thymidine by the progressive rise with 
age in the costo-sternal ratio (Figure 54). This rise suggests 
a progressive localization of the growth zone towards the costal 
end of the cartilage. In adulthood when no growth is occurring 
the ratio returns to unity, a situation obtaining in the foetal 
stages when the whole cartilage is actively growing. This costal 
end growth zone is clearly similar to the one described in the rat 
(Evans et al. 1948) and analogous to the epiphyseal plate of long 
bones.
The failure to demonstrate a sexual dimorphism in cartilage 
responsiveness in vitro (Table 33) and the lack of any such 
dimorphism in serum SM (Chapter 9) suggest that either no 
dimorphism exists in the growth rate of the costal cartilages 
studied or that additional unidentified factors operate in vivo.
Rabbit foetal cartilage metabolism is undoubtedly SM-dependent
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since 20/S serum results in significant increases (p <T),05) in both 
sulphate and thymidine uptake at all three foetal ages studied 
(Tables 30 and 31 and Figure 51). This observation contrasts with 
that of Heins et al. (1970) in the rat, but as shown in Chapter 11 
their findings may not be generally applicable to the rat, or to 
any other species.
Finally, the fall in both sulphate and thymidine uptake after 
20 hours incubation compared to that at 4 hours deserves brief 
comment. In the light of observations by other workers (Daughaday 
and Reeder 1966; Van den Brande 1973) this fall, especially for 
thymidine, is surprising and unexplained. The consistency of its 
occurrence at all ages suggests that a common factor is responsible. 
This factor may be suboptimal in vitro supply of nutrients or 
physical conditions and warrants further study.
10.4. Conclusions
Several important conclusions may be drawn from the work 
described in this chapter.
The GH-dependence of a serum factor(s) that stimulates rabbit 
cartilage sulphation and DNA synthesis has been demonstrated.
While cartilage from growing rabbits of all ages is stimulated 
by serum, the basal uptake and slope of the dose-response curve 
appear to be functions of the age and growth velocity of the 
cartilage, and not of the serum stimulus.
A sexual dimorphism has not been shown in cartilage 
responsiveness, nor in serum SM, and functional basis of the larger 
size of the female rabbit has not been explained.
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CHAPTER 11
COSTAL CARTILAGE TRANSPLANTS IN THE RAT
This chapter describes the response of transplanted costal 
cartilage from rats of different ages in both adults and animals 
of the same age.
The technique was used to complement the in vitro and in vivo 
studies of Chapter 10. In vitro incubations were also performed 
on age-matched cartilages.
11.1. Methods and Materials
Albino Sprague-Dcwley rats were supplied by the University 
Central Animal Unit, as described in Chapter 7. Cartilage donors 
were drawn from two or more litters with equal numbers of males 
and females in each donor group.
The cartilage donors were killed by rapid exsanguination 
under ether anaesthesia. The 4th to 7th bony and cartilaginous 
ribs of both sides and the intervening sternum were dissected out. 
The lengths of the bony and cartilaginous portions were measured 
by placing a monofilament cotton thread along the greatest curvature 
of the rib, cutting it to exact length and then laying the thread 
along a ruler graduated to 0,5mm. The cartilaginous portion was 
separated from the bony through the costochondral junction and 
stripped of adhering soft tissue and perichondrium. The sternum 
was split down the middle leaving the cluster of four cartilages 
joined together. Cartilage clusters were pooled and then allocated 
to one of four protocols:
1: One cluster of cartilages was transplanted into an adult
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male rat. The recipient was lightly anaesthetized with ether. 
Through a mid-line interscapular incision the cluster was 
positioned in a cleft, opened by blunt dissection, in the muscles 
between the scapula and the thoracic wall. A control cluster, 
boiled for 10 minutes in normal saline, was positioned on the 
opposite side of the same recipient. The wound was closed in 
layers.
One hour later the recipient was weighed and given 0,5/jCi/g 
35 3Na£ S0^ and 1,0yuCi/g HTdr by intra-peritoneal injection.
Twenty-four hours later the recipient was sacrificed. The 
transplanted cartilages and the recipient's 4th to 7th costal 
cartilages were removed, cleaned, washed and left overnight in a 
saturated solution of ^£50^. Each costal cartilage, except in 
the case of foetal cartilages, was divided into sternal, middle 
and costal thirds, blotted dry and weighed to 0,01mg. The foetal 
specimens were divided into thirds without separation of the 
individual cartilages. The segments were dissolved in 0,5ml 23N 
HC00H at 80°C, 10ml Instagel added and counted.
2: The same method was followed except that the recipients 
were males of the same age as the donors. Boiled controls were 
not used. Foetal and neonatal recipients could not be used.
3: The same method was followed except that prior to 
transplantation the clusters were pre-incubated for 24 hours in 
incubation medium (Chapter 9) at 37°C. Boiled controls were not 
used.
4: For comparison in vitro uptake was also assessed by the 
methods used in Chapter 10, as follows.
Cartilages were incubated with shaking at 37°C in solutions
of medium and 20% and 40$ dilutions of the standard human serum
pool. After 20 hours the cartilages were transferred for 4 hours
35 3
to medium only containing 2^jCi/ml each of S0^ and HTdr.
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Throughout 2ml of solution per cartilage was provided. Incubation 
was then stopped and uptake measured as before.
Isotope uptake was measured in a group of costal cartilages of 
different lengths. To obtain an estimate of the mean length velocity 
of the cartilage growth the following procedure was adopted: the 
mean length of all cartilages measured at a given age was calculated. 
From these means mean velocities for the intervals were calculated.
By linear interpolation between the mid-points of these intervals 
velocity at each of the ages studied was derived. Velocity at the 
first age studied, viz. 18 days PC, was obtained by linear extra­
polation from the two adjacent velocities. The same method was 
used to obtain velocity estimates for cartilage weight.
11.2. Results
The weights and lengths and respective velocities of the. 4th
to 7th ribs are shown in Tables 35 and 36 and Figure 56.
TABLE 35. Mean weight and mean weight velocity of the cartilaginous 
sections of the 4th, 5th, 6th and 7th ribs in the rat.
Velocity is derived by interpolation - see text
AGE n WEIGHT WEIGHT VELOCITY
(days PC) (mg) (mg/day)
18 96 1,31 0,83
20 80 2,90 0,83
22 96 4,63 0,83
26 96 7,75 0,78
30 96 11,29 0,75
37 96 16,03 0,62
47 96 21,33 0,52
70 80 32,37 0,38
105 80 40,77 0,12
300+ 76 46,80 -
For both dimensions the velocity declines progressively from the 
peri-natal period, the decline being somewhat more rapid for length. 
(Figure 56). The ratio bone velocity : cartilage velocity is
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very close to unity until the age of 70 days PC when it increases 
to 1,71 and it remains elevated at 105 days PC.
TABLE 36. Mean length and mean length velocity of the cartilaginous 
and bony sections of the 4th, 5th, 6th and 7th ribs in 
the rat. "Ratio" indicates the bone : cartilage ratio. 
Velocity is derived by interpolation - see text
AGE
(days
PC)
BODY
WEIGHT
(mean)
n
Bone
LENGTH
(cm)
Cartilage Ratio
LENGTH VELOCITY 
(cm/day)
Bone Cartilage Ratio
18 1,0 32 0,57 0,55 1,04 0,074 0,072 1,03
20 2,6 28 0,70 0,69 1,01 0,068 0,065 1,05
22 5,9 32 0,93 0,81 1,14 0,058 0,059 0,98
26 10,6 28 1,03 1,06 0,97 0,050 0,053 0,94
30 18,4 32 1,18 1,27 0,93 0,057 0,048 1,19
37 25,6 40 1,42 1,35 1,05 0,021 0,026 0,81
47 48,3 32 1,51 1,60 1,06 0,015 0,014 1,07
70 123,4 32 1,96 1,69 1,16 0,012 0,007 1,71
105 152,0 32 2,21 1,87 1,18 0,005 0,003 1,67
300+ 473,1 28 2,47 2,03 1,22 — —
2,0-
Oz
o<
Od<u
1,5
1,0
0,5-
10 20 30 40 50
CARTILAGE WEIGHT mg
Figure 56. Rat costal cartilages (4th to 7th inclusive): mean 
length plotted against mean weight.
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The uptake by the costal cartilages transplanted into adults 
declined progressively from 18 to 105 days PC (Table 37). The 
decline was similar for both isotopes. The decline occurred 
irrespective of whether the cartilage was transplanted immediately 
or pre-incubated for 24 hours before transplantation.
Pre-incubation caused a variable, but consistent, decrease
3
in uptake at a given age. The uptake for H-thymidine was 56-98% 
35and for S0^ 48-88% of the value obtained without pre-incubation. 
Costo-sternal differences were reduced by pre-incubation with the 
ratio for both isotopes falling after incubation at all ages 
except 105 days PC.
Although recipient uptake was not measured in all experiments 
it was fairly constant and in all 4 instances lower than the 
uptake of 105 day PC recipients (Figure 57) Boiled cartilage
showed very low counts.
Figure 57; Uptake of S0^ and H-thymidine by costal cartilage 
transplanted into both adult rats and rats of the same age as the 
donor. The uptake by the costal cartilage of the recipients of the 
same age is also shown. The asterisk indicates that the difference 
between the cartilages transplanted into adults and rats of the same 
age as the donor is significant at the 5% level.
TABLE 37. Costal cartilage transplants into adult rats. Results are expressed as dpm/mg (- SD) for the 
whole cartilage. The ratio of costal zone to sternal zone uptake (0/S) is also shown.
UPTAKE OF UPTAKE OF UPTAKE OF
AGE TRANSPLANTS INTO ADULTS BOILED CONTROLS ADULT RECIPIENTS
(days PC) n immediate
3h 35s
pre-:
3h
Incubated
35s
n
3h 35s
n
3h 35s
18 16 347-68
(2,01)
3079-608
(1,11)
- - - - 8 47±16 
(0,89)
108-48
(1,09)
22 24 290-48
(2,14)
2231-471
(1,27)
202-69*
(1,28)
1520-406*
(1,08)
- - 8 68-27 
(0,89)
108-67
(1,01)
26 16 238-81
(2,66)
1693±287
(1,59)
- - 8 28-17
(1,06)
27^13
(1,03)
- -
30 24 268^49
(2,17)
2068±506
(1,67)
207-38*
(1,23)
1817-604
(0,98)
- - - -
37 22 195^68
(2,31)
853-204
(1,23)
110-78*
(0,91)
548^157*
(1,03)
8 23-16
(1,00)
27-26
(0,86)
73-31
(0,96)
98^78
(0,86)
47 24 208±58
(1,56)
983-301
(1,77)
165±77
(1,07)
743^160*
(0,98)
- - - -
70 16 95±58
(1,03)
524-102
(1,07)
84-63
(0,98)
302-76*
(0,98)
8 28^26
(0,87)
13-21
(0,98)
- -
105 24 93±47
(0,90)
250-98
(0,87)
91-38
(0,98)
120-69*
(0,90)
- - 40-11
(0,99)
26^13
(1,11)
■^indicates that the pre-incubated transplant uptake is significantly lower than 
the immediate transplant uptake at the 5% or lower level . 184
Transplantation with donor and recipient being of the same
age, without any pre-incubation, gave similar results to those
obtained with adult recipients. Uptake of both isotopes increased
from 26 to 30 days PC and then steadily fell until the low levels
of adulthood were approached at 105 days PC (Figure 57). Uptake 
35of S0^ in the transplanted cartilage was lower than that in the
recipients of the same age (70 - 81/0, except at 47 days PC where
3
it was slightly higher (111$). Transplanted uptake for HTdr was
lower at all ages (54 - 86$). There is a good correlation (r=0,9)
3 35between HTdr and S0^ uptake in the transplanted cartilages (Figure 58).
Figure 58. Correlation between the uptake of HTdr and S0^ by 
transplanted rat costal cartilage.
Thymidine uptake in the costal third of the cartilage of 18 
to 37 day PC rats transplanted without pre-incubation was at least 
twice as great as that in the sternal third in both adult (Table 37) 
and same age recipients (not shown). From 47 days PC onwards the
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costo-sternal ratio falls to approximate unity. Except at 26 and
3530 days PC the ratio for S0^ was close to unity.
Pre-incubation lowered the costo-sternal ratio considerably 
and in all cases it approached unity (Table 37).
In vitro incubation yielded a qualitatively similar picture 
to that for transplanted cartilages. It should be noted that the 
ages of the rats studied in this section differ in some respects 
to those in the transplantation section. Rats aged 20 and 304 
days PC were included and no 30 day olds were studied. The 
uptakes and slopes of the dose-response curves are shown (Table 38).
There are several notable features of the in vitro
incubations. The uptake of both isotopes was maximal at 20 days
PC, and then fell progressively to very low levels in adulthood.
The cartilage of the younger of the two foetal ages, 18 days PC,
was relatively refractory to stimulation by SM; a significant
3 35increase (p^0,05) in uptake of both HTdr and S0^ only
occurring with 40$ serum,whereas at 20 days PC 20$ and 40$ caused
significant stimulation. Furthermore, the slope of the dose-
response curve at 18 days PC was more shallow than that at 20 days
3
PC. Significant dose-related stimulation occurred for HTdr up to
3570 days PC and for S0^ up to 105 days PC. At ages greater than 
these the cartilage could not be stimulated.
In addition to basal uptake being greatest at 20 days PC the
35slope of the dose-response curve for S0^ was also greatest at
this age. Thereafter it declined progressively becoming zero at
3
304 days PC. The slope for HTdr was greatest at 22 days PC and
35declined more rapidly than that for S0^ approaching zero at 70 
days PC.
The costo-sternal ratio was not calculated in the foetal rats. 
35For S0^ the ratio remained close to unity with a slight, but not 
consistent, trend to be higher up to 37 days PC. Serum stimulation
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3 35TABLE 38. Uptake of H-thymidine and SO^ by rat costal
cartilage in vitro. Results are expressed as
uptake/mg** of wet cartilage - SD. The ratio of 
costal to sternal zone uptake is shown in brackets.
The slope of the linear regression of the dose-response
curve (m) is also shown.
AGE n 3H (qxlO 12/mq)
days PC MEDIUM 20% SERUM 40fo SERUM m
18 16 20,2 - 4,8 26,6 t 5,8 42,4 - 9,9* 0,56
20 16 48,3 - 2,2 56,3 - 3,4* 78,1 - 4,8* 0,75
22 16 27,9 i 5,4 
(1,49)
52,4 - 8,9* 
(1,97)
71,5 1 8,4* 
(2,31)
1,09
26 16 18,2 ± 4,0 
(2,43)
27,4 - 5,0* 
(2,01)
41,9 - 8,1* 
(2,68)
0,59
37 12 5,7 i 1,1 
(3,67)
8,6 i 2,3* 
(3,96)
11,0 - 2,9* 
(4,70)
0,13
47 16 2,1 i 0,7 
(3,16)
3,7 - 1,0* 
(3,01)
4,2 i 0,7* 
(3,68)
0,05
70 16 0,2 ± 0,08 
(2,03)
0,4 i 0,2* 
(2,17)
0,3 - 0,2* 
(2,86)
0,004
105 16 0,2 i 0,1
(1,04)
0,2 - 0,1 
(0,99)
0,2 ± 0,1 
(0,89)
-
304 16 0,2 - 0,04 
(1,06)
0,2 i 0,1
(0,96)
0,1 - 0,05 
(1,06)
-
* indicates that the response is greater 
than that in medium at the 5% level of 
significance
continued overleaf
loo
TABLE 38.continued
Uptake of
'iR
SO, by rat costal cartilage in vitro.
AGE n
4
35S (q x 10 4/mg)
days PC MEDIUM 20% SERUM 40% SERUM m
18 16 3,4 - 0,8 3,8 - 0,5 4,3 - 0,7* 0,02
20 16 5,4 - 0,3 10,1 - 0,5* 13,7 - 0,7* 0,21
22 16 4,0 - 0,5 
(1,60)
6,9 - 1,1* 
(0,96)
9,0 - 1,7* 
(1,12)
0,13
26 16 4,0 ± 1,1 
(1,11)
4,7 - 0,8* 
(1,30)
6,8 i 1,0*
(1,09)
0,07
37 12 1,6 ± 0,8 
(1,31)
3,5 i 1,1* 
(1,49)
5,7 ± 2,0* 
(1,68)
0,10
47 16 2,1 - 0,4 
(1,23)
2,5 - 0,5* 
(0,98)
5,1 t o,8* 
(1,00)
0,09
70 16 3,7 - 0,8 
(1,09)
3,8 - 0,8 
(0,89)
4,9 ± 1,1* 
(1,13)
0,03
105 16 2,6 - 0,7 
(0,96)
3,3 - 1,1* 
(1,01)
3,5 - 1,2* 
(0,71)
0,02
304 16 0,7 - 0,8 
(0,86)
0,8 - 0,2 
(0,94)
0,7 i 0,1 
(0,98)
** uptake is expressed as jug/lOOmg to 
facilitate comparison with Heins 
et al (1970)
did not increase the ratio for SO.. In contrast the ratio for
3 4HTdr rose to approximately four at 37 days PC and then fell to
unity by 105 days PC. Under conditions of stimulated thymidine
uptake, i.e. with 20$ and 40$ serum compared to medium, the ratio
rose at all ages between 22 and 70 days PC.
The relationships between the cartilage responsiveness, both 
in vivo and in vitro, and the velocity of growth, both in length 
and weight, is shown as correlation coeffients in Table 39.
TABLE 39. Correlation coefficients showing the relationship 
between various measures of rat costal cartilage 
responsiveness and the velocity of growth of the 
cartilage.
Length velocity
Immediate transplant 
uptake - into adults
Immediate transplant 
uptake - ages matched
Age-matched recipient 
uptake
In vitro incubation dose- 
response curve slope
0,94
0,94
0,92
0,92
0,82
0,97
0,84
0,43*
Weight velocity
0,92
0,87
0,81
0,89
0,79
0,88
0,87
0,40*
* not significant. All other values are significant at the 
1$ level.
11.3 Discussion
The technique of cartilage transplantation has been used 
before, but only in studies on the origin of osteogenic cells 
(Holtrop 1966, for example). Crelin (1969) has shown that 
transplanted mouse pelves take on morphological characteristics 
that are host sex-specific. That is to say, transplants from 
young female mice into adult males attain male shape, a qualitative 
feature. To my knowledge there has been no investigation of the 
quantitative aspects of the response of transplanted cartilage.
The results suggest that for the duration of the transplant 
the cartilage is metabolically active. The lower uptake by the 
transplants compared to the age-matched recipients (Figure 57) 
may be caused by several factors. These include the trauma of 
dissection, the immediate tissue reaction of the host site and a 
less effective blood supply. Uptake by the transplanted 
cartilage was undoubtedly an active process as the boiled 
cartilage showed very low activity. Time course studies were 
not done in this study, but Holtrop1s (1966) work suggests that 
osteogenesis does not begin for several days after transplantation. 
Although her paper gives few details it seems reasonable to assume 
that the cartilage in this study did not undergo significant 
osteogenic differentiation in the 24 hour period of transplantation.
Transplant and recipient uptakes are expressed in terms of 
dpm/mg cartilage wet weight. Absolute uptake could not be 
expressed as the endogenous pool sizes of thymidine and inorganic 
sulphate were unknown. The inter-animal variability appears to be 
reasonably small as judged by the coefficients of variation for 
uptake. For thymidine the coefficient ranges between 16 and 28$ 
up to 47 days PC and for sulphate between 17 and 31$ up to 70 
days PC (from Table 37). At the older ages the coefficients are 
greater but because of the low uptakes this is not considered to 
detract from the results. Other authors who also made no
mcorrection for variations in pool size in young rats of equivalent 
ages found similar coefficients of variation (Collins & Baker 1960; 
Chesley 1963). Where correction has been made for variations in 
pool size by measurement of the inorganic sulphate pool (Herbai 
1970b, 1970c) or by the addition of carrier sulphate to the 
radioactive material (Tessler & Salmon 1975) the coefficients of 
variation are no smaller than those in this study or in the others 
(Collins & Baker 1960; Chesley 1963), in which no attempt was made 
to compensate for pool size variability.
The calculation of the velocity of growth in length and 
weight of the cartilage in these rats is beset by the same 
problems and limitations as those encountered in the rabbits 
(Chapter 10). The consistency of the trends within the results 
suggests that the method is valid. The velocities of growth in 
length of the bony and cartilaginous portions of the rib are very 
similar during the active growth phase. As growth slows, from 70 
days PC onwards, the bone velocity exceeds the cartilage velocity 
(Table 35). These observations are in close agreement with the 
general decline in growth velocity in the rat that occurs about 
70 days PC (Hughes & Tanner 1970a). Because the velocities are 
very low at 70 and 105 days PC the interpretation of the bone: 
cartilage ratios must be made with caution. The fact that the ratio 
at these ages is considerably greater than at earlier stages 
suggests that during this period the rate of ossification exceeds 
that of cartilage proliferation in the growth zone at the costo­
chondral junction (Evans et al. 1948). This type of differential 
growth rate is the mechanism by which long bone epiphyses are 
closed and the same process occurs in the rib (Bloom & Fawcett 1962).
All foetal costal cartilages in this study had clearly defined 
ossified segments. This finding is in agreement with the 
observations of others (Strong 1925; Dawson & Spark 1928) who have 
shown that ossification begins at 17 days PC in the 6th to 9th
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ribs and is present in all ribs by 18,5 days PC.
Plotting cartilage length against weight reveals a sinusoidal 
relationship (Figure 56). While little length is gained after 70 
days PC (see Table 35) weight continues to increase. This gain 
in weight must be attributed to subperiosteal oppositional growth 
and to accretional growth (see Chapter 2.2) by subperiosteal 
matrix deposition and interstitial calcification (Strong 1925).
The persistence of sulphation stimulation up to 105 days PC when 
the thymidine response ceases at 70 days PC (Table 38) suggests 
that matrix deposition contributes more to the gain in weight 
after 70 days PC than does oppositional growth. This 
interpretation is strengthened by the fact that pre-incubation 
reduces sulphate uptake, but not thymidine uptake after 47 days PC 
(Table 37). Pre-incubation for 24 hours reduces cartilage 
metabolic activity to basal levels by exhausting any residual . 
stimulus (Van den Brande 1973).
The in vitro response of the foetal cartilage to stimulation 
(Table 38) contrasts with the apparent refractoriness of the 
cartilage studied by Heins et al. (1970). Both 18 and 20 day PC 
cartilage responded to serum, but the younger cartilage did 
require 40$ serum to obtain a significant response. The 
experimental conditions of the two studies were not identical, 
most notably in the concentrations of serum used. Heins et al. 
used only 10$ serum whereas 20$ and 40$ were used in this study.
In respect of other ages of rats investigated the results of the 
two studies are in agreement except that in the present study 
adult cartilage did not respond to stimulation.
The cartilage zone adjacent to the costochondral junction is
the site of the growth centre of the rib, analogous to the
epiphyseal plate of long bones (Bloom & Fawcett 1962). During
the rapid phase of length growth (up to 47 days PC) the costo-
3 35sternal ratio for both H and S0^ is greater than unity (Table 37),
indicating that the regional localization of the isotopes is
functionally significant. There are, however, notable differences
between the in vivo and in vitro findings for each isotope and 
3 35between H and SO^ at each age (cf. Table 38).
Because the thymidine and inorganic sulphate pool sizes are 
not known, including whether there is a change with age, 
quantitative comparisons of differences between the isotopes in 
the cartilage zones cannot be made. Nevertheless, conclusions 
may be validly drawn from changes in costo-sternal ratios for 
each isotope.
3
In vitro there is a trend for the HTdr ratio to increase
with age to a maximum at 37 days PC and then to decrease. In vivo
there is no such increase, the ratio remains near 2,0 until 37
days PC and then decreases (Tables 37 and 38 ). Why the in vitro
ratio is greater than the in vivo at the same age is not clear,
but there are several speculative possibilities. In vitro
3
availability of HTdr to the costal zone may have been enhanced 
by the dissection and stripping of the perichondrium; the 
adjacent bone and its associated blood vessels in vivo may have 
had an influence on the cartilage; or the in vitro stimulus may 
have been greater than that in vivo, and the greater proportional 
response of the costal zone to a given stimulus compared to the 
sternal zone (see below) may be an explanation for the difference.
The sulphate ratios are similar in both situations, being 
just in excess of unity with a tendency to decrease with age. 
Herbai (1970a,c) showed a greater ratio for sulphate, namely 
2,55, than those observed here. The reasons for this difference 
are not understood.
In vitro serum stimulation has a marked effect on the 
thymidine ratio in cartilage up to 70 days PC. Stimulation 
causes a proportionately greater uptake in the costal zone 
compared to the sternal zone, resulting in a rise in the ratio
ITT
with stimulation (Table 38). This does not occur with sulphate, 
suggesting that all cartilage cells are equally sensitive to 
sulphation stimulation, whereas for thymidine stimulation those 
in the growth zone are selectively sensitive.
The slope of a dose-response curve is a valid index of the 
responsiveness of a biological system (Finney 1964). The use of 
the slope has a major advantage over use of absolute uptake as an 
indicator of response as it is independent of variations in basal 
uptake. In this respect its use is similar to the use of the 
percentage stimulation (Heins et al. 1970), but where more than 
one dose is used the slope is probably the more useful parameter.
For thymidine the slope increases with age to a maximum at 
22 days PC and then declines rapidly to zero at 105 days PC 
(Table 38). For sulphate there is a marked change between 18 and 
20 days PC with the slope increasing 10-fold to 0,21. Thereafter 
there is a plateau fluctuating around 0,1, between 22 and 47 
days PC, followed by a decline to zero at 305 days PC.
The post-natal sulphate results are similar to those 
obtained by Heins et al. (1970). The foetal differences have 
already been discussed.
The correlation between the measures of cartilage response, 
both in vivo and in vitro, with the exception of the in vitro 
sulphate slope, and both length and weight velocity suggests that 
the cartilage response and not the serum SM stimulus is the 
major determinant of growth velocity (Table 39). Why sulphate 
slope has such a poor correlation with length and weight velocity 
is not clear. The correlation between the absolute sulphate 
uptakes and velocity is equally poor. It may be speculated that 
sulphation is not as an appropriate index of cartilage growth 
rate as thymidine uptake, and therefore correlations are lower. 
However, the excellent correlations obtained for sulphate in vivo 
mitigate against this argument. This contradiction may be
resolved by investigating other indices of matrix formation such 
as ^C-leucine incorporation.
11.4 Conclusions
These results indicate that the response of the costal 
cartilage depends on the age, and therefore growth rate, of the 
donor, rather than on the stimulus to which the cartilage is 
exposed.
In these experiments the SM stimulus was manipulated in three 
separate ways: by keeping the stimulus constant in vivo (transplant 
in adults), by matching it to the age of the transplanted cartilage 
in vivo (age-matched transplants) and by keeping the stimulus 
constant in vitro (incubation in human serum). In all three of 
these situations the uptake of thymidine and sulphate was closely 
related to the growth velocity of the cartilage, with the 
exception of the slopes of the in vitro sulphate uptake. In other 
words, increasing the stimulus to slowly growing cartilage, or 
decreasing the stimulus to rapidly growing cartilage, does not 
alter the uptake of the isotopic markers of metabolic activity 
in the cartilage, indicating that cartilage responsiveness is the 
major determinant of growth velocity.
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CHAPTER 12
CHARACTERISTICS OF THE RESPONSE OF ISOLATED 
COSTAL CHONDROCYTES TO SERUM SOMATOMEDIN ACTIVITY
The stimulation of thymidine incorporation into DNA is one 
of the established actions of serum SM activity. The original 
observations were made in rat costal cartilage segments 
(Daughaday & Reeder 1966). Since then stimulation of DNA 
synthesis has also been reported in porcine costal cartilage
(Van den Brande 1973), Hela cells (Salmon & Hosse 1971), human
»
glia-like cells (Uthne 1973), isolated chick pelvis chondrocytes 
(Garland et al. 1972) and isolated rabbit articular chondrocytes 
(Binet et al. 1975).
The isolated chondrocyte studies are of particular interest 
for two reasons. Firstly, the preparation of a suspension of 
isolated cells provides a greater homogeneity of cells in the 
aliquots than occurs in segments of whole cartilage thus 
reducing the variability of the responses. This, coupled with 
the greater number of samples which may be assayed, offers 
potential advantages over the conventional bioassay. Secondly, 
removal of the cartilage matrix permits the investigation of a 
possible role for the matrix in determining chondrocyte function 
and response to SM.
This chapter describes the thymidine incorporation response 
to SM by chondrocytes isolated from rabbit costal cartilage.
12.1. Methods and Materials
New Zealand White rabbits from the colony were used (Chapter 7).
All animals were growing at normal body weight velocity. The 
rabbits were sacrificed under ether anaesthesia by cardiac 
puncture exsanguination.
Chondrocyte isolation. A modified version of the chondrocyte 
isolation technique of Smith (1965) was used. The 4th to 7th 
costal cartilages and adjacent sternum were removed in a block 
and soaked in Geys' solution (1936) at room temperature. Each 
costal cartilage was then dissected free, stripped of all 
adherent perichondrium and divided into approximately equal 
sternal, middle and costal third segments. Segments were blotted 
dry, weighed to 0,0001g (Mettler H20 balance) and those from 
different animals pooled by sternal, middle and costal origin in 
fresh Geys' solution at room temperature. Between four and seven 
rabbits from the same litter were used in each experiment.
Portions of approximately 150mg of cartilage were placed in 
4ml Geys' solution in 25ml stoppered Erlenmeyer flasks through 
which air with 5% CC^ was bubbled for several minutes to give a 
pH of 7,2. To each flask was added 1ml crude papain solution 
(BDH, Johannesburg) to give a final concentration of papain of 
4mg/ml. Finally a 1ml solution of 24mg cysteine (Merck, Darmstadt) 
was added. Flasks were incubated in a shaking water bath at 30 
strokes/min at 37°C for 2 hours. The softened cartilage segments 
were washed three times in 10ml Geys' solution, blotted dry and 
transferred to clean flasks containing 4ml collagenase (from 
C. histolyticum Type 1, Sigma, St. Louis) at a concentration of 
2mg/ml. Incubation was continued for 16 hours. To effect 
separation of the clumps of cells 1ml trypsin (from bovine 
pancreas, type III, Sigma, St. Louis) solution was added to give 
a final concentration of 0,5mg/ml for the last hour of incubation. 
The enzymes and cysteine were dissolved in Geys* solution at 
pH 7,2.
The resulting suspension of cells was centrifuged at lOOOg
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for 10 min, the supernatant aspirated and the pellet resuspended 
in the medium of amino acids, buffer glucose and antibiotics 
described previously (Chapter 9). The debris was removed by 
centrifugation at 60g for 10 minutes and the cells resuspended 
in 3ml of medium.
Cell numbers were counted at 400x magnification in a 
haemocytometer. The percentage of viable cells was determined 
by supravital staining with Trypan blue in a final concentration 
of 0,2%. The mean viability,measured in 10 samples, varied 
between 88 and 97%, of the total cell count in each experiment.
Isolated cell assay. The technique described by Garland 
and co-workers (1972) was used and the method is outlined here.
The laboratory reference standard of a pool of adult human 
serum was used as the SM source throughout and diluted to the 
appropriate concentrations in the incubation medium described.
To dilutions of serum in 120 x 15mm glass centrifuge tubes
were added 400 u,l of cell suspension (containing approximately 
5 35 x 10 cells) and 2 5 HTdr (Amersham, specific activity 
17 Ci/mmole) to give a final concentration of 0,15yoCi/ml in 
2,5ml. Immediately prior to addition to each tube the cells 
were suspended by swirling briefly on a vortex mixer. Cell 
cultures were performed in triplicate for each serum dilution. 
Incubation was continued for 24 hours at 37°C in the shaking 
water-bath.
The tubes were then centrifuged at lOOOg for 10 min, the 
supernatants discarded and the pellets washed twice in isotonic 
sodium sulphate. The pellet was resuspended in a 0,5ml solution 
of 200yug of soluble RNA (from Torula yeast grade VI, Sigma,
St. Louis) as a macromolecular carrier (Garland 1975, personal 
communication). Three ml of 5%, trichloroacetic acid (TCA, Riedel 
De Haen Ag Seelze, Hanover) at 4°C was added and the mixture left
overnight at 4°C. Each tube was then shaken on a vortex mixer 
and the contents filtered under suction through 25mm cellulose 
0,22/jm pore size discs (Millipore Corp, USA). Each disc was 
rinsed three times with 3ml 5% TCA and three times with 5ml 95% 
ethanol.
The discs were placed in glass scintillation vials, air dried, 
dissolved in 0,5ml Soluene-350 (Packard, Johannesburg) and bleached 
by addition of 0,5ml 30% hydrogen peroxide (Merck, Darmstadt). 
Finally 0,5ml 0,5N hydrochloric acid and 10ml Instagel (Packard, 
Johannesburg) were added and the vials counted.
To establish the degree of non-specific uptake potassium 
cyanide was added to cell cultures at each serum dilution to give 
a 0,01M solution.
Rib segment assay. To measure the uptake of thymidine by
intact segments of rib cartilage the cartilages were stripped of
perichondrium as already described and randomly allocated in
groups of 8 to 25ml Erlenmeyer flasks containing medium only and
dilutions of serum from 2,5% to 40%>. Flasks were incubated for
20 hours at 37°C in a shaking water bath. The cartilages were
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then transferred to flasks containing 2yuCi/ml HTdr in incubation 
medium for a further 4 hours. In all experiments ribs were 
immersed.in solutions providing lml/rib. The flasks were then 
placed in boiling water for 15 minutes, the cartilages removed 
and washed five times in isotonic sodium sulphate and left over­
night in this solution. Cartilages were blotted dry, divided into 
thirds and weighed to 0,0001g. Each third was dissolved in 0,5ml 
23N formic acid at 80°C in a glass scintillation vial. The 
solution was cooled, 10ml Instagel added and counted.
Removal of inhibitors. Heat-treated and acidified serum from 
the reference pool was prepared. The serum pH was adjusted to 5,5 
with 0,1N hydrochloric acid and the solution heated at 80°C for 15
minutes in a water bath. The extract was lyophilized and 
reconstituted to the original volume with deionized doubledistilled 
water. The SM activity of the extract was assessed in the porcine 
cartilage assay and found to have retained 64$ of its activity 
(potency ratio 0,64, index of precision 0,21), when the untreated 
serum from the same pool was used as the reference standard.
Calculation of thymidine uptake. Serum contains free 
thymidine in solution at a reported concentration of slightly 
greater than 10 (Hughes et al. 1973). Thymidine uptake in 
these experiments was calculated assuming a serum concentration 
of 10 ^M. Precipitation of the serum proteins does not alter the 
free thymidine concentration (Hughes et al. 1973).
12.2 Results
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Thymidine uptake, expressed as moles/10 viable cells, varied 
considerably from one experiment to another when chondrocytes 
were prepared from rabbits of the same age and growth rate.
Figure 59 shows a typical example of the nature of the response 
of the isolated cells of 60 day PC rabbits to increasing 
concentrations of normal human serum. Costal uptake was 
significantly greater than sternal uptake (p(0,05) at 1,25, 2,5 
and 5,0$ serum concentrations. The maximum costo-sternal 
difference occurred at 2,5$ with the costal response being 1,3- 
fold greater than the sternal.
In this and all other experiments the middle zone uptake was 
not significantly different from the sternal zone uptake.
Therefore, in reporting the rest of the observations only costal 
and sternal zone responses are described.
In spite of the considerable range of uptakes observed in 
four separate experiments on 60 day PC rabbits the pattern of the 
dose-response relationship did not vary. Grouped results from 
these four experiments are expressed as the percentage stimulation
ZUi
or inhibition that serum concentrations induce with respect to 
incubation medium only (Figure 60). A progressive increase in 
thymidine uptake occurs from incubation medium only up to 2,5$ 
serum, after which the curve declines, falling below zero 
between 10$ and 40$.
Figure 59. A typical example of the response of isolated rib 
cartilage chondrocytes to normal human serum for sternal, middle 
and costal zones of the rib cartilage. The asterisk* indicates 
that the costo-sternal difference is significant (p ^0,05).
0: costal zone, 0 : sternal zone, A  : middle zone. The serum 
concentration in this and all subsequent figures in this chapter 
is shown on a logarithmic scale.
Comparison of 60 day and 35 day PC responses shows that the 
range of the former is lower than and does not overlap to any 
greater extent with that of the latter (Table 40). The pattern of 
a rise to peak stimulation with 2,5$ serum and then a decline to 
inhibition of uptake at concentrations greater than 10$ is also 
found in 35 day PC rabbits.
TABLE 40. The range of thymidine uptake by isolated costal cartilage chondrocytes from 35 and 60 day PC 
rabbits in response to increasing concentrations of normal human serum. The effect of 0,01M 
potassium cyanide on uptake is also shown. The number of experiments is indicated by n.
Serum
Concentration
Thymidine Uptake 
moles x 10 10^ cells
%
Costal zone
(n = 2)
RANGE
Sternal. zone Costal zone
(n= 4)
RANGE
Sternal zone
with 0,01M KCN 
(n = 2)
MEAN (± SEM)
Costal zone
Medium only 9,3 - 14,1 6,0 - 9,9 3,3 - 9,7 2,8 - 8,8 1,1 (0,3)
0,32 8,1 - 11,4 6,1 - 10,3 4,1 - 11,6 3,7 - 6,9 0,8 (0,4)
0,625 13,7 - 17,9 11,4 - 15,8 7,4 - 13,3 8,3 - 10,7 0,9 (0,3)
1,25 21,4 - 27,0 15,1 - 19,3 11,6 - 20,1 10,6 - 14,0 1,2 (0,5)
2,5 26,1 - 29,5 16,3 - 20,0 14,3 - 25,4 11,2 - 16,3 1,0 (0,3)
5,0 19,3 - 24,6 16,0 - 21,1 8,3 - 17,9 9,9 - 15,6 1,4 (0,4)
10,0 11,4 - 14,9 4,8 - 10,1 3,6 - 7,7 2,1 - 7,9 0,7 (0,6)
20,0 5,3 - 9,8 3,2 - 7,6 2,8 - 7,9 3,6 - 7,1 1,3 (0,5)
40,0 6,7 - 9,7 3,1 - 7,9 3,1 - 6,3 2,9 - 6,3 1,4 (0,6)
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Figure 60 The response of isolated rib cartilage chondrocytes 
to normal human serum expressed as mean percentage stimulation, 
or inhibition, with respect to incubation medium only, for four 
separate experiments. 0 : costal zone, © : sternal zone.
Potassium cyanide, 0,01M, causes a marked reduction in uptake 
(Table 40). The effect was studied in the costal zone of 60 day 
PC rabbits in two experiments. There was no stimulation or 
inhibition of uptake with increasing serum concentrations; the 
binding being constant around 1,0 x 10 14 moles/10 cells.
The heated and acidified serum extract causes only progressive 
stimulation with increasing concentration. Figure 61 shows the 
response to the serum extract of chondrocytes from the same 
harvest as those shown in Figure 59. There is a rise in uptake
between 1,25 and 80% concentrations, with the response becoming 
significantly greater than that induced by medium only at 
concentrations of 10% and greater (p (0,05). It should be noted
that the absolute uptake at the point of maximum stimulation by
-14 5normal serum, viz. 2,5%, was 18,5 x 10 moles/10 cells,
-14 5compared with 13,5 x 10 moles/10 cells for heated-acidified 
serum at 2,5%. This is consistent with the reduced potency of the 
extract in the porcine cartilage assay of 0,64. Costal zone 
uptake is greater than sternal zone uptake throughout the 
concentration range, but not significantly so (p y 0,05).
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Figure 61. A typical example of the response of isolated rib 
cartilage chondrocytes to heated-acidified human serum (see text) 
for sternal and costal zones of the rib cartilage. The cells used 
in this experiment are from the same harvest as those shown in 
Figure 59. 0 : costal zone, © : sternal zone.
In these experiments on 60 day PC rabbits absolute uptake 
also varied as greatly from one cell harvest to another as it did 
with normal serum. Grouped results are therefore expressed for 
the three complete experiments, and shown in Figure 62 as 
percentage stimulation with respect to incubation medium. These 
three experiments were on cell harvests used for three of the four 
experiments with normal serum*
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Figure 62. The response of isolated rib cartilage chondrocytes to 
heated-acidified human serum expressed as mean percentage 
stimulation, with respect to incubation medium only, for three 
separate experiments. 0 : costal zone, 0 : sternal zone.
The intact cartilage segments from 57 day PC rabbits do not 
differ in their responses to normal and heated-acidified sera, 
except that the latter produces a quantitatively smaller response 
(Figure 63). The costo-sternal difference in uptake is much 
greater in the intact cartilage than in the isolated cells, being 
3 to 4-fold over the concentration range studied, compared to the 
1,3-fold maximum difference for the isolated cells.
Chondrocyte densities were higher in the costal zone than in
the sternal, but not significantly so for quadruplicate counts on
cell suspensions in each of the zones within the same harvest (p \0,1).
4 4Cell harvests ranged from 2,05 x 10 to 6,03 x 10 cells/mg in the 
isolations reported here.
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Figure 63. The response of intact rib cartilage segments to both 
normal (costal zone 0, sternal zone ® ) and heated-acidified 
(costal zone , sternal zone A  ) human serum.
In three separate harvests the number of cells exhibiting 
amoeboid movements was counted immediately after isolation and again 
24 hours later after incubation in 2,5$ serum. For each harvest 
counts on five groups of 500 cells each from both costal and sternal 
zones were made blind by two observers. The means of these 10 
observations are expressed as the percentage of amoeboid cells.
After isolation 11$ (range 5 - 17%) of costal cells exhibited 
amoeboid movement and following 24 hours in culture 23$
(range 15 - 37$) of these cells were amoeboid. This difference 
is significant (p ^  0,01). The corresponding results for the 
sternal zone were 4$ (range 1 - 9$) and 19$ (range 12 - 29$).
This difference is significant (p <^0,01). The difference between 
costal and sternal zones is significant after isolation (p ^0,05), 
but not after 24 hours in culture (p ^0,05).
207
12.3 Discussion
The chondrocyte culture technique used in this study maintains 
cells in suspension for 24 hours after isolation. Abbott and 
Holtzer (1966) have demonstrated that when chondrocytes in 
culture are in close contact with each other, either in intact 
matrix or as isolated cells, 98% of cells continue to synthesize 
metachromatic matrix and show no signs of mitotic activity.
However, when cells are dispersed in monolayer culture they rapidly 
de-differentiate, cease specialized metabolic activity and begin 
DNA synthesis. This change was morphologically correlated with 
the onset of amoeboid cell movement, and adoption of a stellate 
rather than round configuration. In the present study the cell 
suspension used lies between the extremes of the centrifuged 
pellet and the monodispersion studied by Abbott and Holtzer. Our 
results are consistent with those of these workers in that both 
studies showed evidence of increasing DNA synthesis and/or 
mitotic activity within 24 hours of freeing chondrocytes from 
their matrix (Table II and Figure 12 of Abbott & Holtzer 1966 and 
the significant increase in the percentage of amoeboid cells in 
the present study).
The very small costo-sternal difference in thymidine uptake 
for the isolated cells compared to the 3 to 4-fold difference in 
the whole segments is consistent with the observation that there 
is a greater increase in the percentage of amoeboid cells in the 
sternal zone than in the costal, and that after 24 hours there is 
no significant difference between the zones in this respect. These 
findings may be explained by dedifferentiation having a 
proportionately greater effect in the sternal zone, where mitotic 
activity is confined to the sub-periosteal region, than in the 
costal zone, where the large interstitial growth centre lies.
An alternative or additional factor contributing to the reduced 
costo-sternal difference may have been enzymatic damage to the
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cells with the more active costal zone cells being more affected 
than the quiescent sternal zone cells. Furthermore the finding 
that cell densities in the costal and sternal zones were not 
significantly different also requires some comment in this 
respect. The autoradiographs of Chapter 10 show much higher cell 
densities in the region of the columns of the growth centre than 
in the rest of the cartilage. The active growth region occupies 
about a quarter of the costal zone at 60 days PC of age and the 
fact that cell counts in the costal zone were higher, but not 
significantly so, than in the sternal suggests that some costal 
cells were lost during isolation. It is possible that the 
actively dividing cells were more susceptible to damage and were 
lost, thus reducing the costal zone density, and therefore also 
reducing the costo-sternal difference in thymidine uptake.
It is not known why uptake varied so considerably from one 
cell harvest to another. Cell viability after isolation was 
high and fairly consistent as assessed by the supravital staining 
method. Although uptake was expressed in terms of the number of 
viable cells two sources of error may have contributed to the 
variability. The first is the possibility that cells judged to 
have been viable by the trypan blue technique may not have been 
capable of DNA synthesis, and the converse may also have been true. 
Secondly viability was only assessed after isolation and not 
during or after the subsequent 24 hour incubation. It is possible 
that the variability in percentage viability at the end of this 
period was greater than after isolation. The consistent 
qualitative reproduction of the results when expressed as the 
percentage changes from the base-line (Figures 60 and 62) 
is, however, reassuring and indicative of a significant biological 
phenomenon.
Putative SM stimulation of isolated chondrocytes at low serum 
concentrations reaching a peak at 6% and declining at 10% (Garland
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et al. 1972) and dose-related up to 10$ (Binet et al. 1975) have 
been reported. Neither of these groups of authors report events 
at higher concentrations. The present study shows a peak 
stimulation at 2,5$ and inhibition from 10$ normal serum 
concentration upwards. This inhibition is interpreted to indicate 
further evidence for the presence of somatomedin inhibitors in 
normal serum. Such inhibitors have been postulated in normal rat 
serum (Salmon 1972, p.180) and in serum of malnourished children 
(Van den Brande & Du Caju 1973). The inhibitory material in 
malnutrition is a neutral, thermolabile molecule with a molecular 
weight in excess of 100 000 daltons (Van den Brande 1974, personal 
communication). Our results with heated-acidified serum support 
the thermolability and acid-sensitivity of the inhibitor, but its 
further characteristics have not been determined in these 
experiments. We only used a single reference pool of three 
adult sera as a source for SM. It is not known whether all human 
sera contain inhibitory factors. The relationship of this 
inhibitor in normal human serum to that in rat serum and that in 
the serum of malnourished children is not known.
The vigorous handling of the serum to remove inhibitory 
material resulted in some loss of SM activity, and a potency of 
0,64 is consistent v/ith previous observations (Van den Brande 
et al. 1971).
The stimulatory activity of serum at low concentrations 
suggests that the activity of the inhibitor is concentration 
dependent, for once effective concentrations are reached, at 10$, 
little or no further inhibition occurs (Figure 60). This 
suggests that inhibition is not competitive as SM activity is 
dose-responsive up to the maximum concentration studied, namely 
80$, once inhibitory material is removed (Figure 62).
Somatomedin inhibition in cartilage segment assays with 
normal human serum has not been reported (Van den Brande 1973)
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and has not been observed in our laboratory using the porcine 
cartilage assay. The dose-response characteristics of the rabbit 
costal cartilage were the same to both normal and heat-treated 
serum; there was no evidence of inhibition (Figure 63). This 
difference between the intact segments and the isolated 
chondrocytes suggests that the matrix plays an important role in 
mediating the net SM effect in vivo. The greater molecular 
weight of the inhibitor, ca. 100 000, compared to that of SM, 
ca. 4000, may be a determining factor, although the details of 
the diffusion characteristics of large molecules through 
cartilage are very poorly understood (Nachemson et al. 1970;
Campo & Dziewiatowski 1961; Kantor & Schubert 1957). Again the 
possibility of enzymatic damage to or alteration of the 
chondrocyte membranes cannot be excluded as a factor causing or 
contributing to the nature of the response of the isolated cells.
The age-related differences in response of intact costal 
cartilage reported in Chapter 10 also occur in the isolated 
cells (Table 40). Chondrocytes from 35 days PC costal cartilage 
with a growth velocity of 0,57mm/day (Chapter 10, Table 26) have 
a 2 to 3-fold greater uptake of thymidine than those from 60 days 
PC cartilage with a velocity of 0,35mm/day. Ehatever the as yet 
unrecognized effects of enzymatic isolation and de-differentiation 
in culture, the inherent responsiveness of the cartilage cell 
appears to remain a function of its age and growth velocity.
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CHAPTER 13
SOMATOMEDIN IN PROTEIN - ENERGY MALNUTRITION
The study of disease processes in man often yields early 
insight into normal function and provides the basis for later 
experimental design either in man or other animals. Protein- 
energy malnutrition (PEM) is one such situation which provided 
opportunities for the study of growth hormone (GH) kinetics in 
man leading to experimental liver perfusion and the investigation 
of hepatic metabolism of GH (Pimstone et al. 1972). The finding 
of an elevated GH secretion in PEM led to the study of serum SM 
in this condition by Pimstone and co-workers. They showed that 
SM was reduced in five children admitted to hospital with low 
body weight, hypoalbuminaemia and oedema, rising in all patients 
after nine days of treatment (Grant et al. 1973). Prior to this 
study Daughaday and Kipnis (1966) had demonstrated that SM levels 
were reduced in the sera of some starved rats, which suggested the 
possible presence of serum factors inhibiting SM activity.
Recently Van den Brande and Du Caju (1973) showed that there are 
thermolabile, macromolecular proteins in serum of some patients 
with PEM that inhibit the stimulatory activity of SM.
In view of the limited number and extent of the studies on 
SM in PEM we have investigated a larger number of children and 
related our findings to an age-matched control series. Further, 
in view of the somewhat paradoxical demonstration of low SM and 
high GH in PEM patients on admission to hospital, we have 
questioned whether the endogenous GH in these patients is 
biologically inactive with respect to SM generation or whether 
there is end-organ insensitivity to a normally active GH. In an
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attempt to answer the first part of this question, namely whether 
endogenous GH is inactive, we have infused GH into children with 
PEM and measured their .serum SM response.
13.1. Subjects and Methods
13.1.1. Patients and control subjects. Two Caucasian 
children (a boy aged 4,5 years and a girl aged 3,0 years) with 
proven isolated hGH deficiency were studied in the Growth and 
Endocrine Clinic of the Transvaal Memorial Hospital for Children, 
Johannesburg. Serum samples were obtained prior to and two weeks 
after commencement of therapy with hGH (Crescormon, Kabi) 0,5 i.u./ 
kg body weight in two divided doses per week.
A series of clinically normal subjects were studied to 
establish the range of normal serum SM in this laboratory. Forty 
one fasting members of the Medical School staff aged 18 to 61 years 
(South African Bantu-speaking Negroes : 7 male and 9 female; 
Caucasians : 14 male and 11 female) donated serum between 07h00 
and lOhOO. Thirteen Negro children, admitted to Baragwanath 
Hospital for minor surgical procedures, who were all clinically 
normal in terms of nutritional and growth status had fasting serum 
collected at the time of routine pre-operative haematological 
assessment. The five girls and eight boys ranged in age from two to 
fortyeight months.
Serum from five patients with hypopituitarism, two with 
isolated GH deficiency and three with panhypopituitarism (two due 
to tuberculous meningitis and one after hypophysectomy),were 
assayed prior to institution of therapy.
Twelve Negro children admitted to Baragwanath Hospital, 
Johannesburg with a primary clinical diagnosis of PEM, and in 
some cases associated complications, were studied. The seven 
boys and five girls were aged from two to twenty nine months.
Based on the Wellcome criteria (Editorial 1970) two were diagnosed 
as having marasmus, three marasmic-kwashiorkor and seven kwashiorkor.
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Treatment in hospital consisted of protein supplements, maternal 
instruction in feeding, and, where necessary, intravenous fluids, 
antibiotics, potassium chloride and vitamin supplements.
Five Cape Coloured children,aged 13 to 27 months, were 
admitted to the Red Cross Children's Hospital, Cape Town with a 
primary clinical diagnosis of PEM, all of the kwashiorkor type 
(Wellcome criteria). Treatment was similar to that of the children 
admitted to Baragwanath Hospital.
Informed consent was obtained from all subjects, or a parent, 
and this work was approved by the ethical committees for human 
experimentation of the University of the Witwatersrand,
Johannesburg and, in the case of the Cape Coloured children, the 
University of Cape Town.
13.1.2. Methods. In the hospital patients serum was 
collected with the children at bedrest by venepuncture between 
07h00 and lOhOO on the day after admission after an overnight 
fast, immediately before starting re-feeding, and stored at -20°C 
until assayed. Further fasting specimens were drawn at 
approximately weekly intervals, the last being obtained before 
discharge, at a stage of clinical and biochemical recovery.
In the Cape Coloured children 4mg of hGH (Kabi) in 5ml saline 
was infused intravenously over 5 minutes on the day after 
admission. Blood was collected 3 and 5 hours after the infusion. 
After recovery, prior to discharge from hospital, the hGH 
infusion and blood collection were repeated.
Serum SM was estimated by the porcine cartilage method using 
6- or 8- point designs, depending on the availability of serum 
(described in Chapter 9). Growth hormone was measured by a 
modification of the double antibody radioimmunoassay of Morgan 
and Lazarow (1963). Insulin was measured by the radioimmunoassay 
method of Morgan and Lazarow (1963). Serum albumin was estimated
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by the biuret method (Wolfson et al. 1948), blood glucose by 
Somogyi - Nelson technique (1952) and free fatty acids (FFA) by 
the colorimetric method (Duncombe 1964).
Attempts were made to remove possible SM inhibitors in some 
sera by the heating and acidification procedure of Coh.en et al. 
(1975), described in Chapter 9.
13.2. Results
13.2.1. GH-dependence of serum SM. Table 41 shows the 
marked rise that occurred in serum SM in both GH-deficient 
children during GH therapy. Only sulphation results are shown, 
those for thymidine being similar.
TABLE 41. Serum SM (sulphation) during GH therapy in 
GH-deficient children
Child Serum Somatomedin (- 95$ limits)
Prior to therapy After two weeks therapy
A 0,14 (0,004 - 0,29) 0,56 (0,34 - 0,76)
B 0,19 (0,09 - 0,31) 0,74 (0,43 - 0,96)
13.2.2. Normal range of Serum SM. Figure 64 shows the 
range of serum SM (measured by sulphation) of the control series 
of adults and children. There is no difference between male ond 
female, nor between Negroes and Caucasians. The range of the small 
series of children falls within the larger series of adults and
no trend with age is apparent. The indices of precision for the 
three standards of the assays for these samples were 0,12, 0,16 
and 0,18. The indices of precision for the samples ranged from 
0,10 to 0,29. Simultaneously determined potency ratios for 
thymidine uptake yielded similar ranges, but the range of indices 
of precision was greater, namely 0,13 to 0,42.
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Figure 64. Human serum SM (sulphation) in 54 normal subjects, 
aged 2 months to 61 years and in 5 hypopituitary subjects, 
aged 3 to 40 years.
13.2.3. Serum SM in children with PEM. The two or more 
serial samples from each child with PEM were assayed together so 
that possible inter-assay variation does not influence the 
comparison of results obtained on each child.
In two children (numbers 1 and 8) none of the sera gave dose- 
response curves parallel to the standard at the 95% level of 
significance, and potency ratios could not therefore be computed. 
In four other children (numbers 4,6,7 and 17) admission and first 
week samples did not give parallel responses, but later samples 
did do so. For all other serum samples Table 42 shows the 
diagnostic category, serum hGH, serum albumin, and serum SM for 
both sulphation and thymidine uptake.
TABLE 42. Changes in serum SM in children with PEM from the time of admission
to h o s p i t a l  to  t h e  s ta g e  iof c l i n i c a l  r e c o v e r y
Case Age Diagnosis Days after Serum Serum Somatomedin Potency
No. admission hGH albumin Ratio
Sulphat,; Thymidine
(months) (ng/ml) (g/lOOnl)
1 2 M* 1 5,5 2,3
8 1,5 - none
15 1,1 3,1 achieve
23 0,8 2,9 parellelism
35 0,6 4,1
49 0,6 3,5
3 4 K 1 3,1 1,7 0,22 0,31
8 0,4 3,0 0,76 0,78
4 10 MK 1 16,1 2,7 neither achieve
parallelism
8 12,4 3,0 0,13 0,10
13 2,3 - 0,23 0,26
38 4,6 3,4 0,10 0,11
58 0,3 4,5 0,50 0,54
6 29 M 1 4,6 2,9 neither achieve
parallelism
8 2.1 - It II I
15 0,1 3,7 0,31 0,24
7 18 K 1 5,2 1,8 neither achieve
parallelism
7 0,8 2,7 0,51 0,42
14 0,1 3,6 0,84 0,74
8 9 MK 1 6,0 2,2 none
7 3,1 2,9 achieve
14 0,5 3,9 parallelism
9 14 K 1 0,3 1,9 0,31 0,48
6 0,1 2,7 0,42 0,63
14 i3 K 1 1,6 2,1 0,73 0,64
7 1,1 1,7 0,58 0,69
14 0,2 1,9 0,84 0,79
26 1,0 3,0 0,81 0,83
15 3 K 1 6,8 2,9 0,22 0,31
7 2,4 2,7 0,72 0,49
16 1,3 3,7 0,75 0,61
25 1,2 3,0 0,74 0,60
16 24 K 1 12,5 1,6 0,10 0,09
8 3,3 1,7 0,17 0,21
17 1,0 1,8 0,49 0,53
23 1,6 3,0 0,73 0,69
29 0,8 4,0 0,84 0,88
17 17 K 1 8,6 1,7 neither achieve
parallelism
9 2,1 3,1 0,19 0,11
19 0,6 2,6 0,46 0,33
25 0,7 3,4 0,48 0,31
18 20 MK 1 8,7 2,0 0,29 not
assayed
6
14
3,4
0,2
2.7
3.7
0,34
0,38
Note: * M indicates marasmus, MK marasmic-kwashiorkor and K kwashiorkor
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The hGH concentrations exhibit the characteristic elevation 
in severe, untreated PEM and rapid fall on institution of therapy.
The number of cases is too small to decide whether there is any 
difference in hGH response between kwashiorkor and marasmus.
Serum albumin was low in all cases on admission and rose on 
therapy. Transient decreases during recovery (case 17, for 
example) may have been related to intravenous fluid therapy.
In those cases in which multiple samples achieved statistically 
acceptable parallelism in the assay SM exhibited a consistent 
trend, namely a progressive rise from very low levels, some in the 
hypopituitarism range, towards normal. Some patients (cases 6,9,
17 and 18), however, although discharged as "normal1, had not 
achieved normal serum SM as judged by the values for the control 
children (cf. Figure 64).
Further details of the nature of the dose-response curves
are seen in the reproductions of the calculator plots in Figures
3565 and 66. These show the uptake of SO^ by porcine costal 
cartilage in response to three concentrations of serum. The non­
parallelism of the first serum sample with parallelism of later 
samples is shown in Figure 65, while Figure 66 demonstrates the 
progressive rise of serum SM that accompanies recovery.
There is a small negative correlation between hGH and SM in 
the serum of patients. For sulphate uptake the coefficient is 
-0,34 (p^0,05) and for thymidine uptake it is -0,37 (0,01<^ p ^ >0,01). 
There is no correlation between serum albumin and SM (sulphate 0,06; 
thymidine 0,02). There is a significant correlation between the 
sulphate and thymidine potency ratios (r = 0,84 p<^0,001).
The indices of precision of the standards in these assays 
ranged from 0,11 to 0,21 (sulphate) and 0,17 to 0,28 (thymidine) 
and for the samples from 0,08 to 0,30 (sulphate) and 0,12 to 0,39 
(thymidine).
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Figure 65. Calculator plot of dose-response curves for serum samples 
from a child with PEM during recovery (case 7). The numerals opposite 
each curve represent the days after admission to hospital and "Standard" 
represents the dose-response curve of the serum from the reference 
standard pool. Each point represents the mean ± sem.
Figure 66. Calculator plot of dose-response curves for serum samples 
from a child with PEM during recovery (case 16). For further details 
see Figure65.
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13.2.4. Effect of infusion of hGH on SM in children 
with PEM. (Table 43). Fasting levels of hGH are significantly 
higher on admission than after recovery in each child (p<f0,001).
Five hours after the infusion the hGH concentration had returned 
to near baseline level in all but one child (case 4) on admission. 
There are no consistent changes in glucose or insulin concentrations. 
Basal FFA concentrations are lower after recovery than on admission 
in three of the five patients, but there is no statistically 
significant difference (p^>0,05). Growth hormone provokes a small 
rise in FFA on admission (range 4 - 55%), but after recovery there
is a much more dramatic rise after infusion (range 76 - 421$).
Potency ratios could not be calculated for SM in three patients 
on admission because of non-parallelism. To assess whether any 
change had occurred in SM at 3 and 5 hours after infusion the 
sulphate uptakes at these times were compared with uptake at time 
zero, i.e. fasting. In this way parallel dose-response curves 
were obtained and potency ratios calculated. The potency ratio 
of 3 and 5 hour samples showing parallelism to the standard was 
calculated in the conventional manner (with reference to the 
standard, results shown in Table 43) and also with reference to 
the fasting sample.
Table 43 shows that SM was low on admission and rose on 
recovery. No change in SM occurred after hGH, either on admission 
or on recovery. The small fluctuations in serum SM that do occur 
at 3 and 5 hours are within the 95% confidence limits of the 
fasting sample and are not considered significant.
13.2.5. Heated - acidified serum. Serum from 7 of the 
13 normal young children and from 6 of the children with untreated 
PEM was acidified and heated (HA), and then assayed at the same 
time as the untreated serum. All HA sera showed less SM activity 
than the paired native sera (Table 44). In the three PEM cases 
where the serum response was not parallel to that of the standard,
TABLE 43. Effect of infusion of hGH in children with PEM on serum hGH (ng/ml), blood glucose (mg/lOOml) serum 
insulin (/jU/ml), free fatty acids (yu/Eq/1) and somatomedin (sulphation) potency ratio.
on admission after recovery
Case Age
(months) Hour hGH glucose insulin FFA SM hGH glucose insulin FFA SM
1 13 0 32 60 4,8 745 0,54 9,2 75 7,2 282 0,85
3 55 63 3,3 778 0,45 20 71 6,2 1027 0,63
5 30 - - - 0,38 6,7 - ■ - - 0,75
2 18 0 47 78 4,1 704 0,22 13,5 61 6,1 700 0,61
3 80 67 4,5 797 0,31 49 56 6,2 1373 0,81
5 43 - - - 0,24 21 - - - 0,79
3 27 0 35 82 3,7 1245 n.p. 19 74 6,7 582 0,81
3 70 89 5,1 1593 n.p. 22 69 6,6 1027 0,68
5 41 - - - n.p. 8 - - - 0,98
4 21 0 29 70 6,6 573 n.p. 13 72 6,4 864 0,57
3 68 47 4,6 890 n.p. 33 69 6,8 1922 0,62
5 52 - - - n.p. 14 - - - 0,84
5 19 0 50 62 8,2 631 n.p. 4,2 109 2,0 291 1,48
3 66 68 6,7 . 932 n.p. 15,7 65 7,0 1515 1,41
5 56 - - n.p. 8,5 - - - 1,10
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heating and acidification did not alter the lack of parallelism 
and in all three cases the sulphate uptake induced by the HA serum 
was lower than that induced by native serum response was not
TABLE 44. Effect on SM (sulphation) of heating and acidifying 
the serum in normal and malnourished children. The 
case numbers of PEM patients correspond with those in 
Table 42. \  indicates the index of precision.
CASE No. Serum SM Potency Ratio
native heated-acidified
Normal X X
101 0,55 0,22 0,21 0,17
103 0,99 0,16 0,15 0,28
108 0,96 0,17 0,48 0,29
110 0,59 0,15 0,57 0,10
111 0,62 0,29 0,08 0,28
112 0,79 0,13 0,31 0,16
113 0,96 0,09 0,58 0,15
PEM
4 not parallel not parallel
6 not parallel not parallel
9 0,31 0,29 0,09 0,26
15 0,22 0,16 0,17 0,24
16 0,10 0,12 0,17 0,23
17 not parallel not parallel
parallel to that of the standard, heating and acidification did 
not alter the lack of parallelism and in all three cases the 
sulphate uptake induced by the HA serum was lower than that 
induced by native serum.
13.3. Discussion
The bioassay used in this study has been shown to measure a 
GH-dependent factor(s) in human serum. In spite of this, and an
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identical assay design to that used by Van den Brande and Du Caju 
(1974), a markedly different pattern of serum SM values in childhood 
has been found compared to that described by Van den Brande 
(Van den Brande and Du Caju 1973). These authors described a series 
of 45 normal subjects, of whom 12 were aged four years or less 
(see Figure 2 of their 1973 publication). In these 12 children 
there was a clear rise in SM with age from about 0,4 to 0,8. In 
the present study no such trend occurred (Table 64). The only other 
published work on children in this age range are the papers of 
Kogut et al. (1963) who studied 10 children and found no trend 
and Almquist and Rune (1961) who studied 10 children and found a 
very modest increase between the 6 month (0,51) and 4 year (0,59) 
means. Before any conclusions can be reached in this field 
longitudinal studies of large numbers of children need to be 
undertaken.
The findings in PEM confirm the work of Grant et al. (1973). 
Somatomedin is low in severe untreated PEM and recovers rapidly 
with re-feeding. Whether this rise in SM is causally related or 
only associated with the catch-up growth of these children is not 
known, and whether the serum SM returns to normal in all patients 
who are refed for prolonged periods of time also remains to be 
investigated.
Non-parallelism was a problem also encountered by Grant et al. 
(1973). This phenomenon has been speculatively ascribed to serum 
SM inhibitors, although Grant's mixing experiments and the heating- 
acidification experiments of this study (Table 44) failed to 
indicate the presence of inhibitors. However, these negative 
findings in the small number of patients studied and the limited 
nature of the experimental approaches to removing the putative 
inhibitors does not exclude their presence.
It is attractive to speculate on the possibility of a negative 
feed-back loop between SM and GH. Although a negative correlation
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between SM and GH was found in this study it cannot be construed 
as evidence for such a feed-back. Such evidence will have to be 
based on short- to medium-term dynamic experiments using purified 
SM preparations. The significant correlation (r = 0,84) between 
the SM potency ratios, based on sulphate and thymidine uptake, is 
reassuring evidence that the assay system has internal consistency.
The only previous study of the effect of intravenous GH on 
SM is that of Hall (1971). The 7 patients with hypopituitarism 
were infused with 2mg of GH and showed a considerable and 
consistent rise in SM 3 hours after infusion. In the present study 
exogenous GH did not cause any discernable rise in SM. The change 
in the FFA response with recovery may suggest an end-organ 
resistance to GH in PEM, but there are alternative possibilities 
that may explain this change that must be considered. The simple 
fact that the fat mass of the children increases during recovery 
may influence the response to GH or the explanation may lie in an 
alteration of the lipolytic activity of adipose tissue. Furthermore 
the results of these short-term intravenous studies do not 
preclude the possibility that intramuscular GH over several days 
may raise serum SM (should the ethical and clinical problems of 
such a study be overcome).
In summary, the basis of a low serum SM in the face of an 
elevated GH in patients with PEM has not been elucidated.
Finally, the difference between fasting levels of GH in 
patients with PEM in Cape Town (Table 43) and Johannesburg 
(Table 42) bears comment. The same assay technique was used but 
in different laboratories in each city, introducing the possibility 
of the difference being due to technical discrepancies, although 
the range of normal values adopted by the two laboratories is 
similar. The alternative explanation lies in the possible 
pleomorphic nature of the disease and the variable response of 
different populations (Gardner, L.I. and Amacher, P. 1973).
This question warrants further investigation in South Africa.
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CHAPTER 14
SUMMARY OF THE MAIN CONCLUSIONS
"To be conscious that you are 
ignorant of the facts is a 
great step to knowledge"
Benjamin Disraeli
The research described in this thesis explores some of the 
factors that regulate the velocity of growth in mammals. On 
theoretical grounds such regulatory relationships would be most 
fruitfully investigated by simultaneous longitudinal measurement 
of the regulating factors and the growth velocity of the animal. 
This theoretical ideal can rarely, if ever, be achieved for 
technical, cost-benefit and, in the case of man, ethical reasons. 
The results of the present research have added new knowledge to 
this field, but the experimental investigation of the regulatory 
inter-relationships of mammalian growth control is far from 
complete.
The measurement of changes in tissue responsiveness with age 
requires controlled in vitro experimentation. This implies, 
except possibly in the case of blood and skin, that tissue can 
only be acquired post-mortem on a cross-sectional basis, or by 
serial operative procedures that would seriously interfere with 
normal growth, on a longitudinal basis. Lack of tissue homogeneity 
is a further problem that would beset the sampling of tissue on a 
serial longitudinal basis. These difficulties also hamper attempts 
to collect longitudinal series of serum samples until well after
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birth, usually at an age when growth has slowed considerably.
The main obstacle that the work in this thesis did not 
overcome was the technical difficulty of sampling serum and 
cartilage from animals growing at their normal velocity. Therefore, 
while the growth study was of a longitudinal design, the 
physiological study of serum SM and cartilage responsiveness was 
of a cross-sectional nature. This shortcoming is common to all 
previous work of this nature. The limitations imposed on the 
interpretation of the results by this situation have been partly 
offset by using a highly inbred strain of rabbits and rearing 
them under strictly controlled uniform conditions. A further 
strength of the present studies, lacking in previous published 
work, is the attempt to relate cartilage responsiveness to the 
actual velocity of growth of the cartilage under study at the time. 
This novel approach yielded one of the most significant results of 
the thesis, namely the demonstration that the degree of in vitro 
responsiveness of costal cartilage does not depend on the stimulus 
to which it is exposed. That is to say, cartilage responsiveness 
appears to be determined by some "intrinsic growth capacity"
(Needham 1964) that is a function of the age of the animal and 
the growth velocity of the cartilage. The demonstration of a close 
correlation between the metabolic responsiveness and growth 
velocity of costal cartilage under several different experimental 
conditions suggests that the prime determinant of growth velocity 
is the growing tissue itself. It may then be asked, what is the 
role of serum and other micro-environmental stimuli in the 
regulation of normal growth? It is suggested that in this 
situation the role of serum stimuli such as somatomedin may be one 
of superimposing fine controls on the growth process. Such control 
may be envisaged as modulating the influences of external and 
internal environmental influences on growth.
Evidence is accumulating that this type of cell-mediated
control of growth does occur. Harris (1970) has elegantly shown 
that "the same sets of genes in the same cytoplasm may be switched
on at very different rates .... determined ....  by differences
in the physiological states of the nuclei which contain them."
The nature of the switching signals remains unknown, but the 
eventual elucidation of their mechanism of action and control will 
expand much of our understanding of the regulatory processes 
involved in growth.
It is submitted that although the results presented and 
discussed in this thesis may have advanced our knowledge of the 
control processes of mammalian growth, more new questions have 
undoubtedly been raised than answers provided. In the final 
paragraphs some areas for future research are suggested.
Single static measurements of a hormone yield very limited 
information. Techniques that will permit the estimation of 
secretory and turnover rates of SM are needed and will have to be 
applied to the longitudinal study of the role of SM in the control 
of growth in order to provide maximum understanding of this role. 
Such studies may indicate sex differences and a role for serum SM 
in the primate pubertal growth spurt.
To facilitate the investigation of the role of the end-organ 
in growth control other tissues need to be studied. Somatomedin- 
sensitive cells in the blood, skin or other readily accessible, 
reasonably homogeneous tissues should be sought and examined in 
a longitudinal manner. Such experimental situations would provide 
the opportunities to investigate the possibilities of sex 
differences in responsiveness and the contribution that other 
endocrine factors may make to their ontogenesis. These studies 
would also provide insights into the relationship of SM to other 
serum and tissue growth factors.
The studies on isolated chondrocyte have raised the
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fascinating possibility of the occurrence of SM inhibitors in 
normal serum. It is conceivable that a dynamic balance exists 
between stimulatory and inhibitory serum fractions throughout life. 
More sensitive and selective assay systems, such as the radioreceptor 
and radioimmunoassay, may separate these fractions and assist in 
the elucidation of their control systems, functions and inter­
relationships. Nevertheless, the bioassay will not lose its 
usefulness since it measures the true biological, or net, SM 
activity in serum, and it is this activity that most closely 
approximates the in vivo situation. The isolation and identification 
of SM inhibitory fractions from the sera of patients with PEM will 
provide further insight into the metabolic disorders of this 
disease.
APPENDIX A
Programme for data handling and spline-set interpolation 
FORTRAN IV
0001
0002
0003
0004
0005
0006
0007
0008
0009
0010 
0011 
0012
0013
0014
0015
REAL X(100),Y(100),C(4,100-
REAL XIN(69,20),YIN(69,20),XINTV(67),YINTV(69,67),YDASH(69,67) 
REAL HEADI(10),HEAD2(10)
REAL SI (67,2), S2( 67,2), VI (67,2), V2( 67,2), D1 (67,2), D2( 67,2) 
INTEGER ISEX(69)
READ(5,140)(XINTV(I),1=1,16)
140 FORMAT(16F4.C)
XINTV CONTAINS THE POINTS AT WHICH WE WISH TO INTERPOLATE
DO 15 1=17,69
J=I+33
15 XINTV(I)=J
DO 20 1=1,69 
DO 20 J=l,20 
XIN(I,J)=0 
20 YIN(I,J)=0
READ (5,130)NS,HEAD1
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0016 130 FORMAT(13,10A4)
0017 DO 30 1=1,69
0018 30 READ(5,150)(XIN(I,J),J=1,20)
0019 150 FORMAT(7X,20F3.0)
0020 READ(5,130)NS,HEAD2
0021 WRITE(6,300)HEAD2
0022 300 FORMAT ('1M0A4)
0023 DO 40 1=1,69
0024 READ(5,159)ISEX(I),(YIN(I,J),J=l,18)
0025 40 READ(5,160)(YIN(I,J),J=19,20)
0026 159 FORMAT(3X,11,3X,18F4.2)
0027 160 FORMAT(7X,18F4.2)
WE HAVE READ THE DATA
NOW ELIMINATE ALL ZERO ORDINATES
0028 DO 60 1=1,69
0029 KK=21
ASSUME 20 ELEMENTS 
SAMPLE SIZE=69
0030 DO 51 J=l,20
0031 KK=KK-1
0032 IF(YIN(I,KK).GE.O.O)GO TO 52
roCJo
0033 51 CONTINUE
0034 WRITE(6,900-
0035 900 FORMAT ('OERROR 1 - NULL RECORD')
0036 52 M=0
KK IS NO OF ELEMENTS IN ROW I
0037 DO 55 J=1,KK
0038 IF(YIN(I,J).EQ.O.O)GO TO 55 
SCAN FOR EMPTY SPACES
0039 M=M+1
0040 X(M)=XIN(I,J)
0041 Y(M)=YIN(I,J)
AND COMPRESS THE VECTOR TO WHAT WE ACTUALLY KNOW
0042 55 CONTINUE
0043 WRITE(6,260)1,M
0044 260 FORMAT('O',13,2X,13)
I=ROW NUMBER, M=NUMBER OF COORDINATES POINTS
0045 WRITE(6,265)(X(JJ),JJ=1,M )
0046 WRITE(6,265)(Y(JJ),JJ=1,M)
0047 265 FORMAT(8(2X,E13.7))
0048 IF(M.LT.4)G0 TO 111
WE CAN NOW INTERPOLATE FROM THIS DATA
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0049 CALL SPLC0N(X,Y,M,C)
0050 DO 57 J=l,69
0051 YINTV(I,J)=0
0052 YDASH(I,J)=1.E-7C
0053 XINT=XINTV(J)
0054 CALL SPLINE(X, Y , M, C , XINT,YINT,YD)
0055 YINTV(I,J)=YINT
0056 YDASH(I, J)=YD 
DISPLACEMENT AND VELOCITY
0057 57 CONTINUE
0058 GO TO 333
0059 111 CONTINUE
0060 DO 222 J=l,69
0061 YINTV(I,J)=-l
0062 222 YDASH(I,J)=-l
0063 333 WRITE(6,270)(YINTV(I,JJ),JJ=1,16)
0064 270 F0RMAT(16(1X,F7.1))
0065 60 CONTINUE
0066 WRITE(6,280)HEAD2
0067 280 FORMAT('1ALL INTERPOLATED DATA -
0068 WRITE (6,284)(XINTV(J),J=l,16)
0069 284 FORMAT( '0X=',16(F7.1,IX)/'0')
\10A4, 'DISPLACEMENT')
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0070 DO 70 1=1,69
0071 70 WRITE(6,286)1,(YINTV(I,J),J=1,16)
0072 286 FORMAT(' ',12,16(F7.3,IX))
0073 WRITE(6,287)HEAD2
0074 287 FORMAT('1ALL INTERPOLATED DATA',10A4,' VELOCITY*)
0075 WRITE(6,284)(XINTV(J),J=l,16)
0076 DO 72 1=1,69
0077 72 WRITE(6,286)1,(YDASH(I,J),J=1,16)
0078 DO 80 KS1=1,3
0079 KS2=KS1-1
0080 WRITE(6,288)HEAD2
0031 288 FORMAT(* 1',1CA4/'CN0',3X,'N*,8X,*X VALUE',6X,'Y VALUE', 
16X,'DEVIATION',5X,'Y VEL',7X,'DEVIATION')
0082 DO 80 J=l,69
0083 SM=0
0034 DF=0
0085 SD=0
0086 SMD=0
0087 DFD=0
0088 SDD=0
0039 DO 75 1=1,69
0090 IF(KS2.EQ.2) GO TO 601
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0091 IF(ISEX(I).NE.KS2)G0 TO 75
0092 601 CONTINUE
0093 IF(YINTV(I,J).EQ.O.O)GO TO 75 
ONLY SUM DISPLACEMENTS .GT. Zl
0094 DF=DF+1
0095 SM=SM+YINTV(I,J)
• ACCUMULATE THE TOTAL
0096 75 CONTINUE
0097 SM=SM/DF
0098 DO 76 1=1,69
0099 IF(KS2.EQ.2)G0 TO 602
0100 IF(ISEX(I).NE.KS2)G0 TO 76
0101 602 CONTINUE
0102 IF(YDASH(I,J).LE.O.O)GO TO 76 
ONLY SUM VELOCITIES .GT. ZERO
0103 DFD=DFD+1
0104 SMD=SMD+YDASH(I,J)
0105 76 CONTINUE
0106 SMD=SMD/DFD 
SAMPLE MEAN
0107 DO 77 1=1,69
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0108 IF(KS2.EQ.2)G0 TO 603
0109 IF(ISEX(I).NE.KS2)G0 TO 77
0110 603 CONTINUE
0111 XT=YINTV(I,J)
0112 IF(XT.EQ.0.0)G0 TO 77
0113 SD=SD+(XT-SM)*(XT-SM) 
SUM OF SQUARES
0114 77 CONTINUE
0115 SD=SD/(DF-1.)
0116 DO 78 1=1,69
0117 IF(KS2.EQ.2)G0 TO 604
0118 IF(ISEX(I).NE.KS2)G0 TO 78
0119 604 CONTINUE
0120 XT=YDASH(I,J)
0121 IF(XT.LE.0.0)G0 TO 78
0122 SDD=SDD+(XT-SMD)*(XT-SMD)
0123 78 CONTINUE
0124 SDD=SDD/(DFD-1.)
0125 IF(KS1.EQ.3)G0 TO 400
0126 SI(J,KS1)=SM
0127 S2(J,KS1)=SMD
hoCOOT
0128 D1(J,KS1)=DF
0129 D2(J,KS1)=DFD
0130 Vl(J,KS1)=SD
0131 V2(J,KS1)=SDD
0132 400 CONTINUE
0133 SD=SQRT(SD)
0134 SDD=SQRT(SDD) 
STANDARD DEVIATION
0135 WRITE(6,302)J,DF,XINTV(J),SM,SD,SMD,SDD
0136 302 FORMAT(' 1,I2,2X,F3.0,5(3X,F10.4))
0137 80 CONTINUE
0138 DO 420 J=l,2
0139 WRITE(6,300)HEAD2
0140 DO 420 1=1,67
0141 WRITE(6,480)S1(I,J),D1(I,J),V1(I,J)
0142 420 WRITE(6,482)S2(I,J),D2(I,J),V2(I,J)
0143 480 F0RMAT('0\3(2X,F9.3))
0144 482 FORMAT(' ',3(2X,F9.3)) 
NOW DO THE T-TESTS
0145 WRITE(6,300)HEAD2
0146 DO 450 1=1,67
0147 DBM1=S1(1,1)-SI(1,2)
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0148 
DBM2=S2(I,1)-S2(I,2)
0149 
WRITE(6,470)DBM1,DBM2
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SUBROUTINE 2:
0017
0018
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0020 
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0024
7
101
1-C(1,K)*(XINT-X(K+1))*(XINT-X(K+1))) 
RETURN 
WRITE(6,101)
FORMAT(' OUT OF RANGE FOR INTERPOLATION')
YINT=0
YD=-l.E-70
RETURN
DEBUG SUBCHK 
END
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